Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRP,Agouti-related protein,40058,0.21465202221544,0.00469165619269778,0.205456376077752,0.223847668353128,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN1,CCN family member 1,39758,0.302679775364095,0.00671614211055584,0.289516136827406,0.315843413900785,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.144201075288065,0.00275795904086835,0.138795475567963,0.149606675008167,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.087586339798638,0.00189969043303257,0.0838629465498942,0.0913097330473819,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLR,Low-density lipoprotein receptor,39882,0.359050749207663,0.00399763628785252,0.351215382083472,0.366886116331854,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPY,Pro-neuropeptide Y,40030,0.286036451576829,0.00575699911830847,0.274752733304944,0.297320169848713,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.193459156162853,0.00239517683770958,0.188764609560942,0.198153702764764,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROC,Vitamin K-dependent protein C,39908,0.102442633120058,0.00226347778307242,0.0980062166652359,0.10687904957488,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI,Tissue factor pathway inhibitor,39843,0.136995443037626,0.00272500347192533,0.131654436232652,0.142336449842599,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F7,Coagulation factor VII,39899,0.100653976589313,0.00267636178440966,0.0954083074918702,0.105899645686756,1.01615383257082e-296
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.142410783355038,0.00380467915747625,0.134953612206385,0.149867954503692,4.49486091506287e-294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APCS,Serum amyloid P-component,37333,0.115352659599036,0.00310128656375966,0.109274137934067,0.121431181264005,2.38771311907587e-288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.195012282755887,0.00528702694712289,-0.205374855572248,-0.184649709939526,7.79486624089522e-286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFGE8,Lactadherin,39858,0.144465537948744,0.00391915634737995,0.13678399150788,0.152147084389609,1.45899205250893e-285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL27,C-C motif chemokine 27,39868,0.203690353710244,0.00559970985106271,0.192714922402161,0.214665785018327,1.98223822208238e-278
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOM,Apolipoprotein M,39908,0.0866758603694872,0.00238778846623672,0.0819957949756632,0.0913559257633112,2.35806762522046e-277
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.104622569775411,0.00293660854238419,0.0988668170323382,0.110378322518484,1.06582700419261e-267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,39949,0.144521450430002,0.0042531442434917,0.136185287712759,0.152857613147246,1.76994311818023e-244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0585059151478833,0.00173891701705343,0.0550976377944585,0.061914192501308,8.1781047284798e-240
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.228426111282804,0.00690272249912378,0.214896775184522,0.241955447381087,5.46369228901233e-231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAMR1,Inactive serine protease PAMR1,39858,0.081613543179466,0.00250320098255053,0.076707269253667,0.0865198171052651,8.31692802702433e-226
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCHE,Cholinesterase,37208,0.0806571322098484,0.00248146031278206,0.0757934699967956,0.0855207944229012,4.13284492483713e-223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFP,Properdin,37453,0.0662167667823592,0.00208872080498221,0.062122874004594,0.0703106595601243,7.40255473618165e-213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTR,Transthyretin,37309,0.071686507639309,0.00227277816893003,0.0672318624282062,0.0761411528504119,1.01015800138962e-210
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHR,Growth hormone receptor,37124,0.08066562006998,0.00259921657887639,0.0755711555753823,0.0857600845645777,3.35047545917706e-204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROS1,Vitamin K-dependent protein S,37453,0.0679154056481473,0.00221519435937394,0.0635736247037744,0.0722571865925202,1.16394325573285e-199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.070655618345952,0.00235843351021896,0.0660330886659229,0.0752781480259812,5.62021673327381e-192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL23,C-C motif chemokine 23,39931,0.111493486291946,0.00373600504628504,0.104170916401228,0.118816056182665,1.6400310195593e-190
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37224,0.0365628843308766,0.00122185813256841,0.0341680423910425,0.0389577262707107,1.7103596121963e-190
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOC1,Apolipoprotein C-I,37424,0.101232779633332,0.0033919219599456,0.0945846125918382,0.107880946674825,1.27263806148695e-189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH,Parathyroid hormone,37039,0.214639560381917,0.00722633258141745,0.200475948522339,0.228803172241495,1.01813669723277e-187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.30314863218829,0.010295794130189,0.282968875693119,0.32332838868346,1.30769887647273e-185
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0980222406090918,0.0033234421235338,0.0915082940469656,0.104536187171218,2.35662586021984e-185
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFH,Complement factor H,36763,0.0611441082190104,0.00213283402256585,0.0569637535347813,0.0653244629032394,2.79987786383962e-175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA4,Kallistatin,37241,0.0605985967865552,0.00212298297882285,0.0564375501480624,0.064759643425048,5.15393581576998e-174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FURIN,Furin,39913,0.087407613053503,0.00308541944425279,0.0813601909427676,0.0934550351642385,2.54266458590664e-172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,P4HB,Protein disulfide-isomerase,39776,0.0989148390496534,0.00354675448441364,0.0919632002602027,0.105866477839104,3.70765925773981e-167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCS1,Neuronal calcium sensor 1,40030,0.0713707585530477,0.00256232356791281,0.0663486043599386,0.0763929127461568,8.16224328174682e-167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.207845392285711,0.00752623669810424,0.193093968357426,0.222596816213995,6.02517599464082e-164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLKB1,Plasma kallikrein,37187,0.0629101568841511,0.00227412883899542,0.05845286435972,0.0673674494085821,7.8074398507771e-164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0693250286098572,0.00252376617184759,0.0643784469130359,0.0742716103066785,2.27174863879884e-162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRN,"Attractin, Isoform 2",37453,0.0404961460696965,0.00148289778548784,0.0375896664101403,0.0434026257292526,6.6231426472951e-160
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD4,T-cell surface glycoprotein CD4,39839,0.0715252748025724,0.00263096877926006,0.0663685759952227,0.0766819736099221,3.88974391429613e-159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBC,Inhibin beta C chain,39858,0.102222153824014,0.00378146822123741,0.0948104761103884,0.109633831537639,2.07039419982293e-157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37283,0.0784862288701225,0.00289752336376565,0.0728070830771418,0.0841653746631031,2.26961346944319e-157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOST,Sclerostin,39846,0.0940010834787108,0.00348857209484547,0.0871634821728137,0.100838684784608,1.97183717688418e-156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0472201224829789,0.00176033504237861,0.0437698657999168,0.050670379166041,5.58021962381054e-155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFI,Complement factor I,37453,0.0488019079752105,0.00181937379565297,0.0452359353357307,0.0523678806146903,1.74396434949205e-154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL6,C-X-C motif chemokine 6,40058,0.186054602249586,0.00700813187653151,0.172318663771584,0.199790540727587,4.7176058848236e-152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A5,Zinc transporter ZIP5,39866,0.127518650738808,0.00482279616116015,0.118065970262934,0.136971331214682,7.92566980901231e-151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN3,Contactin-3,39858,0.0788306238683427,0.00298162392651734,0.0729866409723687,0.0846746067643167,8.36647137979907e-151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F10,Coagulation factor X,37445,0.0639728812144562,0.00241525546025932,0.059238980512348,0.0687067819165645,8.9198834787664e-151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.209248243432253,0.00794115909293409,0.193683571610103,0.224812915254404,8.22300490568961e-150
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPL,Lipoprotein lipase,39868,-0.113506612863972,0.00431478340808741,-0.121963588343823,-0.105049637384121,2.37523530502952e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0602101787085847,0.00229204647651871,0.0557177676146081,0.0647025898025614,5.96433043435831e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPIND1,Heparin cofactor 2,37424,0.0673990182442879,0.00256993139934992,0.062361952701562,0.0724360837870137,6.34137891372413e-148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB2,Carboxypeptidase B2,37424,0.0536969996180013,0.00206025158340366,0.0496589065145301,0.0577350927214724,3.65802924451056e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYAP1,Synapse-associated protein 1,37124,0.135210022169894,0.00524992188642676,0.124920175272497,0.14549986906729,8.95877211737697e-143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCA,Alpha-synuclein,37124,0.27247567998307,0.0105929202889056,0.251713556216815,0.293237803749325,1.97700614110364e-142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAT,Tissue-type plasminogen activator,40002,0.116304225061092,0.00453643045319086,0.107412821372838,0.125195628749346,3.98091634980353e-142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FN1,Fibronectin,37453,0.0623847740604404,0.00243220241386063,0.0576176573292735,0.0671518907916072,9.80683235729284e-142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.248716159357155,0.00975700641335594,0.229592426786977,0.267839891927332,1.60346528822447e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,39913,0.0594282083453237,0.00233668430710902,0.05484830710339,0.0640081095872574,6.37686526238099e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0908001170970216,0.00357167313714764,-0.0978005964458309,-0.0837996377482122,8.37336723165822e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP6,Charged multivesicular body protein 6,37437,0.129495560620394,0.00517501093732532,0.119352539183236,0.139638582057551,3.84952031576723e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.192898492072851,0.00774276785323272,0.177722667080514,0.208074317065187,2.12307173385545e-134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.328194626494355,0.0132733517314149,0.302178857100782,0.354210395887928,1.88573851326463e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.179707314098609,0.00728385400337824,0.165430960251988,0.193983667945231,6.32451633125932e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.149907776637388,0.00610046820719,0.137950858951296,0.16186469432348,6.62202364179111e-131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0460386098578241,0.00188097827241854,0.0423518924438838,0.0497253272717645,6.62201415829248e-130
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0577931948106871,0.00237207378482923,0.0531439301924218,0.0624424594289524,2.76858516073556e-128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES1,Liver carboxylesterase 1,39854,0.175608390110192,0.00730010534482066,0.161300183634343,0.18991659658604,1.23169441565209e-125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP1,Neuropilin-1,39949,-0.0605799808664518,0.00253951743470805,-0.0655574350384796,-0.055602526694424,1.25037233417368e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL22,C-C motif chemokine 22,39686,0.110009412661096,0.00461713551059925,0.100959827060321,0.11905899826187,2.61827851327864e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0738807215190641,0.00310806004841447,0.0677889238241717,0.0799725192139564,8.50394668799716e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39477,0.239672168810891,0.0100929119086647,0.219890061469908,0.259454276151874,1.74899044588323e-122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0457531885076379,0.00194356267356265,0.0419438056674551,0.0495625713478207,1.65581708313314e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYNU,Kynureninase,40058,0.0981258309960139,0.00416956332445059,0.0899534868800907,0.106298175111937,1.91402228073152e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFM,Afamin,37453,0.0409936594770888,0.00173917698277353,0.0375848725908527,0.0444024463633249,1.97388899834529e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0845440034595218,0.00359716922355359,0.0774935517813568,0.0915944551376869,3.87734870754035e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORT1,Sortilin,39846,0.0798982864400762,0.00341907264776761,0.0731969040504517,0.0865996688297007,8.70713225803984e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPM,Carboxypeptidase M,39955,0.0736717966278965,0.00316254012908883,0.0674732179748824,0.0798703752809106,4.42804666811005e-118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN2,Ficolin-2,39810,0.0860753557613128,0.00371867586830632,0.0787867510594324,0.0933639604631932,1.29853788383473e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR5,Cadherin-related family member 5,39868,0.0822913907064687,0.00355728651293774,0.0753191091411107,0.0892636722718267,1.73378022869704e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRP,Gastrin-releasing peptide,37043,0.110348074999201,0.00476573459236287,0.10100723519817,0.119688914800232,2.69816874691968e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F9,Coagulation factor IX,39908,0.0385336863501434,0.00166849915086935,0.0352634280144394,0.0418039446858473,4.05341022274792e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG2,Desmoglein-2,39858,-0.0560094005275469,0.00244954126413804,-0.0608105014052575,-0.0512082996498364,6.84839673863202e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.295906486703981,0.0129336987456196,0.270556437162567,0.321256536245396,1.07653466176193e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0452186313944331,0.0019827734902864,0.0413323953534718,0.0491048674353945,5.89778650496069e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINC1,Antithrombin-III,37424,0.0304307226210143,0.00133619414661966,0.0278117820936397,0.0330496631483888,1.06042394939484e-112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR37,Prosaposin receptor GPR37,39585,0.134194524191332,0.00590992307550148,0.122611074963349,0.145777973419315,2.44867739329947e-112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA1,Glutathione S-transferase A1,39841,0.175889636198624,0.0077929514833442,0.16061545129127,0.191163821105979,4.58734258790948e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F13B,Coagulation factor XIII B chain,37380,0.0525859039766758,0.00234162472878556,0.0479963195082561,0.0571754884450955,1.09538373429115e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAB2,Stabilin-2,37437,0.0576364892420592,0.00257062158826584,0.0525980709290582,0.0626749075550603,2.33525406247385e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIP2,Cysteine-rich protein 2,39749,0.0738325807930233,0.00329831093063934,0.0673678913689702,0.0802972702170764,2.68387027388657e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,39868,0.061910241809729,0.00277194668625658,0.0564772263046661,0.0673432573147918,7.79779595034524e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37411,0.118834874878858,0.00532461281510771,0.108398633761247,0.129271115996469,2.19183783013294e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA3,Glutathione S-transferase A3,39477,0.155902429793153,0.0070221996524599,0.142138918474331,0.169665941111974,1.52666299701488e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.141395650476113,0.00636575871639335,0.128918763391982,0.153872537560244,2.18113970934861e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37056,0.175078758191254,0.00790533320614772,0.159584305107204,0.190573211275304,9.72035213261271e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR2,Cadherin-related family member 2,39788,0.147666085179511,0.00671510311620332,0.134504483071752,0.160827687287269,1.32616329690889e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL17,C-C motif chemokine 17,39836,0.182315316128158,0.00829140348157592,0.166064165304269,0.198566466952046,1.35982012468951e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR3,Anterior gradient protein 3,39464,0.118898896940645,0.00541900436051698,0.108277648394032,0.129520145487258,4.06737315675214e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37039,0.241618369586049,0.0111042951913623,0.219853951010979,0.263382788161119,3.67640925661439e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL17,C-X-C motif chemokine 17,40058,0.0851713186544982,0.00394603034789258,0.0774370991726288,0.0929055381363677,6.88401480831012e-102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUMB,Protein numb homolog,37056,0.168079568523372,0.00777511929788314,0.152840334699521,0.183318802347223,7.10756392790579e-102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.147021307047223,0.00681485302401517,0.133664195120153,0.160378418974292,9.12045753266051e-102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLN,Promotilin,39866,0.176279419497827,0.00818534175698176,0.160236149654143,0.192322689341511,1.96327502847068e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0573123208562684,0.00266342059792952,0.0520920164843265,0.0625326252282102,2.7400220286717e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2,Prothrombin,37453,0.0290028717375177,0.00135037191081812,0.0263561427923142,0.0316496006827212,1.17566470744387e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTBDN,Retbindin,39788,0.057930421663995,0.00270073570170483,0.0526369796886535,0.0632238636393364,1.21000780012166e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCG,Pro-glucagon,39477,0.241950479722737,0.0112806090008736,0.219840486081025,0.26406047336445,1.33136141230498e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5E,5'-nucleotidase,39913,0.108975976504954,0.00508997725744779,0.0989996210803562,0.118952331929551,2.71769237151607e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBP,Protein AMBP,40003,0.0380460511791664,0.00177727155815167,0.0345625989251891,0.0415295034331436,2.83756047118098e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT2,Linker for activation of T-cells family member 2,39788,0.24547191201801,0.0114691323822603,0.22299241254878,0.267951411487241,3.22944142188895e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.102886425143913,0.00480983942897153,0.093459139863129,0.112313710424697,3.97138320752742e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0567192641177719,0.00265289849403302,0.0515195830694672,0.0619189451660766,4.91803422527302e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0574306950765699,0.00268743975183146,0.0521633131629802,0.0626980769901595,1.10452704439386e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAP1,Proline-rich acidic protein 1,37437,0.0788946417523097,0.00370081503546363,0.071641044282801,0.0861482392218185,3.23078089129481e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.132378201025017,0.00621643662525625,0.120193985239515,0.14456241681052,3.24642532785204e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELN,Elastin,37437,0.0654900349066306,0.00308406814796092,0.0594452613366272,0.0715348084766341,1.79967595424301e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO3,Beta-enolase,37043,0.117540680005702,0.00554018360275188,0.106681920144308,0.128399439867095,2.95768308464921e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,39877,0.0767272913517913,0.00362216112152869,0.0696278555535951,0.0838267271499876,3.05519204830428e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37254,0.0497958958417656,0.00235415018542947,0.0451817614783238,0.0544100302052073,1.03148367199603e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP5,Retinol-binding protein 5,39788,0.108616461574721,0.00515817039476067,0.0985064476009896,0.118726475548451,4.12391553319879e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0574597116795896,0.00272577286110938,0.0521171968718153,0.062802226487364,4.37927449454544e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0582669661715909,0.00277508534653588,0.0528277988923805,0.0637061334508012,1.43197586031541e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTD,Biotinidase,37453,0.0394308646226033,0.00188947583465085,0.0357274919866877,0.043134237258519,3.18863938124847e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.119214875951658,0.00572025769868662,-0.130426581041084,-0.108003170862232,3.29537726754484e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.153363039531329,0.00735498651660419,0.138947265958784,0.167778813103873,4.6053459539151e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YTHDF3,YTH domain-containing family protein 3,39587,0.16311141676191,0.00785099977473027,0.147723457203439,0.178499376320381,1.32924342998428e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS15,Enteropeptidase,39788,0.170229346270776,0.00821542426824733,0.154127114705011,0.18633157783654,3.9183930853755e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADIPOQ,Adiponectin,37453,-0.125965755786803,0.00608501881616072,-0.137892392666478,-0.114039118907128,9.42475611819028e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,39892,0.0667859176504068,0.00324378128468616,0.0604281063324219,0.0731437289683916,5.48847033374707e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTYMK,Thymidylate kinase,37437,0.129616641495583,0.0063105449113145,0.117247973469406,0.141985309521759,2.39665622373741e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37124,0.142591546646298,0.00697806194485353,0.128914545234385,0.156268548058211,2.10576550122307e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP29,Synaptosomal-associated protein 29,39913,0.170870884303025,0.00841522920708931,0.154377035057129,0.18736473354892,1.58936954191699e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EEF1D,Elongation factor 1-delta,37437,0.170542947134227,0.00839097306097975,0.154096639934707,0.186989254333748,1.72160643721157e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YES1,Tyrosine-protein kinase Yes,39788,0.213383513704991,0.0105173333756745,0.192769540288668,0.233997487121313,2.23681443571082e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0632030973386158,0.00312962247738662,-0.0693371573942936,-0.0570690372829381,1.36789034247251e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP4,Dipeptidyl peptidase 4,39575,0.0555611666751279,0.00276077298848857,0.0501500516176903,0.0609722817325655,5.84739395662541e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,39913,0.0399905462197524,0.00198826926323111,0.0360935384638194,0.0438875539756854,7.01609532446277e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0763526149343071,0.00379930236581047,0.0689059822973185,0.0837992475712956,1.54448362568985e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0416168500871845,0.00208418084983944,0.0375318556214992,0.0457018445528698,1.26977991375222e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHBP1,EH domain-binding protein 1,37437,0.137931002597211,0.00690545082872592,0.124396318972908,0.151465686221514,1.65980442583582e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0720642600642343,0.00361262842576166,0.0649835083497414,0.0791450117787271,1.82494252323308e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THPO,Thrombopoietin,39585,0.0701255906126714,0.00351603119555072,0.063234169469392,0.0770170117559509,2.00967374262172e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C4BPB,C4b-binding protein beta chain,39913,0.0727525696768271,0.00365739986102972,0.0655840659492088,0.0799210734044453,5.33295903031652e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.108430747986823,0.00545317535817873,0.097742524284793,0.119118971688854,6.64639807779951e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0567723981295481,0.00286062002419788,0.0511655828821203,0.062379213376976,1.28993586510503e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0476198232525061,0.00239949009096967,0.0429168226742056,0.0523228238308067,1.33635043871853e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFR,Epidermal growth factor receptor,40052,0.0292839066018599,0.00147826766786461,0.0263865019728453,0.0321813112308745,2.58402151364589e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,39788,0.124927972228483,0.00631144825995373,0.112557533638974,0.137298410817992,3.64266511735959e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC5,Glypican-5,39749,0.101736793913192,0.00515552521401817,0.0916319644937165,0.111841623332668,1.17636059693566e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC4,Syndecan-4,39868,0.0823580819945063,0.00418013635752702,0.0741650147337533,0.0905511492552592,2.11532043142701e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEG1,Protein HEG homolog 1,37124,0.0491065029153173,0.00249847272296303,0.0442094963783098,0.0540035094523248,8.4556071829171e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0589106582580808,0.00300157763881398,0.0530275660860054,0.0647937504301562,9.14595967431038e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL5,C-X-C motif chemokine 5,39805,0.205897297845323,0.0104953765103488,0.185326359885039,0.226468235805607,1.08196800155477e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH9,Myosin-9,37437,0.201208657724525,0.0102594294867275,0.181100175930539,0.221317139518511,1.79262302739615e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPB1,Beta-ureidopropionase,37437,0.165946511877254,0.00847298372705217,0.149339463772232,0.182553559982276,2.98596666099546e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.0895532641710243,0.00458315586426198,0.0805702786770708,0.0985362496649778,4.8350444769014e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11,Coagulation factor XI,37249,0.0562561820094781,0.00288433724886709,0.0506028810016986,0.0619094830172576,1.45931375512941e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF9,Protein turtle homolog A,37437,0.147883468090782,0.00758832656511562,0.133010348023155,0.162756588158408,1.8983780231138e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FYB1,FYN-binding protein 1,39836,0.164048567043561,0.0084604592865933,0.147466066841838,0.180631067245284,8.36651207317238e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0592265295401298,0.00305799947254501,0.0532328505739416,0.065220208506318,1.26337338900604e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAB2,Disabled homolog 2,40030,0.198678916766489,0.0102883465533532,0.178513757521917,0.218844076011062,3.64450913241692e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SARG,Specifically androgen-regulated gene protein,37390,0.194554766826367,0.0100868357557674,0.174784568745063,0.214324964907671,8.46342374561712e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUSB,Beta-glucuronidase,39919,0.104249926320834,0.00541089472985987,0.0936445726503082,0.114855279991359,8.55791346952924e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.12862497805023,0.00668056017536325,0.115531080106518,0.141718875993942,1.0856387981041e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJAP1,Tight junction-associated protein 1,39913,0.147278814234628,0.0076651094241923,0.132255199763211,0.162302428706045,2.30441594267085e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK1,Dickkopf-related protein 1,40009,0.105394398583119,0.00550677863890947,0.0946011124508566,0.116187684715382,9.35048991699626e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPD52L2,Tumor protein D54,37124,0.192774480277744,0.0100719938653152,0.173033372301726,0.212515588253762,1.43425548890144e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP20,Centrosomal protein 20,39477,0.13006667539166,0.00681306896165484,0.116713060226816,0.143420290556503,2.47404709976038e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY1,Aminoacylase-1,39868,0.10814114497453,0.00568983809889171,0.096989062300702,0.119293227648358,1.14505825370079e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.156114438331338,0.0082634212354979,0.139918132709762,0.172310743952914,9.66267258001771e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEP,Leptin,39868,0.11801114802537,0.00624875640671228,0.105763585468214,0.130258710582526,1.07406716077328e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.187338735740631,0.0099201887761096,0.167895165739456,0.206782305741806,1.54556862262348e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCXR,L-xylulose reductase,39913,0.0937093854102242,0.00497501187991882,0.0839583621255834,0.103460408694865,2.67105396249365e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.111773938943006,0.00594702649965656,0.100117767003679,0.123430110882333,8.05454559810229e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39489,0.137773978136861,0.00734210902189065,0.123383444453955,0.152164511819767,1.0437072693711e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORD,Sorbitol dehydrogenase,39963,0.118451783523504,0.00632232694251042,0.106060022716184,0.130843544330825,1.69445066925492e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0755286408946689,0.00403305752033199,0.0676238481548182,0.0834334336345196,2.00661685474432e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL16,Pro-interleukin-16,40058,0.0711284271819676,0.00379957790374751,0.0636812544906225,0.0785755998733127,2.22383845821756e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPC,C-type natriuretic peptide,39866,0.0788639574249629,0.0042140488701517,0.0706044216394656,0.0871234932104603,2.51798877159255e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE4,Ribonuclease 4,37051,0.0448756735563707,0.00239624507368617,0.0401790332119458,0.0495723139007956,2.95841218643301e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN1,Perilipin-1,39489,0.0596511671320341,0.0031928797815176,0.0533931227602596,0.0659092115038086,4.73527854851465e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0675674902551366,0.00362067206203551,-0.0746640074967262,-0.060470973013547,6.6555940308046e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.105723021516317,0.00567713579262366,0.0945958353627745,0.116850207669859,1.35713819293809e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0342103822179532,0.0018372491636131,0.0306093738572715,0.0378113905786349,1.41998044402448e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINK1,Misshapen-like kinase 1,37388,0.159879988753225,0.00858523093500981,0.143052936120606,0.176707041385844,1.89535659377979e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,39866,0.0745194734615837,0.0040060220626512,0.0666676702187874,0.0823712767043801,1.9822337170698e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.168053137297227,0.00902558563259997,0.150362989457331,0.185743285137123,1.99588437747799e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.159078173044362,0.00855271281759543,-0.175841490166849,-0.142314855921875,2.06038351229173e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH1,Somatotropin,39846,-0.308267350687386,0.0166508209314299,-0.340902959712988,-0.275631741661783,9.91233592492628e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL16,C-C motif chemokine 16,40052,0.0890592530137093,0.0048128789661301,0.0796260102400943,0.0984924957873243,1.14688445491878e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1S,Complement C1s subcomponent,37453,0.035794639573973,0.001933291560504,0.0320053881153852,0.0395838910325608,1.32905838766263e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS1,Protein MTSS 1,37382,0.188370963539905,0.010198225800126,0.168382440971658,0.208359486108152,2.97393642598712e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP10,Stromelysin-2,39857,-0.0999221460188716,0.00541947564826082,-0.110544318289463,-0.0892999737482804,3.93329584766235e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0440637967673089,0.0023951808312932,0.0393692423379742,0.0487583511966436,1.13160612581581e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZN,Kazrin,37382,0.176715008661236,0.00962356392567044,0.157852823366922,0.19557719395555,2.09004826554234e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD63,CD63 antigen,39720,0.0870478170073765,0.00475334049700828,0.0777312696332402,0.0963643643815127,3.78506549126817e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNA4,Plexin-A4,39866,0.137131900990457,0.00749165591556322,0.122448255395953,0.151815546584961,4.33011083343551e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPOCK1,Testican-1,39749,0.042911282238931,0.00234419993513454,0.0383166503660673,0.0475059141117947,4.33176053994165e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.165630586111445,0.00905164932475785,0.14788935343492,0.18337181878797,4.84341175886984e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,39749,0.0490876508556347,0.00268666004027855,0.0438217971766888,0.0543535045345807,8.03854261180539e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0451784733690389,0.00247338140343245,0.0403306458183113,0.0500263009197665,8.74178395305301e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFC,Vascular endothelial growth factor C,39913,0.0937748806688362,0.00513455413007747,0.0837111545738843,0.103838606763788,9.01959013425558e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.183301080982929,0.0100309244576565,0.163640469045922,0.202961692919935,1.03233301773321e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.190791974850539,0.0104542065727061,0.170301729968035,0.211282219733043,1.61910318513456e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.141855531343998,0.00780462412599667,0.126558468057044,0.157152594630951,5.92396975805458e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.178087273172533,0.00980956212228975,0.158860531412845,0.197314014932221,6.37714542837493e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.137518661420392,0.00757921572958347,0.122663398590409,0.152373924250376,1.04026419819767e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,39931,0.211128161982658,0.0116670846958097,0.188260675978871,0.233995647986445,1.79313745485495e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11R,Junctional adhesion molecule A,39858,0.0945102034786353,0.00522446095497477,0.0842702600068848,0.104750146950386,2.01383540932948e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL3,C-X-C motif chemokine 3,39859,0.158237444941993,0.00875146281748183,0.141084577819729,0.175390312064257,2.34988488142767e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37382,0.161212694183485,0.00891133430367506,0.143746478948282,0.178678909418689,2.67826142629081e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0751032840211059,0.00415193959135545,-0.0832410856201625,-0.0669654824220492,2.76461462643671e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37411,0.191279461000992,0.0105885834663084,0.170525837407028,0.212033084594957,4.23093422581044e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF2,Growth/differentiation factor 2,39868,0.0587282794131147,0.00325756652345833,0.0523434490271364,0.065113109799093,6.01300850155952e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRN,Agrin,39931,0.0543210264839741,0.00301324232914539,0.0484150715188492,0.0602269814490991,6.06394557582667e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.141117158483112,0.00782504365859873,0.125780072912258,0.156454244053965,7.67008813318639e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.136795354671415,0.00760384941796591,0.121891809812202,0.151698899530628,1.16182703698954e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFC,Platelet-derived growth factor C,39477,0.0484442431046045,0.00269313332082605,0.0431657017957855,0.0537227844134236,1.27544044037077e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCLY,Selenocysteine lyase,39984,0.0814066620376301,0.00454385448103236,0.0725007072548066,0.0903126168204535,4.33996575001686e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXIN1,Axin-1,39866,0.157784795649183,0.00880840008335575,0.140520331485806,0.17504925981256,4.61077351673442e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0373094244356941,0.00208641066629159,0.0332200595297625,0.0413987893416256,7.91931359489572e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0440494207593099,0.00246508645981951,0.0392178512980637,0.0488809902205562,9.92367324488529e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40009,0.158914904482872,0.00889523652954054,0.141480240884973,0.176349568080772,1.05478198954186e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MME,Neprilysin,39788,0.130035249511583,0.0072787869185165,0.115768827151291,0.144301671871876,1.08158112101411e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHBG,Sex hormone-binding globulin,37445,-0.0850396710104483,0.00476094753553703,-0.0943711281801008,-0.0757082138407957,1.4937204487302e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.139488047420725,0.00781367602943139,0.12417324240304,0.154802852438411,1.79192197456773e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA5,Integrin alpha-5,39858,0.0407824878030112,0.00229046951328767,0.0362931675569673,0.045271808049055,3.05942063090649e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.110580982529814,0.00621036346644285,0.0984086701355856,0.122753294924042,3.14422293342818e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0457049308699715,0.00256760040225117,0.0406724340815592,0.0507374276583838,3.31676515104742e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELP,P-selectin,39931,0.0943164151789565,0.00530035860542193,0.0839277123123296,0.104705118045584,3.68021340670915e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.0847277306869298,0.00476102699758808,0.0753961177716571,0.0940593436022024,3.72641733992253e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL5,C-C motif chemokine 5,39931,0.165827201576249,0.00932768525661154,0.14754493847329,0.184109464679207,4.90234134564467e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37424,0.0309080609244963,0.00173892643678986,0.0274997651083882,0.0343163567406044,6.92965830014737e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.135678387345551,0.00763983058565683,0.120704319397664,0.150652455293439,9.34974854705664e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMIP,C-Maf-inducing protein,37368,0.136043863523064,0.0076632200104152,0.12102395230265,0.151063774743478,1.01316121623167e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.117982729028897,0.00665490464351136,0.104939115927614,0.131026342130179,1.18345943799906e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXLNA,Alpha-taxilin,39749,0.145950060621258,0.00824309239382732,0.129793599529356,0.162106521713159,1.75931215711941e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRL,Appetite-regulating hormone,39868,0.125346933544656,0.00708540744295014,0.111459534956473,0.139234332132838,2.25428050765792e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLA,Alpha-galactosidase A,37088,0.0617869860894253,0.00349268808739512,0.0549413174381309,0.0686326547407197,3.11279419454422e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB3,Plexin-B3,39812,0.0777299523540036,0.00440021065197707,0.0691055394761285,0.0863543652318786,3.54995116142034e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPY30,Protein dpy-30 homolog,39979,0.0963814686286978,0.00547557515806861,0.0856493413188833,0.107113595938512,1.04276212365258e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18R1,Interleukin-18 receptor 1,40058,0.0528894045940867,0.00300669796004888,0.046996276592391,0.0587825325957825,1.26454249662408e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS2,Protein MTSS 2,37368,0.162215555887829,0.00921507648621036,0.144154005974857,0.180277105800801,1.35358178563696e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37445,0.0433354994795871,0.00246265881835099,0.0385086881956192,0.0481623107635551,1.4927988226823e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37411,0.104360009855785,0.00593172105997517,0.0927338365782337,0.115986183133336,1.59236950720754e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHK,Ketohexokinase,37043,0.105064591490884,0.0059720226129892,0.0933594271694252,0.116769755812343,1.69263420057806e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37382,0.13920449934084,0.00795414745480791,0.123614370329417,0.154794628352264,7.87792834406158e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUOM,Fucose mutarotase,37124,0.102724011714093,0.00587071256851586,0.0912174150798021,0.114230608348384,8.5958253427278e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOMO1,Nodal modulator 1,39858,0.0382984252181932,0.00219228952759459,0.0340015377441078,0.0425953126922786,1.03755468117933e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES2,Cocaine esterase,39788,0.0874632656434499,0.00501085425675913,0.077641991300202,0.0972845399866978,1.34750044880369e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS1,Galectin-1,39868,0.0540112235243882,0.00309664312609826,0.0479418029972356,0.0600806440515408,1.66977744128942e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.116989186621571,0.00670796962642626,0.103841566153775,0.130136807089366,2.32141116706074e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99L2,CD99 antigen-like protein 2,39858,0.0387466870585806,0.00222656170110859,0.0343826261244078,0.0431107479927534,3.30982039631672e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0450895896180815,0.00259126940741878,0.0400107015795407,0.0501684776566223,3.39174217862385e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AAMDC,Mth938 domain-containing protein,37043,0.0859149219168952,0.00493296015332916,0.0762463200163701,0.0955835238174204,3.48807490828863e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.084250428333062,0.00483856437561084,0.0747668421568647,0.0937340145092592,3.59864138760923e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.0877991172722931,0.00504865509798785,0.0779037532802369,0.0976944812643493,4.12502576270649e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39489,0.0818805462990529,0.00471516527933225,0.0726388223515617,0.0911222702465441,6.40745996009749e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.165139217528411,0.00950760475627256,0.146504312206117,0.183774122850705,7.82072798910466e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX2,Heme oxygenase 2,39489,0.0754908616418727,0.00436754216169959,0.0669304790049415,0.0840512442788039,2.54372232028501e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKB,Creatine kinase B-type,37437,-0.0928846766085183,0.0053730631572323,-0.103415880396694,-0.082353472820343,3.00788640167514e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK10,Kallikrein-10,39856,0.0629287945872398,0.00364449757783435,0.0557855793346844,0.0700720098397951,3.33018234807516e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD6,T-cell differentiation antigen CD6,40040,0.0836230450114005,0.00484541632110258,0.0741260290220394,0.0931200610007616,3.79660617414456e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.0852048170860982,0.00494077082596002,0.0755209062672166,0.0948887279049798,4.84730023437029e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL13,C-X-C motif chemokine 13,40009,0.0936370460943748,0.00543666139921993,0.0829811897519037,0.104292902436846,6.88754169478045e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0388017721710089,0.00225285378792213,0.0343861787466815,0.0432173655953362,6.96040282298371e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.155574660357348,0.00903911173725515,0.137858001352327,0.173291319362368,8.59809291905739e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARF6,ADP-ribosylation factor 6,37382,0.169463565810571,0.00984226938512688,0.150172717815723,0.18875441380542,9.76899301438484e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0639403097079441,0.00371471195535883,0.0566594742754407,0.0712211451404474,1.06687697509831e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.11813614956619,0.00688014657470517,0.104651062279768,0.131621236852612,2.26244475688783e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPL,N-acetylneuraminate lyase,37437,0.0696252223991078,0.00406231089552401,0.0616630930438808,0.0775873517543349,3.65656914229328e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN2,CCN family member 2,39880,0.0923885366252274,0.00540658443934415,0.0817916311241128,0.102985442126342,6.83246938319655e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCR,Breakpoint cluster region protein,39866,0.144970938276286,0.00849214647340666,0.128326331188409,0.161615545364163,9.10234188967672e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.143201751066922,0.00841459766115642,0.126709139651055,0.159694362482788,2.80407567456251e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON2,Spondin-2,39775,-0.0526262751885435,0.00309832886925215,-0.0586989997722777,-0.0465535506048093,3.86998916773079e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM20A,Pseudokinase FAM20A,37437,0.0442749218667657,0.00260848611381803,0.0391622890836824,0.049387554649849,5.89227652063773e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL10,C-X-C motif chemokine 10,39931,0.102927554815945,0.006095492796632,0.0909803889345459,0.114874720697343,2.01361457406299e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.176602611036715,0.0104622953806238,0.156096512090692,0.197108709982738,2.23398067406934e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK2,Docking protein 2,39868,0.191243972193744,0.0113396060263429,0.169018344382111,0.213469600005376,2.85608179252739e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBIN,Erbin,39788,0.160309243721167,0.00951659618080368,0.141656715206792,0.178961772235543,4.0006640888975e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS6,Growth arrest-specific protein 6,39947,-0.0397848051100717,0.00236277414572111,-0.0444158424356851,-0.0351537677844583,4.44296946351299e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.161598370411126,0.00960074319997046,0.142780913739184,0.180415827083068,4.96477151991906e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCK2,Cytoplasmic protein NCK2,39931,0.165163242503589,0.00982496351771314,0.145906314008871,0.184420170998307,7.03248685884641e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,39866,0.051532225404027,0.00306720685030588,0.0455204999774274,0.0575439508306265,8.27850829158857e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP23,Synaptosomal-associated protein 23,39868,0.134961372029221,0.00803994230309582,0.119203085115153,0.150719658943289,1.0552888482516e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUCB2,Nucleobindin-2,39995,0.0581685822821354,0.00346688543886116,0.0513734868219676,0.0649636777423033,1.19360245807972e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANG,Angiogenin,39843,0.0523648251787822,0.00312352422410446,0.0462427176995374,0.0584869326580269,1.5139298272054e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILPL2,RILP-like protein 2,37437,0.152658278957394,0.00912247785610717,0.134778222359424,0.170538335555364,3.09480192546876e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEC31A,Protein transport protein Sec31A,37043,0.119018834700333,0.00711473030870852,0.105073963295264,0.132963706105401,3.55090896123004e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37388,0.136603727016627,0.0081688245826834,0.120592830834568,0.152614623198686,3.77274795823328e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3F,Semaphorin-3F,39868,0.0394165587522126,0.00235921189270604,0.0347925034425088,0.0440406140619164,3.88127320488182e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.167279019765709,0.0100239984319104,0.147631982839165,0.186926056692253,6.6768168135465e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.145923544024267,0.00876119414487602,0.12875160350031,0.163095484548224,9.07861045371137e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLG,Plasminogen,37162,0.0348613371358451,0.00209251708776337,0.0307600036438289,0.0389626706278613,1.07877242716818e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLA2,Src-like-adapter 2,37411,0.162466780071088,0.00975611788404092,0.143344789018367,0.181588771123808,1.18239294505153e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USO1,General vesicular transport factor p115,39788,0.138231295856861,0.00831387710976284,0.121936096721725,0.154526494991996,1.47725227225526e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLTP,Phospholipid transfer protein,39976,-0.0552159776784426,0.00332244531339703,-0.0617279704927008,-0.0487039848641844,1.64766418230848e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.188709767073661,0.0113631160400133,-0.210981474512087,-0.166438059635235,1.99528933366979e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37437,0.138947980204463,0.00837327060369244,0.122536369821225,0.1553595905877,3.07309843960815e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCTN3,Tectonic-3,37437,0.0451785889692996,0.00272496914587303,0.0398376494433885,0.0505195284952107,3.90886645829692e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLSCR3,Phospholipid scramblase 3,37373,0.0912892260406873,0.0055156461169465,0.0804785596514722,0.102099892429902,6.26239473130612e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP5,Fatty acid-binding protein 5,39972,0.104088464554345,0.00630743615721347,0.0917258896862065,0.116451039422483,1.10765487859744e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39477,0.0974144934055365,0.00590802089205699,0.0858347724571048,0.108994214353968,1.44155466489656e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37388,0.0719311813583507,0.00436040494012223,0.0633847876757111,0.0804775750409902,1.51680598107573e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37124,0.126311390442051,0.00766447163055284,0.111289026046167,0.141333754837934,2.03012787387545e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.0707065020228186,0.00430095290727067,0.062276634324568,0.0791363697210691,3.13659123917063e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD1,Sushi domain-containing protein 1,39585,0.0739428170665533,0.00450303032489883,0.0651168776297515,0.082768756503355,4.30193660966394e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEFTY2,Left-right determination factor 2,40011,0.0810338737007574,0.00493742783302745,0.0713565151480236,0.0907112322534912,4.79244006854234e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESM1,Endothelial cell-specific molecule 1,39862,-0.0517302826633891,0.00315246224146205,-0.0579091086566547,-0.0455514566701235,5.05678368610834e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THOP1,Thimet oligopeptidase,39798,0.0461707365243534,0.00281377130267555,0.0406557447711093,0.0516857282775975,5.13246212013307e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.161362838529438,0.00982797819848963,0.142100001260399,0.180625675798478,5.45709772817764e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0681288039390786,0.00415421871725543,0.059986535253258,0.0762710726248993,7.27116834110984e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0355908637621849,0.00217236846556318,0.0313330215696811,0.0398487059546887,7.71053103683932e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.165764447103516,0.0101156195263165,0.145937832831935,0.185591061375096,8.94003841483082e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.107450647433567,0.00656407212356201,0.0945850660713854,0.120316228795748,9.92151677554167e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.129398969568906,0.00792335359894517,0.113869196514973,0.144928742622839,2.26531601091308e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL13,C-C motif chemokine 13,40024,0.103667956363534,0.00636276064709934,0.0911969454952191,0.116138967231848,3.28337574498811e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R9B,Neurabin-2,40058,0.142725001709732,0.0087609866780176,0.125553467820817,0.159896535598646,3.38025106696312e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.0925939806390599,0.00569063080096423,0.08144034426917,0.10374761700895,4.8213050396076e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.102711787771343,0.00633567737899633,0.0902938601085105,0.115129715434176,1.5381408033074e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC3B,Tetranectin,37138,0.0316576482358332,0.00195807872174177,0.0278198139412194,0.0354954825304471,3.06328056953743e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINH1,Serpin H1,37169,0.191994681465835,0.0118812632200634,0.168707405554511,0.215281957377159,3.48327655399684e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.105204683357627,0.00651712227664003,0.0924311236954122,0.117978243019841,3.74178765697338e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.093227930535864,0.00577561260379597,0.0819077298324239,0.104548131239304,3.84030002555562e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.174963909479959,0.0108441668253366,0.153709342502299,0.196218476457619,4.22297965376699e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,39931,0.127695266208004,0.00793055930840982,0.112151369963521,0.143239162452487,7.0426838490085e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0470414887812718,0.00292581643426666,0.0413068885701091,0.0527760889924344,1.03431431280938e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,39788,0.204879680430406,0.012759064889667,0.179871913246659,0.229887447614154,1.4319439824238e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37411,0.107925681491458,0.00671896286805813,0.0947565142700642,0.121094848712852,1.57755493913625e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0719339253964579,0.00449263588630689,0.0631283590592964,0.0807394917336194,2.92134333990026e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0588137119459274,0.00367863672300488,0.0516035839688378,0.0660238399230169,4.37007274475282e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBPL,FK506-binding protein-like,37382,0.0882153808590479,0.00551826336022652,0.0773995846730039,0.0990311770450919,5.31444364104562e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0566062453815267,0.00355813921159773,-0.0635801982362583,-0.0496322925267952,1.48411555466611e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO1,Forkhead box protein O1,39866,0.126489052104684,0.00795272248261424,0.11090171603876,0.142076388170608,1.58228932169069e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LG,CMRF35-like molecule 9,39858,-0.0539112256284483,0.00339082113419303,-0.0605572350514666,-0.0472652162054299,1.73853623399738e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.061879739064566,0.00389217902204567,0.0542510681813565,0.0695084099477755,2.10662758748782e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,39713,0.034580048389797,0.00218005822779278,0.0303071342633231,0.0388529625162708,3.14420384079321e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAP,Prolyl endopeptidase FAP,40052,0.0400305025530271,0.00252591097629097,0.0350797170394968,0.0449812880665574,3.83798586730976e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37411,0.175925539455376,0.0110949313901834,0.154179473930616,0.197671604980135,4.05568493868771e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D23,TBC1 domain family member 23,39788,0.132194442475441,0.00834832354433589,0.115831728328542,0.148557156622339,4.78727634282884e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BECN1,Beclin-1,37043,0.0885986707955426,0.00559544273406996,0.0776316030367654,0.0995657385543197,5.93234612646391e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0441249200887815,0.00278679968889225,-0.0495870474790103,-0.0386627926985527,5.93906991452225e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PENK,Proenkephalin-A,37124,0.0426423616500667,0.0026990669228347,0.0373521904813107,0.0479325328188227,1.01867016546931e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKBKG,NF-kappa-B essential modulator,39866,0.134511331723826,0.00852336725654006,0.117805531901008,0.151217131546645,1.0970839930988e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.11312804030216,0.00717926596710171,0.0990566790066407,0.127199401597679,1.89044273493692e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.0779906717624977,0.0049639595189349,0.0682613111053853,0.0877200324196101,3.95118009864352e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.0842851123326596,0.00537533639389062,0.073749453000634,0.0948207716646852,5.35650046289531e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EZR,Ezrin,40009,0.0348243285800251,0.00222406815630813,0.0304651549936611,0.039183502166389,7.42277068255865e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.148723863341957,0.00949438098687115,0.13011487660769,0.167332850076225,8.0281649158034e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37056,0.128303462506907,0.00819724382376999,0.112236864612318,0.144370060401496,9.98575131755334e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.131531894849599,0.0084128907115787,0.115042629054905,0.148021160644293,1.27183444380612e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0287733045576653,0.00184109218672534,0.0251647638716837,0.032381845243647,1.39879327542391e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.108501688206827,0.00694363519953429,0.0948921632157396,0.122111213197914,1.49444869739896e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2,Complement C2,39908,0.0341363278222942,0.00218850634013576,0.0298468553956282,0.0384258002489603,1.88546950347164e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.165384248323943,0.0106040494778854,0.144600311347288,0.186168185300599,2.29549759035078e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.053031951500491,0.00340310189253216,0.046361871791128,0.0597020312098541,2.36671205729144e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFX1,Transcriptional repressor NF-X1,37021,0.0973673224217857,0.00624552941842508,0.0851260847616725,0.109608560081899,2.60608829403724e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0458419334514376,0.00294381334433135,0.0400720592965482,0.0516118076063271,2.78325996883721e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.143456188167866,0.00922219883069705,0.1253806784597,0.161531697876032,3.59746496457521e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN1,Pantetheinase,37445,0.104399094530189,0.00671010323056092,0.09124729219829,0.117550896862089,4.08064033809389e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0767080260771614,0.00493758447818218,0.0670303604999243,0.0863856916543985,5.83148335354695e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN1,Dynactin subunit 1,40030,0.0934490846426739,0.00602202701266589,0.0816459116978488,0.105252257587499,6.42703548328962e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARA5,Scavenger receptor class A member 5,40009,0.0418797514427457,0.0027021990289019,0.036583441346098,0.0471760615393934,8.67630250018758e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.145517418599853,0.0093891893505455,0.127114607472784,0.163920229726922,8.74443273531819e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C3,Complement C3,36816,0.0661994444615528,0.00426899243041287,0.0578322192979436,0.074566669625162,9.44584357923891e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPK2,SRSF protein kinase 2,39866,0.12050787954592,0.00778105125465323,0.1052570190868,0.13575874000504,1.03580199949834e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.0916691850697055,0.00591914276990406,0.0800676652406936,0.103270704898718,1.22225046068639e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGLAP,Osteocalcin,37437,0.123945190796495,0.00800406471412077,0.108257223956818,0.139633157636172,1.25290724689809e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.10407734715486,0.00673575448747007,0.0908752683594184,0.117279425950301,1.78903030787351e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.148933170579958,0.00964038224180054,0.130038021386029,0.167828319773887,1.85943779918179e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLK1,Protein delta homolog 1,40052,0.0796183562951259,0.00516426936730746,0.0694963883352033,0.0897403242550485,2.99907673302125e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.17539656641993,0.011389200267126,0.153073733896363,0.197719398943497,4.02940073586409e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.159728970775583,0.0103742562550958,0.139395428515595,0.180062513035571,4.17489664895375e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0676589665024883,0.00439564787030987,0.0590434966766809,0.0762744363282956,5.29871785467395e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0445215191671456,0.00289333006090101,0.0388505922477796,0.0501924460865116,5.71601316155376e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.121160106345688,0.00788033210974923,0.105714655410579,0.136605557280796,5.88315610668535e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.126854323596092,0.00826496154580371,0.110654998966316,0.143053648225867,1.00892371450666e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0571139563198593,0.00373080161414154,0.0498015851561419,0.0644263274835767,1.58828917997572e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BID,BH3-interacting domain death agonist,39866,0.0936884494633691,0.00612060698644584,0.0816920597699353,0.105684839156803,1.61547424471385e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.118175280258983,0.00772482443772839,0.103034624361035,0.13331593615693,1.849336088925e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES3,Carboxylesterase 3,39788,0.0976605296293584,0.00638560429757545,0.0851447452061105,0.110176314052606,1.98092688051798e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGCC,Regulator of cell cycle RGCC,37411,0.10743847599961,0.00702377372281379,0.0936718795028947,0.121205072496325,2.21196964353602e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY4,Protein canopy homolog 4,39788,0.107273423706975,0.0070184413567748,0.0935172786476964,0.121029568766254,2.28201165391951e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA11,Annexin A11,39829,0.0945317007399042,0.00618723375607671,0.0824047225779939,0.106658678901815,2.49336610052864e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.133529189012364,0.00876472409867413,0.116350329778962,0.150708048245765,4.84164949219727e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BACH1,Transcription regulator protein BACH1,39866,0.104506958951739,0.0068615891023868,0.0910582443110612,0.117955673592417,5.12048679975901e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APPL2,DCC-interacting protein 13-beta,37124,0.159746291632783,0.010481263062203,0.139203016030865,0.180289567234701,5.1982876832753e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.155307374619757,0.0101979270059629,0.13531943768807,0.175295311551445,5.21326705705336e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.11025697445329,0.00723862291705595,0.0960692735358608,0.12444467537072,5.85934936957872e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.0956404289613737,0.00628629489711537,0.0833192909630276,0.10796156695972,7.86257668437227e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.150327109358272,0.00989228635998141,0.130938228092709,0.169715990623836,9.96721939274959e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA1,Ephrin type-A receptor 1,39904,0.0469355142075497,0.00309305301564028,0.0408731302968948,0.0529978981182047,1.19123418474055e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.130077760194954,0.00857317332793763,0.113274340472196,0.146881179917711,1.22706953014887e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.144911492372379,0.00955494787941495,0.126183794528726,0.163639190216032,1.34589933840366e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFP,Alpha-fetoprotein,39699,0.0947716834035497,0.00626125388883364,0.0824996257814358,0.107043741025664,2.13802450690811e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40052,0.0301050227575676,0.00198993318149123,0.0262047537218448,0.0340052917932904,2.35188785244883e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37056,0.137060022404029,0.00905356755933373,0.119315029987735,0.154805014820323,2.42384769553059e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37411,0.107495239129113,0.00710562430579263,0.0935682154897596,0.121422262768467,2.76768754151733e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.135952839415955,0.00899372307422966,0.118325142190465,0.153580536641445,2.89308854603853e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.0686373184598963,0.00454142885910011,0.0597361178960601,0.0775385190237326,3.51319706345167e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.0782529433557286,0.00518939794273132,0.0680817233879752,0.088424163323482,4.91350216388185e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.0890754370185458,0.00590650732326009,0.077498682664956,0.100652191372136,4.94720209591878e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTPBP2,GTP-binding protein 2,37039,0.113208535823003,0.00750432205494937,0.0985000645953021,0.127917007050704,5.35198887876894e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A4,Protein S100-A4,39913,0.0794292914797752,0.00527024826233235,0.0690996048856038,0.0897589780739466,5.58698941250403e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCC,Tubulin-specific chaperone C,39749,0.113495845046213,0.00753384547821288,0.0987295079089158,0.12826218218351,6.20357323813403e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IST1,IST1 homolog,37287,0.139217093016797,0.00926156456636337,0.121064426466725,0.15736975956687,1.17498313962061e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD36,Platelet glycoprotein 4,37056,0.0637146762409131,0.00423876552290469,0.0554066958160199,0.0720226566658063,1.19942007810362e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNMBP,Dynamin-binding protein,39749,0.086301614145618,0.00574712165422719,0.0750372557033327,0.0975659725879033,1.27377258119133e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAX,Protein max,39489,0.146500353730326,0.00976306633649563,0.127364743710794,0.165635963749857,1.51822667354998e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLM2,Protein GOLM2,40009,0.0307565435374594,0.0020504796657862,0.0267376033925184,0.0347754836824004,1.61470780620509e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,39931,0.180069441494324,0.0120076579286705,0.15653443195413,0.203604451034519,1.70643226631428e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,39585,0.105515337298902,0.00703971729716448,0.0917174913964594,0.119313183201344,1.94445892978754e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0526691056681299,0.00351704736510461,0.0457756928325248,0.0595625185037349,2.32514026404219e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAG1,Dystroglycan,39931,0.0672967978619844,0.00449765179963258,0.0584814003347046,0.0761121953892643,2.8079546221707e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.0913201075036071,0.00609984891577171,0.0793644036286945,0.10327581137852,2.86952631065368e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR5,Complement factor H-related protein 5,37267,0.0572921977967843,0.00382703248553686,0.0497912141251321,0.0647931814684365,2.91861643137926e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.116159401960568,0.00776857812541325,0.100932988834758,0.131385815086378,3.77829203999921e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD1,COMM domain-containing protein 1,37043,0.0857908439111796,0.00573729349766674,0.0745457486557527,0.0970359391666064,3.82316745961774e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.0829798691107475,0.00555664753265381,0.072088839946746,0.093870898274749,4.3128655144803e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.103880752333817,0.00695650523992836,0.0902460020635578,0.117515502604077,4.37643321133751e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEXIM1,Protein HEXIM1,39866,0.112856841447362,0.00755772090228994,0.098043708478874,0.127669974415851,4.39188282135545e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MITD1,MIT domain-containing protein 1,39749,0.134474832402208,0.00900669130325748,0.116821717447824,0.152127947356593,4.55669718460394e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2B3,SH2B adapter protein 3,39477,0.136105911750526,0.00912945269911345,0.118212184460264,0.153999639040789,6.4026156020138e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.130136171404796,0.00873179031493715,0.113021862387519,0.147250480422073,6.82787840518033e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37124,0.175058014840273,0.0117394037509496,0.152048783488412,0.198067246192134,6.9792231928993e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK11,Serine/threonine-protein kinase STK11,39585,0.101302465006422,0.00679795356156498,0.0879784760257546,0.114626453987089,7.013331331886e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPT,Dermatopontin,40052,0.036998530958928,0.00248344061853272,0.0321309873466039,0.0418660745712521,7.25506249787635e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.114513790752076,0.00768985181615797,0.0994416811924061,0.129585900311745,8.21541793034025e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS1BP3,HCLS1-binding protein 3,37043,0.12629901213605,0.00847739544487767,0.10968331706409,0.14291470720801,8.58426966148402e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.0996803338172273,0.00669237782823101,0.0865632732738945,0.11279739436056,9.01653778883505e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0410570721047933,0.00275844311626124,0.0356505235969213,0.0464636206126653,9.06323702912378e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37382,0.105987854973404,0.00712056056531653,0.0920315562653831,0.119944153681424,1.02413864122566e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP25,Synaptosomal-associated protein 25,36991,0.0652050459367558,0.00438043050800326,0.0566194021410695,0.0737906897324422,1.03996999309759e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.0957858082572448,0.0064417295748212,0.0831600182905952,0.108411598223894,1.27979755969547e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBNL,Drebrin-like protein,39931,0.128128041554406,0.00862399960268646,0.11122500233314,0.145031080775671,1.33425309382176e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37445,0.100444570369565,0.00676412485700337,0.0871868856498387,0.113702255089292,1.70976668654048e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.143753215880295,0.00968917326655529,0.124762436277846,0.162743995482743,1.82274604013175e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0359170342629575,0.00242219316930016,0.0311695356511292,0.0406645328747858,2.33532279469111e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO2,Roundabout homolog 2,40009,0.0311847444862618,0.00210625171533638,0.0270564911242025,0.0353129978483211,2.82765163123394e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FETUB,Fetuin-B,39908,0.0461303192971343,0.00311851567608233,0.0400180285720129,0.0522426100222556,3.45798518027397e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT,Linker for activation of T-cells family member 1,40058,0.103913079555923,0.00702763822275446,0.0901389086393244,0.117687250472522,3.75297226978673e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL16,C-X-C motif chemokine 16,40034,0.0318076344931169,0.00215379274170617,0.0275862007193728,0.0360290682668609,4.90099666641823e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDHD2,Phospholipase DDHD2,37411,0.091459725175016,0.00619109139695115,0.0793251860369917,0.10359426431304,5.27578481834062e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",39818,0.150136236588195,0.0101790988908073,0.130185202762213,0.170087270414178,6.50983444597482e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.104203898715507,0.00706806005765445,0.0903505010025039,0.118057296428509,8.14381946781149e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYDGF,Myeloid-derived growth factor,37437,0.138198937681157,0.00937927452091312,0.119815559620167,0.156582315742146,9.20777413875868e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0521933659823458,0.00354531306589863,0.0452445523731845,0.0591421795915071,9.76468840218801e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA1,GDNF family receptor alpha-1,40011,0.0366796074525941,0.00249286881074175,0.0317935845835403,0.0415656303216479,1.08601222555443e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0672025004952667,0.0045690939941284,0.058247076266775,0.0761579247237584,1.21045488007759e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6A,Ras-related protein Rab-6A,39866,0.0629637210122571,0.00428483843209602,0.0545654376853489,0.0713620043391653,1.44768728250739e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.0779821715898167,0.00531030317511538,0.0675739773665906,0.0883903658130429,1.93819593222262e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.078463439819581,0.00535026997609109,0.0679769106664425,0.0889499689727195,2.2544849126701e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37437,0.098125691268012,0.00669165730129397,0.0850100429574758,0.111241339578548,2.56999178841434e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2AP,CD2-associated protein,39868,0.0859816688336911,0.00586733789845531,0.0744816865527187,0.0974816511146635,2.59955413380937e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB1,BPI fold-containing family B member 1,39786,-0.0860098268836836,0.00586950201510941,-0.097514050833298,-0.0745056029340692,2.63218915915944e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.0962190444867447,0.00656629260896398,0.0833491109731753,0.109088978000314,2.66403018504234e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK1,Docking protein 1,37388,0.186795096037966,0.012741567533806,0.161821623671706,0.211768568404226,2.71569415282366e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.032033811124809,0.00219193663529044,0.0277376153196397,0.0363300069299783,4.63391277622181e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTBS,Di-N-acetylchitobiase,37296,0.0374083126697668,0.00255912743904554,0.0323924228892375,0.042424202450296,5.06701954869345e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37021,0.0831496378833409,0.00569690359228038,0.0719837068424714,0.0943155689242105,7.08704421852158e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOL1,Apolipoprotein L1,37445,0.0830196607632307,0.00568904772384475,0.071869127224495,0.0941701943019665,7.17455268697513e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRKL,Crk-like protein,39881,0.14469332090402,0.00992301842893534,0.125244204783306,0.164142437024733,7.45175008398075e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0869073851831786,0.00596101411833767,0.0752237975112367,0.0985909728551204,8.90496083594025e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYN,Tyrosine-protein kinase Lyn,39788,0.11435072693465,0.00785854045000564,0.0989479876526385,0.129753466216661,1.16137400006275e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSNL1,Visinin-like protein 1,37388,0.051035694748348,0.00350685355202828,0.0441622617863726,0.0579091277103234,1.27710645298094e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT2,Omega-amidase NIT2,37377,0.101603478629687,0.00698256528488033,0.0879176506713214,0.115289306588052,1.31727871195693e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIA,Melanoma-derived growth regulatory protein,39913,0.0487515529680331,0.00335335482861311,0.0421789775039514,0.0553241284321148,1.39323041747442e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.103567681865306,0.00712542910952084,0.0896018408106451,0.117533522919967,1.48743316954979e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.087276675809556,0.00600787811143542,0.0755012347111426,0.0990521169079694,1.66673200354772e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSO,Cathepsin O,40058,0.0402622031175444,0.00277386779749496,0.0348254222344542,0.0456989840006345,1.93751469355953e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,39585,0.0463274387059751,0.00319211918540433,0.0400708851025827,0.0525839923093676,2.02817207571297e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37124,0.104835002610415,0.00723134639273835,0.0906615636806478,0.119008441540182,2.89471920146843e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD5,Programmed cell death protein 5,40009,0.077826546232615,0.0053727439371453,0.0672959681158102,0.0883571243494198,2.96264925892893e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.113649190653056,0.00784686075925761,0.0982693435649106,0.1290290377412,3.07957502892605e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.0731770881381716,0.00505500354227773,0.0632692811953073,0.083084895081036,3.47213911434987e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZI2,5-azacytidine-induced protein 2,37411,0.0745219766658986,0.00514539819915498,0.0644369961955548,0.0846069571362424,3.48058611635376e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4D,Semaphorin-4D,40009,0.0401587569578036,0.00277497946215434,0.034719797211981,0.0455977167036261,3.60713258516305e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRAP,BRCA1-associated protein,37249,0.147987222869002,0.0102252226074475,0.127945786558404,0.168028659179599,4.08287167550432e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.107808784128115,0.0074580189230946,0.09319106703885,0.122426501217381,5.18278697361848e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,A1BG,Alpha-1B-glycoprotein,37453,0.0229113483355429,0.00158526148056043,0.0198042358336444,0.0260184608374413,5.37309022334866e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD22,B-cell receptor CD22,40058,0.053689669873758,0.00371722484645162,0.0464039091747128,0.0609754305728031,5.397844981204e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH2,Neutral ceramidase,39749,0.0701172873462847,0.00485653959546009,0.0605984697391829,0.0796361049533864,5.93989312791515e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0675281385426791,0.00467890486448182,0.0583574850082947,0.0766987920770634,6.47503147922289e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP43,Centrosomal protein 43,39476,0.0935849552410681,0.0064879529159338,0.0808685675258378,0.106301342956298,7.26923425875537e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNST,Consortin,39868,0.144218108259241,0.0100078138886969,0.124602793037395,0.163833423481087,8.71587824304973e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST3,Cystatin-C,39897,0.0354803539753054,0.00246250165608914,0.0306538507293707,0.0403068572212402,8.99560474811469e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL18,C-C motif chemokine 18,39715,0.0942654630281363,0.00654446728976981,0.0814383071401874,0.107092618916085,9.65499421555756e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR4,Complement factor H-related protein 4,37409,0.0961325124566971,0.0066792751217596,0.0830411332180483,0.109223891695346,1.26960962385969e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0610984636263081,0.00424677164895679,0.0527747911943528,0.0694221360582634,1.40556292799058e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0464257753855984,0.00323051874431537,0.0400939586467403,0.0527575921244565,1.53009742963881e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPHN1,Oligophrenin-1,37388,0.144110862517711,0.0100280846217644,0.124455816659053,0.16376590837637,1.73681406716643e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.039235834933232,0.00273305568561043,0.0338790457894355,0.0445926240770284,1.89727609882117e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM13A,Protein FAM13A,37382,0.0902677567065422,0.00629166080703656,0.0779361015247506,0.102599411888334,2.42698301842167e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0372779518929993,0.00260074155400958,0.0321804984471405,0.0423754053388581,2.61990484184501e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.11478753716621,0.00801696230567126,0.0990742910470947,0.130500783285326,3.73176042986539e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMVK,Phosphomevalonate kinase,39480,0.147200097047606,0.0102886929908259,0.127034258785587,0.167365935309624,3.87296924560472e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R2,Interleukin-1 receptor type 2,39830,0.025981766875948,0.00181747784310215,0.0224195103034678,0.0295440234484282,4.49149724733827e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.0891495858345878,0.0062374862005014,0.076924112881605,0.10137505878757,4.75055534677608e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSHB,Follitropin subunit beta,37043,0.0866093172949249,0.00605872412106717,0.0747342180176332,0.0984844165722165,5.18967252036628e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPART,Spartin,37124,0.103417532735598,0.00724426654452977,0.0892187703083201,0.117616295162877,6.77548756206323e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.195375508292599,0.0136964945184933,0.168530379036353,0.222220637548846,7.81398286818879e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0739380812183034,0.00518701405816414,0.0637715336643017,0.0841046287723052,7.97612291393679e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRG1,Scrapie-responsive protein 1,37437,0.0349324856086787,0.00244969205696858,0.0301310891770203,0.0397338820403371,8.32293726103429e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0516017938854812,0.00362487494958114,0.0444970389843022,0.0587065487866603,1.06106717793674e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TWF2,Twinfilin-2,37437,0.111463909520604,0.00783851425470482,0.0961004215813825,0.126827397459825,1.46119378518384e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP2,Methionine aminopeptidase 2,40011,0.0759688276443962,0.00535499395216053,0.0654730394981615,0.0864646157906308,2.08003638985109e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.100794703031431,0.0071277096779903,0.08682439206257,0.114765014000292,3.9659892351992e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39477,0.0803930242587364,0.00568561756260101,0.0692492138360384,0.0915368346814343,4.10265500256863e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0665873458433023,0.00471299347881302,0.0573498786248287,0.0758248130617758,5.41406208693954e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0681269345301681,0.0048259537793666,0.0586680651226096,0.0775858039377267,5.56342403948967e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLMH,Bleomycin hydrolase,40052,0.0418114590756158,0.00296695118050774,0.0359962347618206,0.047626683389411,7.78478222837303e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGL1,Fibrinogen-like protein 1,37445,-0.0810036109883347,0.00574507771527716,-0.0922639633102779,-0.0697432586663914,7.89965513182443e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37382,0.062071734556039,0.00440360587350011,0.0534406670439788,0.0707028020680992,8.38076668044839e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0806933597394226,0.00572932255730087,0.0694638875271129,0.0919228319517323,1.000762733463e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM17,Splicing factor 45,37411,0.100143967628533,0.0071120115144648,0.0862044250601821,0.114083510196884,1.02727447922382e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,39749,0.10371375787484,0.00738756929395284,0.0892341220586926,0.118193393690988,1.66081368988917e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.0817026035447716,0.00581968851932923,0.0702960140468863,0.0931091930426569,1.84512392583653e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC1,Stanniocalcin-1,40009,0.054516637612376,0.00388614717810081,0.0468997891432984,0.0621334860814536,1.90381414416066e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIFBP,KIF-binding protein,39788,0.108168984115864,0.0077105244619303,0.0930563561704803,0.123281612061247,1.91185159803701e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.060021537115843,0.00427691805236807,0.0516387777332016,0.0684042964984844,1.98265340197726e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HJV,Hemojuvelin,37411,0.0577306948477305,0.00411949279568689,0.0496564889681842,0.0658049007272768,2.60726042661382e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD69,Early activation antigen CD69,39785,0.114011677424674,0.00814477728490536,0.0980479139462593,0.129975440903088,2.9272923612637e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0463832273924289,0.00331536572511199,0.0398851105712094,0.0528813442136484,3.62393798659119e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAXX,Protein PAXX,37124,0.0596951260448446,0.004266999549784,0.051331806927268,0.0680584451624213,3.69668275850843e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",39585,0.121088320001244,0.00866110113945718,0.104112561767908,0.13806407823458,3.75728250051398e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39477,0.119959142486508,0.00858404201531974,0.103134420136481,0.136783864836535,4.10274532965564e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX15,Sorting nexin-15,37124,0.0699446846531687,0.0050030960789377,0.0601386163384509,0.0797507529678866,4.22673822049955e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRADD,Death domain-containing protein CRADD,39713,0.0989348888441944,0.00708124973651786,0.0850556393606194,0.112814138327769,4.255165225152e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP1,Secreted frizzled-related protein 1,39689,0.055065111636174,0.0039420320616026,0.0473387287954329,0.0627914944769151,4.42006149059448e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.0950549415554045,0.00681250164688254,0.0817024383275148,0.108407444783294,6.19014964440532e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPP,Lipoma-preferred partner,37021,0.0869711322514315,0.00623960393063587,0.0747415085473852,0.0992007559554778,7.56652719302564e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP5,Platelet glycoprotein V,37124,0.0468118285742715,0.00335904489933432,0.0402281005715762,0.0533955565769668,7.79054769847705e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPI,Mannose-6-phosphate isomerase,39788,0.11166717847086,0.00801951732934792,0.0959489245053381,0.127385432436382,8.13136810673066e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR,GMP reductase 1,40058,0.0640486120964962,0.00460081133361765,0.0550310218826056,0.0730662023103868,8.42475527429153e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMN,Protein amnionless,39587,0.061544222030982,0.00442130302915318,0.0528784680938418,0.0702099759681222,8.71807994563898e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,39868,0.104165658031599,0.00748439628126099,0.0894962413203274,0.11883507474287,8.89641061209696e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGLL,Monoglyceride lipase,39908,0.112696099484672,0.00810142129387796,0.096817313748671,0.128574885220673,9.79281539269745e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM5,Tripartite motif-containing protein 5,39866,0.110630354052719,0.00799878169573979,0.0949527419290689,0.126307966176369,2.94280941264444e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATOX1,Copper transport protein ATOX1,39913,0.0934413401519061,0.00675654712042109,0.0801985077958808,0.106684172507931,2.98482757419298e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F12,Coagulation factor XII,37453,0.0532270936426799,0.00384978099450119,0.0456815228934575,0.0607726643919022,3.48069311579993e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDC,Nuclear migration protein nudC,40058,0.0823723867576687,0.00596846851683614,0.0706741884646699,0.0940705850506676,4.39061171484624e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.0940149732432222,0.00681102155793446,0.0806653709896707,0.107364575496774,4.81381559597843e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSTN,Growth/differentiation factor 8,39585,0.0663920579519771,0.00481322746746698,0.0569581321157418,0.0758259837882123,4.95436906181237e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0801373602901767,0.00580896515619434,0.0687517885840358,0.0915229319963176,5.40357368824414e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD2,Polycystin-2,37021,0.0764111402873525,0.00553894936545417,0.0655547995310623,0.0872674810436426,5.4199652090701e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB27B,Ras-related protein Rab-27B,37437,0.104847033952352,0.0076019725673692,0.0899471677203081,0.119746900184395,5.5420802185663e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCG,Gamma-synuclein,39749,0.0830676136480314,0.00602726488437944,0.0712541744746477,0.0948810528214151,5.78053483584429e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0420536645384271,0.00305444401042499,0.0360669542779941,0.0480403747988601,7.93166575934751e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QDPR,Dihydropteridine reductase,39790,0.0554204449908401,0.00402857403781594,0.0475244398767209,0.0633164501049594,8.14058948422092e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAMBP,STAM-binding protein,39713,0.08211713475775,0.00597378264024902,0.070408520782862,0.0938257487326381,9.43262441764345e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRAP2,GRB2-related adapter protein 2,39868,0.163650811572243,0.011907972279286,0.140311185904842,0.186990437239643,9.81297916204813e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNLR1,Interferon lambda receptor 1,39866,0.0476193104506862,0.00346648544853683,0.040824998971554,0.0544136219298184,1.0637406982598e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0732942993526185,0.00533264182006775,0.0628423213852857,0.0837462773199513,1.0834126414323e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.0927956865869317,0.00675416914088388,0.0795575150707993,0.106033858103064,1.14706959709287e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFB,Complement factor B,37220,0.0419849269258406,0.00306087646438014,0.0359856090556555,0.0479842447960256,1.56691292354207e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE2,Angiotensin-converting enzyme 2,39585,0.0634793474143608,0.00463168069261987,0.0544012532568259,0.0725574415718958,1.6524581240741e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICA1,Islet cell autoantigen 1,39587,0.102008914637216,0.00744305911238299,0.0874205187769449,0.116597310497486,1.65744843798853e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40052,0.0859596532980099,0.00627671459831112,0.0736572926853201,0.0982620139106997,1.87492846342037e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7,Interleukin-7,39866,0.0827214879552061,0.00604438890189828,0.0708744857074854,0.0945684902029267,2.14239803532749e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN4,Cerebellin-4,40030,0.0393520278886689,0.00287635282077547,0.033714376359949,0.0449896794173889,2.26323779276898e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.0900208770899959,0.0065871527565252,0.0771100576872065,0.102931696492785,3.07804809989819e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGFR,Opioid growth factor receptor,39788,0.041425127431599,0.00303667099973034,0.0354732522721275,0.0473770025910704,3.90608587626599e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9,Complement component C9,37445,-0.06714809363888,0.00492115197917236,-0.0767935515180578,-0.0575026357597021,4.10771230074148e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.115390203812121,0.0084610872034387,0.0988064728933807,0.13197393473086,4.60311174893781e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASHC3,WASH complex subunit 3,37388,0.0959076627059899,0.00704534044416844,0.0820987954354197,0.10971652997656,6.33629641071256e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1R,Complement C1r subcomponent,37453,0.0244077225737634,0.00179608073046971,0.0208874043420428,0.027928040805484,8.67212289633256e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0627370124617194,0.00462055065600202,0.0536807331759555,0.0717932917474834,1.02761996031021e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YJU2,Splicing factor YJU2,37368,0.0409166636604902,0.00301525825562727,0.0350067574794607,0.0468265698415196,1.13310024472634e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.123586666424878,0.0091095166381774,0.10573201381405,0.141441319035706,1.18037968777696e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD207,C-type lectin domain family 4 member K,39496,0.047379521728282,0.00349534075104933,0.0405286538562253,0.0542303896003387,1.27097275964806e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGA,Protein O-GlcNAcase,37382,0.0896848083795436,0.00661483087524108,0.076719739864071,0.102649876895016,1.32593869310118e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GASK1A,Golgi-associated kinase 1A,37021,0.0539087012874112,0.00397870660407935,0.0461104363434157,0.0617069662314068,1.51877302259698e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2,Microtubule-associated protein 2,37388,0.0579671698443875,0.00427952303091696,0.0495793047037902,0.0663550349849847,1.57656807730639e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.0860380927427954,0.00635605328040803,0.0735802283131957,0.0984959571723951,1.60613858872574e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37405,0.0771556442374423,0.00569678657711944,0.0659899425462882,0.0883213459285963,1.60800986449782e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL24,C-C motif chemokine 24,39908,0.103497578275358,0.00764813595935638,0.0885072317950197,0.118487924755697,1.70068928689498e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",39788,0.102156357342785,0.00755595205969637,0.0873466913057797,0.116966023379789,2.01732637016665e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.055233834030124,0.00409212558930395,0.0472132678750883,0.0632544001851598,2.72506652574464e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0481664912885022,0.00356973626372127,0.0411698082116085,0.0551631743653959,2.87442054924109e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FIS1,Mitochondrial fission 1 protein,39855,0.0979210120435567,0.00726113403988109,0.0836891893253898,0.112152834761724,3.19200657435148e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.038413946125824,0.00284759588583036,0.0328326581895965,0.0439952340620515,3.30880163274244e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37056,0.0624016466881265,0.00463626442576737,0.0533145684136225,0.0714887249626305,5.04982829286741e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK13,Kallikrein-13,39490,0.052693362565241,0.00391940069272341,0.0450113372075031,0.0603753879229789,5.62198588792361e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTX3,Pentraxin-related protein PTX3,39866,-0.0619354354258785,0.00460797983008451,-0.0709670758928442,-0.0529037949589129,5.80652869985949e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.0846884719284673,0.00629766054736471,0.0723450572556324,0.0970318866013021,5.82101649232154e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAX1BP1,Tax1-binding protein 1,37388,0.0788545537789029,0.00586504785595693,0.0673590599812273,0.0903500475765784,6.04722660888716e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37056,0.0983736600078545,0.00731658716741484,0.0840331491597214,0.112714170855988,6.10110378812721e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAM1,Vascular cell adhesion protein 1,39908,-0.0332441999602157,0.00247437803322693,-0.0380939809053405,-0.0283944190150909,6.24369729749131e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN3,Centrin-3,37382,0.0986589075473165,0.00734043111120844,0.0842716625693479,0.113046152525285,6.41003230201215e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.123306823633106,0.00918939308326894,0.105295613189899,0.141318034076313,7.83221711741088e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASC3,Protein CASC3,37039,0.0523112855681002,0.00389692596122798,0.0446733106840934,0.059949260452107,8.13840506283058e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.119767818989718,0.00893252956624062,0.102260061039886,0.13727557693955,9.01115529887863e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.0870134812664022,0.0064878821215577,0.0742972323081491,0.0997297302246553,9.55088151363951e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAEP,Glycodelin,39749,-0.180082515176281,0.0134384571525467,-0.206421891195273,-0.15374313915729,9.98848069176998e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.13017371770645,0.00971564242490787,0.11113105855363,0.149216376859269,1.02436518418809e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS8,Galectin-8,40009,0.0759109842950782,0.00567365654059745,0.0647906174755072,0.0870313511146492,1.31011705255755e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKA,Diacylglycerol kinase alpha,37056,0.0681106220838568,0.00508862255370571,0.0581369218785937,0.07808432228912,1.3631139350596e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP1,Syntaxin-binding protein 1,37411,0.0972086447098428,0.00726505381121665,0.0829691392398582,0.111448150179827,1.42581442948947e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EREG,Proepiregulin,39713,0.0989953080204557,0.00740816229733043,0.084475309917688,0.113515306123223,1.64764842785769e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.124781485179842,0.00933845889819781,0.106478105739375,0.14308486462031,1.65946034580086e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGF,Pro-epidermal growth factor,39808,0.12834402970169,0.00962055964300106,0.109487732801408,0.147200326601972,2.2119054822347e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.0843709688947838,0.00632286595397355,0.0719781516249956,0.0967637861645719,2.34345796898302e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP7,Matrilysin,39563,0.0612299366310025,0.00459242075437089,0.0522287919524356,0.0702310813095695,2.47113772229388e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4R,Reticulon-4 receptor,40030,0.0409696026317478,0.00307486080936445,0.0349428754453934,0.0469963298181021,2.73600893991653e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.123086427411743,0.0092377775586065,0.104980383396875,0.141192471426612,3.05299528987714e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.10557620741346,0.00793364726436032,0.0900262587753135,0.121126156051606,3.75150179039156e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.13903988689435,0.010454862803533,0.118548355799426,0.159531417989275,3.87301876968607e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAN,Aggrecan core protein,39730,0.0347314780314101,0.0026134334311957,0.0296091485062665,0.0398538075565537,4.35629887233154e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP7,Caspase-7,37388,0.104041455296314,0.00784362718662233,0.0886679460105347,0.119414964582094,6.60370481568671e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.105125904355632,0.00794345684331246,0.0895567289427395,0.120695079768524,9.81240166001203e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK24,Serine/threonine-protein kinase 24,39489,0.0763190074659745,0.00577115287681598,0.0650075478274152,0.0876304671045339,1.03919457447867e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRY2,Protein sprouty homolog 2,39587,0.113634587488069,0.00859885955148313,0.096780822767162,0.130488352208976,1.16842472978526e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED8,Protein TMED8,37382,0.127126461609934,0.00962194405687264,0.108267451258464,0.145985471961404,1.31376341429917e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.106427272477159,0.00806676855009068,0.0906164061189817,0.122238138835337,1.54048210162447e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37056,0.097453731409841,0.00739190312615071,0.0829656012825856,0.111941861537096,1.92964267708826e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COCH,Cochlin,37437,0.055894620344122,0.00424029346601733,0.0475836451507281,0.064205595537516,1.95116933503936e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0690456916310349,0.00525881383462705,0.0587384165151659,0.0793529667469039,3.56358634825675e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0714923684050733,0.00544290393152034,0.0608242766992934,0.0821604601108532,3.65416749494997e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHD3,EH domain-containing protein 3,37043,0.14303104365566,0.0109002665968826,0.12166652112577,0.16439556618555,4.3411152060448e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM1,Isthmin-1,39866,0.0483957091900259,0.00369706698654501,0.0411494578963977,0.0556419604836541,5.93065497441174e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX6,Peroxiredoxin-6,40030,-0.0717808748472665,0.00548712444316352,-0.082535638755867,-0.061026110938666,6.60331211267161e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MVK,Mevalonate kinase,39587,0.0959574222453867,0.00734491577555267,0.0815613873253034,0.11035345716547,8.36727537938901e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0619034903879381,0.00473970604068878,0.0526136665481881,0.0711933142276881,9.48833291445104e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTDH,Protein LYRIC,37056,0.11229811434189,0.00859925261865129,0.0954435792093339,0.129152649474447,9.80601827014098e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSB,Arylsulfatase B,39788,0.0669372377378635,0.00513685534574486,0.0568690012602036,0.0770054742155234,1.28831409094396e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB6,Serpin B6,39970,0.0727472583949462,0.00558578492004409,0.0617991199516598,0.0836953968382326,1.40609218125036e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.132359654327556,0.0101584197257216,0.112449151665141,0.15227015698997,1.45824922816031e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0306512455133628,0.00235499333758291,0.0260354585717003,0.0352670324550253,1.57051125818723e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFA,Vascular endothelial growth factor A,39993,0.0687001433645069,0.00528621328538223,0.0583391653251577,0.0790611214038561,2.00745725779351e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,39931,0.0548831616688105,0.00422740262452639,0.0465974525247387,0.0631688708128822,2.39075389329368e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.10991182782016,0.00846617372787329,0.0933181273135282,0.126505528326791,2.42177106610176e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.103871944713456,0.00800018761488968,0.088191576988272,0.11955231243864,2.59150688145358e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37124,0.143901124925052,0.0110999482691721,0.122145226317474,0.165657023532629,3.33454905115218e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0567100739616691,0.00437476619384603,0.0481355322217309,0.0652846157016073,3.34569441063692e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.0949129197123438,0.00733017579568784,0.0805457751527957,0.109280064271892,3.77475600251665e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.102494384971448,0.00791664091922256,0.0869777687697718,0.118011001173124,3.85385144722214e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.105448525546972,0.00814965800047302,0.0894751958660452,0.1214218552279,4.55079949571362e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM106A,Transmembrane protein 106A,37368,0.0856248620875036,0.0066183191618254,0.0726529565303259,0.0985967676446814,4.64910168998657e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.115542177208193,0.00894401450514654,0.0980119087781056,0.13307244563828,5.48922872043956e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.113969143226989,0.00882516796904037,0.0966718140076696,0.131266472446308,5.81176644432741e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD226,CD226 antigen,37056,0.0503288952362864,0.00389550722869331,0.0426937010680475,0.0579640894045253,5.91682942627329e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RWDD1,RWD domain-containing protein 1,40009,0.0764586262549268,0.00592338447481201,0.0648487926842952,0.0880684598255583,6.25455113075023e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREG1,Protein CREG1,39660,0.0451012053212783,0.00349501375729582,0.0382509783569785,0.0519514322855782,6.60331367882997e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPY,Pancreatic prohormone,39826,0.119584557864157,0.00930111045452019,0.101354381373298,0.137814734355017,1.20755808596182e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.09384825558202,0.00730098504128651,0.0795383249010985,0.108158186262942,1.25467083566891e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0536020283181308,0.00417692275747443,0.0454152597134809,0.0617887969227807,1.64559797848145e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0388704170655246,0.00302979691443479,0.0329320151132324,0.0448088190178168,1.71761703779134e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2R,Proteinase-activated receptor 1,39908,0.0695308775263937,0.00542293195078379,0.0589019309028574,0.0801598241499299,1.89411346769208e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.145736167927079,0.0113675441707652,0.123455781352379,0.168016554501778,1.92708409595577e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF2,TNF receptor-associated factor 2,39866,0.0844528743304834,0.00658942580387921,0.0715375997548801,0.0973681489060866,2.02674112169702e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM,Paralemmin-1,37299,0.0338919927867292,0.00264382472192715,0.028710096331752,0.0390738892417065,2.11702473193311e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0729222596541982,0.0056962461024933,0.0617576172933113,0.084086902015085,2.44365158523412e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GLB2,Endophilin-B2,37388,0.0788307157195521,0.00615511515864575,0.0667666900086065,0.0908947414304978,2.45704884852134e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.0865204136556182,0.00675724403102741,0.0732762153548045,0.0997646119564319,2.59466909534354e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0646802696903275,0.00505536742029125,-0.0745887898340983,-0.0547717495465567,2.69024826730595e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.121573082509733,0.00949726648122278,0.102958440206536,0.14018772481293,2.70370679774694e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0598349041661141,0.00467787891877873,0.0506662614853078,0.0690035468469204,2.80205202776636e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0589548629049593,0.00460875770359873,0.0499216978059058,0.0679880280040129,2.98466892121743e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLG4,Disks large homolog 4,37388,0.0852895695631939,0.00666856367103732,0.0722191847679608,0.0983599543584271,3.0718511320866e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.105378857049501,0.00824927263325887,0.0892102826883138,0.121547431410689,3.4727547916683e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF21,Fibroblast growth factor 21,40011,0.141342264103715,0.0110666905143732,0.119651550695543,0.163032977511886,3.56244023714238e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.0909773691722221,0.007125631141824,0.0770111321342471,0.104943606210197,3.76981234182554e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.142969323701815,0.0112012344201599,0.121014904238302,0.164923743165329,3.95967018956647e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3,Galectin-3,39901,0.0349282991450302,0.00274067079584713,0.0295565843851698,0.0403000139048906,5.06220735230116e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.116366987335112,0.00913033270131179,0.0984715352405408,0.134262439429683,5.07600810571984e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRAS,Ras-related protein R-Ras,37039,0.156147691879924,0.0122467926077676,0.132143978368699,0.180151405391148,5.1511509648275e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCB,Tubulin-folding cofactor B,39749,0.119909180042621,0.00941022200755418,0.101465144907815,0.138353215177428,5.21247413104598e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0328292272527739,0.00257775499355818,0.0277768274653999,0.0378816270401479,6.16981011592068e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MESD,LRP chaperone MESD,39858,0.144189186244288,0.0113345030869135,0.121973560193938,0.166404812294639,6.79898611786668e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA2,Integrin alpha-2,37124,0.0397633265864919,0.0031261208641996,0.0336361296926607,0.0458905234803232,7.54317479945776e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0609020738148598,0.00479349001072152,0.0515068333938456,0.0702973142358739,8.33556575201758e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D5,TBC1 domain family member 5,39866,0.0918329435289243,0.00722852072102106,0.077665042915723,0.106000844142126,8.43148232400026e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39489,0.100486540384206,0.00791296872648166,0.084977121680302,0.11599595908811,9.10292768174891e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL4,C-C motif chemokine 4,39882,0.0734935747628897,0.00578816594389513,0.0621487695128552,0.0848383800129241,9.21296042676479e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.0862209207707753,0.00679280872233479,0.0729070156749991,0.0995348258665515,9.72463715878136e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTF1,Cardiotrophin-1,39585,0.10005403809754,0.00788300347956665,0.084603351277589,0.11550472491749,9.86925175458881e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS9,Galectin-9,39859,0.0370760558025372,0.00292394503431782,0.0313451235352743,0.0428069880698001,1.14373172477659e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0687218502273343,0.00542325820570462,0.0580922641441532,0.0793514363105153,1.38260807876233e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.0919866241156718,0.00726306272153444,0.0777510211814643,0.106222227049879,1.39858183119478e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0748351650804651,0.0059098480374169,0.063251862927128,0.0864184672338022,1.41787025765694e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB1,Heat shock protein beta-1,39617,0.0817262159566452,0.00646263883062947,0.0690594438486114,0.094392988064679,1.77146457770285e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGH,Gamma-glutamyl hydrolase,39573,0.0398523895875829,0.00315234236548665,0.0336737985512291,0.0460309806239367,1.86041068069086e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGA,Fibrinogen alpha chain,37149,0.0361480907960355,0.00286099602025641,0.030540538596333,0.0417556429957381,2.19730366021889e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VGF,Neurosecretory protein VGF,37411,0.0343331720181793,0.00271844492736082,0.0290050199605521,0.0396613240758065,2.32062319665995e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACYBP,Calcyclin-binding protein,37088,0.12181193604177,0.00964653764193031,0.102904722263586,0.140719149819953,2.41245356190181e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH2,Cadherin-2,39868,0.041026818532706,0.00325581770953791,0.0346454158220117,0.0474082212434003,3.09497748207258e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,39858,0.0603520139658015,0.00479054701156814,0.0509625418231279,0.0697414861084751,3.21184746613613e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLGA3,Golgin subfamily A member 3,37411,0.0910179259670717,0.00722189161212961,0.0768630184072977,0.105172833526846,3.24215423827528e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN2,Centrin-2,39489,0.0791272184748375,0.00628537477757131,0.0668078839107978,0.0914465530388773,3.63136089537119e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPN,Asporin,37437,0.0315011212901612,0.00250290103609015,0.0265954352594245,0.0364068073208979,4.0188536634114e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGT1,Protein SGT1 homolog,39477,0.0946574982286189,0.00752591394595149,0.079906706894554,0.109408289562684,4.1988335238925e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0717790406229157,0.00571394631321316,0.0605797058490179,0.0829783753968135,5.04106825976957e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37368,0.0642290422816393,0.00511300710239592,0.0542075483609433,0.0742505362023353,5.43518025009737e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0659930938246552,0.00525798852636709,0.0556874363129757,0.0762987513363347,5.79829717987617e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37043,0.0663599544536116,0.00528942685485235,0.055992677818101,0.0767272310891222,6.72224059589722e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAO1,Hydroxyacid oxidase 1,40030,0.150074646753815,0.0119724402851986,0.126608663794826,0.173540629712805,7.05210629138189e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0650354417925592,0.00518835443441901,0.054866267101098,0.0752046164840205,7.13908575374569e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIN2,Bridging integrator 2,39858,0.104302438587305,0.00832783080891383,0.087979890201834,0.120624986972776,8.0676556154576e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37437,0.0290540666463071,0.00232196673618239,0.0245030118433896,0.0336051214492246,1.0015131234451e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.109903236315514,0.00880076367740637,0.0926537395077974,0.12715273312323,1.36604821517381e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO9B,Unconventional myosin-IXb,39587,0.0765473226999693,0.00613886673287457,0.0645151439035352,0.0885795014964035,1.61630868924937e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF19,Fibroblast growth factor 19,39931,0.0885685563511326,0.00710575968944155,0.0746412673598272,0.102495845342438,1.70495710558209e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2L,Ataxin-2-like protein,37411,0.0556170891776637,0.00446750865626357,0.0468607722113871,0.0643734061439403,2.20414658141132e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53,Cellular tumor antigen p53,39477,0.050961629820264,0.00410026663918941,0.0429251072074528,0.0589981524330753,2.6763491516854e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37437,0.0709380040577972,0.00570880843903448,0.0597487395172896,0.0821272685983048,2.93397345893823e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37382,0.0673698200359698,0.0054259643323966,0.0567349299444724,0.0780047101274671,3.32047927034081e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST13,Hsc70-interacting protein,37124,0.063739861652733,0.00514012218424547,0.0536652221716119,0.0738145011338542,4.06695813953346e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEXN,Nexilin,37445,0.0792714316904967,0.00639452697334834,0.066738158822734,0.0918047045582595,4.21212971977346e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0521414594882325,0.0042077853615062,0.0438942001796803,0.0603887187967846,4.23958613453857e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB9,Serpin B9,39749,0.0384649484981425,0.00310543114214061,0.0323783034595469,0.0445515935367381,4.49809631623428e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX8,Syntaxin-8,39866,0.056021344461779,0.00452585312146543,0.0471506723437068,0.0648920165798513,4.96826270055192e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0704597333886349,0.00569728605064873,0.0592930527293634,0.0816264140479064,6.14066585879812e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.114316941168422,0.00925826647138475,0.096170738884508,0.132463143452336,7.72883884603372e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.0889969134127021,0.00721097530067411,0.0748634018233808,0.103130425002023,7.76305054347972e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0792534618122588,0.00642478296458566,0.0666608872016709,0.0918460364228467,8.34948753362339e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40009,0.0764598991911313,0.00619945591028089,0.0643089656069808,0.0886108327752819,8.59431636019217e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.032136822274024,0.00260576229980443,0.0270295281664073,0.0372441163816407,8.65772299024439e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.128247248400411,0.0104204669316689,0.10782313321434,0.148671363586482,1.18600289434749e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.085566203512224,0.00695744285858934,0.0719296155093889,0.0992027915150591,1.32526584647064e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBXN1,UBX domain-containing protein 1,37124,0.0792945208709959,0.00645521612744155,0.0666422972612105,0.0919467444807814,1.70420050548688e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40052,0.0818209606265141,0.00667034795160471,0.0687470786413689,0.0948948426116594,1.95185759427148e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.123106731703601,0.0100412926555683,0.103425798098687,0.142787665308515,2.26006786219847e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.09314144247107,0.00760773964316076,0.0782302727704749,0.108052612171665,2.60812791246471e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.144782701483248,0.0118230514199616,0.121609520700123,0.167955882266373,2.68557852605646e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP3R1,Calcineurin subunit B type 1,39749,0.0472006941173072,0.00385735810048952,0.0396402722403477,0.0547611159942666,2.82908577965573e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUB1,NEDD8 ultimate buster 1,39866,0.0955050939160266,0.00781905681348196,0.080179742561602,0.110830445270451,3.69592244743841e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIAE,Sialate O-acetylesterase,39875,0.0535561787328197,0.00438501259451544,0.0449615540475694,0.0621508034180699,3.73776232995773e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.100230587081064,0.00820682798716036,0.0841452042262301,0.116315969935899,3.75922760908214e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPBP,Platelet basic protein,37371,0.0965665374243859,0.00790902641221588,0.0810648456564428,0.112068229192329,4.17467776843488e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0385678997788144,0.00316036009595052,0.0323735939907513,0.0447622055668774,4.20903042811931e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0558300229943876,0.00457583743208772,0.0468613816274956,0.0647986643612795,4.38593865278198e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA13,Carbonic anhydrase 13,39657,0.119399148079262,0.00979646160410755,0.100198083335211,0.138600212823313,5.12033440256611e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.100038493201437,0.00820497082204323,0.0839567503902327,0.116120236012642,5.18636011317807e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0419258791776022,0.00344062812355146,0.0351822480554413,0.0486695102997631,5.63891692538528e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGA,Glycoprotein hormones alpha chain,39858,0.100015547148185,0.0082140865975189,0.0839159374170478,0.116115156879322,5.8899643736016e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP2,Caspase-2,39866,0.0771680908411264,0.00634175851594898,0.0647382441498664,0.0895979375323864,6.47804053876045e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C19orf12,Protein C19orf12,39489,0.0732519871638091,0.00602647143345104,0.061440103154245,0.0850638711733731,7.66682325990201e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37366,0.0998474524456267,0.008215592202409,0.083744891728905,0.115950013162348,8.26057718339832e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0306801119063355,0.00252573790487637,0.0257296656127778,0.0356305581998932,8.45220468097563e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40052,0.0453412064938115,0.0037362380871708,0.0380181798429567,0.0526642331446662,9.5944045370961e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACTB2,Endoribonuclease LACTB2,39868,0.0750415719886476,0.00618362618551599,0.0629216646650363,0.087161479312259,9.63091169957397e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.118085079436091,0.00973226552549768,0.0990098390061156,0.137160319866067,1.06042328998938e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0262901746496935,0.00216956141101481,0.0220378342841045,0.0305425150152825,1.19638899461119e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL11,Eotaxin,40058,0.0429377174178294,0.00354386390486465,0.0359917441642947,0.0498836906713641,1.21380798710917e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID1,Nidogen-1,39892,0.0422460856746518,0.00348856511258064,0.0354084980539938,0.0490836732953099,1.31275176753508e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMFG,Glia maturation factor gamma,37437,0.080969240779743,0.00668774159645906,0.0678612672506832,0.0940772143088027,1.4420870937872e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXJ3,Forkhead box protein J3,37056,0.0504801775686602,0.00417259686834155,0.0423018877067108,0.0586584674306097,1.62746399445165e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0655005014157299,0.0054170521587547,0.0548830791845707,0.0761179236468891,1.65570840436986e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTD,Deoxycytidylate deaminase,37124,0.107715827997551,0.00890641049567587,0.0902592634260263,0.125172392569076,1.7008295842875e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0433465014673583,0.00358656769170537,0.0363168287916158,0.0503761741431008,1.86591524338406e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL7,C-C motif chemokine 7,39866,0.0653108265459465,0.00540881951547026,0.0547095402956248,0.0759121127962682,2.00347027282847e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,39913,0.0263138765477956,0.00218014081378539,0.0220408005527762,0.0305869525428149,2.12756496677791e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0542985245100736,0.0044980389453208,0.0454823681772449,0.0631146808429024,2.21602237599647e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CERT,Ceramide transfer protein,39489,0.0689972705500799,0.00571994228733084,0.0577861836669115,0.0802083574332484,2.34177308423661e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT1,Deaminated glutathione amidase,37043,0.0526990435758556,0.00437418184007613,0.0441256471693064,0.0612724399824048,2.97968702594597e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L1,Bcl-2-like protein 1,37388,0.112179910544705,0.00931618096336633,0.0939201958565068,0.130439625232903,3.18274486145753e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NSFL1C,NSFL1 cofactor p47,40009,0.072591329907072,0.00603386003768265,0.060764964233214,0.08441769558093,3.39966857568103e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP6,Platelet glycoprotein VI,39836,0.0990697890481634,0.00823726313345701,0.0829247533065876,0.115214824789739,3.56376638337464e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TALDO1,Transaldolase,37415,0.0499162012988351,0.00415528663342132,0.0417718394973293,0.0580605631003409,4.48583516709478e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39477,0.0595104930024455,0.00495626322358691,0.0497962170842152,0.0692247689206759,4.55807980009228e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARC,SPARC,39913,0.0785140276464423,0.00655467991037429,0.0656668550221087,0.091361200270776,6.37687337852447e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.0991001329385243,0.00827212718548262,0.0828867636549784,0.11531350222207,6.62617840083171e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.134067066293746,0.0112158880151949,0.112083925783964,0.156050206803528,8.60328540298756e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0824094665502553,0.00690857487153295,0.0688686598020508,0.0959502732984599,1.16420849947656e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TST,Thiosulfate sulfurtransferase,39455,0.0846515771651,0.00709980429368576,0.0707359607494759,0.0985671935807241,1.24369959629265e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0515045608667993,0.00432433747297061,0.0430288594197769,0.0599802623138217,1.43458660739472e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6AP2,Renin receptor,39477,0.0450341419520335,0.00378392579873631,0.0376176473865103,0.0524506365175566,1.60803872507749e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,39866,0.0697689222490418,0.00586633831757659,0.0582708991465917,0.081266945351492,1.76157696253793e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0521007341019306,0.00437976045973458,0.0435164036008508,0.0606850646030104,1.82431317184452e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0559075968152335,0.00470142580724929,0.0466928022330249,0.0651223913974421,1.89857291700942e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PF4,Platelet factor 4,37385,0.106780309815683,0.00898627821477745,0.0891672045147189,0.124393415116647,2.1127622331426e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBN1,Drebrin,37056,0.0578428622739018,0.00487484907590929,0.0482881580851196,0.067397566462684,2.6080709042909e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMT,Catechol O-methyltransferase,39403,0.0937929242745748,0.00790941577914927,0.0782904693474422,0.109295379201707,2.68280024583813e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.0846823714385546,0.00714081684628423,0.0706863704198376,0.0986783724572717,2.82239095989347e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0739375934940142,0.00623951357142817,0.061708146894015,0.0861670400940134,3.12868616858434e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDHB,Succinate dehydrogenase,37382,0.0773365201253734,0.00652981906102446,0.0645380747657655,0.0901349654849813,3.35083845172547e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB2,Calretinin,39489,0.032047272392111,0.00270814865438579,0.0267393010295148,0.0373552437547071,3.58816012096456e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL1,Growth-regulated alpha protein,39839,0.10424382332346,0.00882002270355367,0.0869565788244952,0.121531067822426,4.23634689915151e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37382,0.108927177600716,0.0092155932885795,0.0908646147551006,0.126989740446332,4.43220174496134e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0748646131997064,0.0063378670215885,0.0624423938373929,0.0872868325620199,4.61864853231603e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB1,Beta-crystallin B1,37437,0.0730352408430689,0.00618117382022832,0.0609201401554214,0.0851503415307164,4.64587193851529e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AREG,Amphiregulin,39788,-0.0513321477865328,0.00435089908879816,-0.0598599100005771,-0.0428043855724884,5.42795255219963e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0511755551842822,0.00433667314276687,0.0426756758244592,0.0596754345441053,5.55004376024415e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0392796925408179,0.00333255269408955,0.0327478892604023,0.0458114958212334,6.55341784039006e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37021,0.0772187566629962,0.00655112273012389,0.0643785561119534,0.090058957214039,6.58176903889827e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0503200846645063,0.00427025686748255,0.0419503812042405,0.0586897881247721,6.83356055852555e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR2,GMP reductase 2,37124,0.0733492961765053,0.0062364895371598,0.0611257766836721,0.0855728156693386,8.88285245358453e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0332702378987987,0.00282935629322807,0.0277246995640717,0.0388157762335257,9.08851180251882e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0405433069964266,0.00345157511326355,0.03377821977443,0.0473083942184231,1.00302340285716e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRGN,Neurogranin,37445,0.100158743458044,0.00852543416410159,0.0834488924964048,0.116868594419683,1.02669270082628e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0436934952673215,0.00372591633494679,0.0363906992508258,0.0509962912838172,1.24996999431247e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37043,0.0840022777125807,0.0071633811434148,0.0699620506714877,0.0980425047536737,1.33614257578058e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.102171253729072,0.00871589396821292,0.0850881015513748,0.119254405906769,1.39005293099425e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,39931,0.0959193915718883,0.00819666464705708,0.0798539288636564,0.11198485428012,1.66597401149176e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIAPIN1,Anamorsin,39913,0.0686453959999257,0.0058701850427978,0.0571398333160421,0.0801509586838094,1.83707073569148e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.122116001828255,0.0104480459077494,0.101637831849066,0.142594171807444,1.9819204135471e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESYT2,Extended synaptotagmin-2,37388,0.0896303485319957,0.00766772333657601,0.0746016107923068,0.104659086271685,2.04685567409178e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THTPA,Thiamine-triphosphatase,37345,0.096001803339379,0.00821387420801872,0.0799026098916623,0.112100996787096,2.08627892858659e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RP2,Protein XRP2,39788,0.0453821261627361,0.00388582999753846,0.0377658993675607,0.0529983529579115,2.19434712424355e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0705765299513731,0.00604702965831385,0.058724351821078,0.0824287080816683,2.52559091478791e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37411,0.0654200059064244,0.0056168603818525,0.0544109595579935,0.0764290522548553,3.34363952707528e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB2B,Ras-related protein Rab-2B,37368,0.067903823869606,0.00583374179901936,0.0564696899435281,0.0793379577956839,3.64068074881511e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37382,0.0956236797450272,0.00821891988256033,0.0795145967752089,0.111732762714845,3.86851744069164e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0672549354033522,0.00578789853656994,0.0559106542716751,0.0785992165350293,4.57893234049381e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YWHAQ,14-3-3 protein theta,37124,0.0802274809179975,0.00690913870307178,0.0666855690599768,0.0937693927760182,5.07121161346354e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.074114040428515,0.00638308127122975,0.0616032011369047,0.0866248797201253,5.12847880649577e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POMC,Pro-opiomelanocortin,37043,0.0763226579264489,0.00659004831581309,0.0634061632274552,0.0892391526254425,7.21346767371296e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0306984986101106,0.00265182003538194,0.025500931340762,0.0358960658794592,7.57684452199726e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP3,Caspase-3,40052,0.0955911998184073,0.00826610390111211,0.0793896361722276,0.111792763464587,8.26466787889041e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0434898271569668,0.00376838984262308,0.0361037830654256,0.050875871248508,1.15539536024584e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.0862397999605348,0.00747386644704606,0.0715910217243245,0.100888578196745,1.17914064757954e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,39720,0.042363826105525,0.00367443098860394,0.0351619413678613,0.0495657108431887,1.2430598035303e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG6,Large proline-rich protein BAG6,39585,0.0396287620367598,0.00343719783600023,0.0328918542781993,0.0463656697953202,1.24570614869338e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0598011402505302,0.00518878178191713,0.0496311279579726,0.0699711525430878,1.37572571993167e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37437,0.0295176597769535,0.00256202679964315,0.0244960872496529,0.034539232304254,1.4307080012979e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE2,Glia-derived nexin,37437,0.0689006146955726,0.0059976988532829,0.0571451249431381,0.0806561044480071,2.0985147147381e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSP1,Lymphocyte-specific protein 1,39866,0.0430875209195204,0.00375333566377092,0.0357309830185294,0.0504440588205114,2.19187364871108e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0575021007056544,0.00502253738156689,0.0476579274377834,0.0673462739735255,3.12983604446019e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.0983048484717012,0.00858943488440876,0.08146955609826,0.115140140845142,3.46428772734469e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NHLRC3,NHL repeat-containing protein 3,36838,0.0339436499264587,0.00296827343640677,0.0281258339911015,0.039761465861816,3.8751362164632e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL8,C-C motif chemokine 8,40003,0.0639298136496595,0.00560683556011384,0.0529404159518364,0.0749192113474826,5.31532998476088e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM2,Paralemmin-2,37388,0.0401724041173379,0.0035235758115471,0.0332661955267056,0.0470786127079702,5.66181415982953e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,39811,0.0947793408864401,0.00831942587267889,0.0784732661759894,0.111085415596891,5.94743078728266e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARCO,Macrophage receptor MARCO,39868,0.0277307373973415,0.00243515721242237,0.0229578292609936,0.0325036455336893,6.28096589347257e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FST,Follistatin,39908,0.0544219441384935,0.00477970777013403,0.0450537169090308,0.0637901713679562,6.39348875929615e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM1,Dynamin-1,37382,0.121383358886874,0.0106726136392368,0.10046503615397,0.142301681619778,7.75629494324975e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAP3,Cytosol aminopeptidase,39587,0.0514045058341458,0.00452141322575682,0.0425425359116624,0.0602664757566292,7.79122099965698e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0411656378696784,0.00361952654179664,0.034071365847757,0.0482599098915998,7.81547948916425e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0782560597330033,0.00688297897618874,0.0647654209396734,0.0917466985263333,8.09206103513925e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRG,Histidine-rich glycoprotein,37380,0.0334737405566624,0.00294562447100914,0.0277003165934845,0.0392471645198403,8.63587425241235e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMTN,Smoothelin,37342,0.101978081437018,0.00897462873816617,0.084387809110212,0.119568353763823,8.73758800451588e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37445,0.0267638524062356,0.00235554952258041,0.0221469753419779,0.0313807294704932,8.80535740966092e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN9,Septin-9,39788,0.0299398908869768,0.00263629351302771,0.0247727556014425,0.0351070261725111,8.93035739318403e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSL,Cathepsin L1,39868,0.0251788380848908,0.0022184014330049,0.0208307712762012,0.0295269048935804,9.63643282249355e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0640865022349377,0.00564600087549928,0.0530203405189591,0.0751526639509163,1.0079017824929e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164,Sialomucin core protein 24,39858,0.0275987789474597,0.00243548570749106,0.0228252269607772,0.0323723309341422,1.18266594444189e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT1,Angiopoietin-1,39794,0.088824361616544,0.00784184182086516,0.0734543516476483,0.10419437158544,1.25235174589803e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FADD,FAS-associated death domain protein,39868,0.0808164967565708,0.00714172745185336,0.0668187109509382,0.0948142825622034,1.41472657154457e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX4,Syntaxin-4,39788,0.0624227268750334,0.00551649584264333,0.0516103950234525,0.0732350587266143,1.4238007310669e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.103833837572168,0.00917323937572112,0.0858542883957549,0.121813386748582,1.4301879070089e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0684570104901927,0.00604985402063951,0.0565992966097393,0.0803147243706462,1.50609093028793e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS10,Regulator of G-protein signaling 10,37411,0.0630911938704968,0.00557749947385249,0.0521592949017459,0.0740230928392477,1.55713230723696e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD244,Natural killer cell receptor 2B4,40058,0.0280459791909434,0.00248128644773025,0.0231826577533921,0.0329093006284947,1.63565346049061e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0687277405828233,0.00608078637682177,0.0568093992842526,0.0806460818813939,1.65849640069847e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAD,Chondroadherin,37124,0.0529322665421273,0.00469054818767028,0.0437387920942935,0.062125740989961,2.12177824435066e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,39866,0.0592008852448233,0.00525276587008197,0.0489054641394626,0.0694963063501839,2.36953421483123e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLUL1,Clusterin-like protein 1,39840,-0.047229252515733,0.00419807352133793,-0.0554574766175553,-0.0390010284139106,2.97587355119024e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.0806275565378069,0.00717018173792402,-0.0946811127441379,-0.0665740003314758,3.15808221840275e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0710915123999498,0.00632425354389845,0.0586959754539088,0.0834870493459908,3.29612283326885e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,39826,0.0676259823043702,0.00601783823047376,0.0558310193726416,0.0794209452360987,3.43077525147224e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICALL2,MICAL-like protein 2,37039,0.0711890372539437,0.00633354725958313,0.0587752846251608,0.0836027898827267,3.52119839554576e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1B,Meprin A subunit beta,39868,0.119739551110976,0.0106997175060253,0.0987681047991665,0.140710997422786,5.78686003487193e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RFC4,Replication factor C subunit 4,37368,0.0222553718311423,0.00198842083581502,0.0183580669929449,0.0261526766693397,5.95058821048704e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB33A,Ras-related protein Rab-33A,37021,0.0699581202043998,0.00625860154835432,0.0576912611696253,0.0822249792391743,7.05600079342718e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL26,C-C motif chemokine 26,39866,0.0887833890529452,0.00794614890742191,0.0732089371943983,0.104357840911492,7.0595067538114e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0434305282473843,0.00388873588053017,0.0358086059215452,0.0510524505732234,7.48449995654849e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0414235450338535,0.00371219854224369,0.0341476358910559,0.0486994541766512,8.65715162470171e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLU,Clusterin,37453,0.0330671958968503,0.00296482768926359,0.0272561336258936,0.0388782581678069,9.21182835927621e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TADA3,Transcriptional adapter 3,37368,0.0410872906056657,0.00368634848134101,0.0338620475822373,0.0483125336290941,1.00168873121915e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPSE,Heparanase,37306,0.0974580655736625,0.00875022196626921,0.0803076305197748,0.11460850062755,1.09657375323227e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0566952790936303,0.00509273045986559,0.0467135273922937,0.0666770307949668,1.11095868212597e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGF,Hepatocyte growth factor,40058,0.0351132830673584,0.00315612422179099,0.0289272795926481,0.0412992865420687,1.19809379764644e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0720088703328072,0.00647058117537972,0.0593265312290629,0.0846912094365514,1.22123891983317e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1,Allograft inflammatory factor 1,39477,0.0545302971767265,0.00490266997951385,0.0449210640168793,0.0641395303365736,1.24798847233582e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0263793806088593,0.00237316082156146,0.0217279853985989,0.0310307758191198,1.33878856171533e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.0943464911145318,0.00848472090917701,0.0777164381325448,0.110976544096519,1.34980792980657e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC22D1,TSC22 domain family protein 1,37411,0.0701521905890593,0.006310178207213,0.0577842413029218,0.0825201398751968,1.37373127958496e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0435928212264199,0.00392371308683636,0.0359023435762206,0.0512832988766192,1.49737265337739e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAN,Neurocan core protein,40009,0.0378580467148598,0.00341058283462838,0.0311733043589882,0.0445427890707314,1.58790599877203e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTC,Probetacellulin,39477,0.076336621485184,0.00687909780000226,0.0628535897971796,0.0898196531731884,1.66000247057919e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF1,Scavenger receptor class F member 1,40052,0.0440778836063598,0.00397600574687697,0.0362849123424809,0.0518708548702386,1.85772950891631e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK6,Kallikrein-6,39889,0.0304184059558551,0.00275029891330548,0.0250278200857763,0.0358089918259338,2.48189058141403e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QA,Complement C1q subcomponent subunit A,39971,-0.0235841678456741,0.00213244337535214,-0.0277637568613643,-0.0194045788299839,2.4883777972982e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0367833178083694,0.00332846533772806,0.0302595257464224,0.0433071098703164,2.74097512114558e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXN,Paxillin,39489,0.0530653247147347,0.00480224494709324,0.043652924618432,0.0624777248110375,2.78657826596309e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0860046079073689,0.00778675694594555,0.0707425642933157,0.101266651521422,2.93030552292207e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0559655149176745,0.00508424451920732,0.0460003956600282,0.0659306341753209,4.42736402175637e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40058,0.0692538242372635,0.00629894747200486,0.056907887192134,0.0815997612823931,5.10181750473002e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH9,Protocadherin-9,37382,0.0340303221727589,0.00309583014273705,0.0279624950929943,0.0400981492525235,5.46639220353048e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARFIP1,Arfaptin-1,37411,0.0707817902068591,0.00644948823737917,0.0581407932615959,0.0834227871521223,6.62135589423511e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM3,Dynamin-3,37411,0.0560881967404314,0.00511073458815615,0.0460711569476453,0.0661052365332174,6.6363055343363e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGF,Placenta growth factor,40058,0.026180531059999,0.00239007879073487,0.0214959766301587,0.0308650854898393,7.97456368792716e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.0965451906994051,0.00882457969420149,0.0792490144987702,0.11384136690004,9.27059635664496e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAL,Integrin alpha-L,37056,0.0434686186769345,0.00397909757750062,0.0356695874250333,0.0512676499288357,1.1594866632996e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0724128240509648,0.00663461144082732,0.0594089856269432,0.0854166624749863,1.28111349731039e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPI,Glucose-6-phosphate isomerase,37445,0.0481346518099944,0.00441657174146579,0.0394781711967214,0.0567911324232673,1.52096996345446e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEMIP2,Cell surface hyaluronidase,37056,0.032464783169004,0.00298000121382769,0.0266239807899017,0.0383055855481062,1.60842193739606e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0723026006707605,0.00664192404045318,0.0592844295514723,0.0853207717900488,1.68111034580253e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBI,Acyl-CoA-binding protein,39793,0.0808087903257471,0.00743342945437273,0.0662392685951765,0.0953783120563176,1.97796846774008e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM3,Junctional adhesion molecule C,37124,0.0511775134968907,0.00471142601979316,0.0419431184980961,0.0604119084956853,2.26941370652115e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0718530758478905,0.00662221670743256,0.0588735311013227,0.0848326205944583,2.5764118858296e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0542481300773367,0.00500817423825228,0.0444321085703622,0.0640641515843112,3.14303125212317e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS2,Thrombospondin-2,39858,-0.0362027853060488,0.00334862572826864,-0.0427660917334554,-0.0296394788786423,3.77991334701176e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0366800696257348,0.00339238732176287,0.0300309904750796,0.0433291487763901,3.90638484655499e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0591776190526784,0.00547611989536478,0.0484444240577635,0.0699108140475934,4.00060074793688e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPACT,Protein IMPACT,37388,0.0557634763658927,0.00515952879452022,0.0456507999286331,0.0658761528031524,4.07714726949529e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0218302009949981,0.00202122158957277,0.0178686066794355,0.0257917953105608,4.24951927448184e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTNB,Dystrobrevin beta,37348,0.0441625954658428,0.00409156421617737,0.0361431296021352,0.0521820613295505,4.76098242041758e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0597505850165023,0.0055396404241982,0.0488928897850738,0.0706082802479308,4.9836247258086e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGLN1,Egl nine homolog 1,39866,0.053433505224466,0.00495519544641678,0.0437213221494891,0.0631456882994429,5.11030936072682e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP2B1,AP-2 complex subunit beta,37039,0.049175285797863,0.00457013221587017,0.0402178266547575,0.0581327449409686,6.86546871861637e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37411,0.0624686034306245,0.00580782400878365,0.0510852683734085,0.0738519384878404,7.13296425580456e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0323622927690882,0.00301051004932001,0.026461693072421,0.0382628924657554,7.61851974926552e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMSB10,Thymosin beta-10,39858,0.0771677407626809,0.00718274724893987,0.0630895561547587,0.091245925370603,7.85189062164448e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0862207698332203,0.00804080073585205,0.0704608003909503,0.10198073927549,1.02375863663715e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.119612689825917,0.0111665688297471,0.0977262149196123,0.141499164732221,1.10458388723302e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASS1,Argininosuccinate synthase,37021,0.0796203150181524,0.007451627028805,0.0650151260416946,0.0942255039946102,1.53776295195304e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH7,Protocadherin-7,37382,0.033427131050644,0.00312885129228566,0.0272945825177641,0.0395596795835239,1.5512865324402e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XG,Glycoprotein Xg,39985,0.0298470760225493,0.00279582627754968,0.024367256518552,0.0353268955265467,1.62380557781344e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNMT,Histamine N-methyltransferase,39669,0.0458599550573313,0.00429842380185708,0.0374350444056914,0.0542848657089712,1.74893857987358e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0663142384852488,0.00621976167922425,0.0541235055939692,0.0785049713765283,1.96762890067191e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA6,Integrin alpha-6,39866,0.0524824168659949,0.00492893849463584,0.0428216974165086,0.0621431363154811,2.18761155857668e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0570647624910152,0.00536714411687439,0.0465451600219414,0.0675843649600891,2.5863843948585e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZD2,PDZ domain-containing protein 2,37021,0.0594652703321237,0.00559125300287423,0.0485064144464902,0.0704241262177572,2.60781729967438e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APP,Amyloid-beta precursor protein,39829,0.0657668363649614,0.00618662300793329,0.0536410552694122,0.0778926174605107,2.63233818008375e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7,Complement component C7,37149,-0.0316746276829627,0.00298748628585152,-0.0375301008032317,-0.0258191545626938,3.69288090039639e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP10,Caspase-10,39489,0.0701426949330819,0.00664029539893393,0.0571277159511714,0.0831576739149924,5.40081082016485e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0592605180757611,0.00561276002966665,0.0482595084176145,0.0702615277339077,5.69570693173572e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0469132863349129,0.00444302220608779,0.0382049628109808,0.055621609858845,5.82976072603068e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37430,0.0472742889738361,0.00447788354755684,0.0384976372206247,0.0560509407270475,5.9262302478749e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DXO,Decapping and exoribonuclease protein,37388,0.044698837645129,0.00423814839473206,0.0363920667914542,0.0530056084988038,6.62573972719787e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0638632553837066,0.00606209919033441,0.0519815409706511,0.075744969796762,7.54809345523598e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,39587,0.0660137201656471,0.00627029630687848,0.0537239394041653,0.0783035009271289,7.82221715282656e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT2A1,Bile salt sulfotransferase,39866,0.054566155514492,0.00518860728547622,0.0443964852349586,0.0647358257940254,8.79782930403848e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIF,Macrophage migration inhibitory factor,39826,0.0665815722289813,0.00634120728576655,0.0541528059488788,0.0790103385090837,1.0494869052137e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPB,Natriuretic peptides B,39585,-0.123644709217272,0.0117799955878691,-0.146733500569495,-0.100555917865048,1.09396519942162e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C8B,Complement component C8 beta chain,37453,0.0296319703525091,0.00282328536590367,0.0240983310353379,0.0351656096696803,1.13493353214572e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0328377716974468,0.00312977344591663,0.0267034157434503,0.0389721276514434,1.13908330769739e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGFAC,Hepatocyte growth factor activator,37318,0.0276542077679492,0.0026349474828013,0.0224897107016587,0.0328187048342398,1.14226807678543e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARD3,Partitioning defective 3 homolog,37169,0.0721622807701831,0.006882080912503,0.0586734021816772,0.0856511593586889,1.26702470649987e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0249105937947404,0.00237580393899664,0.020254018074307,0.0295671695151738,1.2679162179127e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA3,Annexin A3,39985,0.0679361795798555,0.00648890613466511,0.0552179235559119,0.0806544356037991,1.43922023979599e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRZB,Secreted frizzled-related protein 3,39695,0.0256650756840793,0.00245190877583884,0.0208593344834351,0.0304708168847234,1.47794241610481e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLNK,B-cell linker protein,37056,0.0381363008636772,0.00364231656552057,0.0309973603952569,0.0452752413320975,1.488677465916e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPA1,Inositol monophosphatase 1,39749,0.0596523888739457,0.00570452350728654,0.0484715227996641,0.0708332549482273,1.64632274176418e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD84,SLAM family member 5,39866,0.0302517503294201,0.00289436615394664,0.0245787926676847,0.0359247079911555,1.73408505675111e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDS,Iduronate 2-sulfatase,40058,0.00874175874927407,0.000837092579995208,0.00710105729248346,0.0103824602060647,1.90005187203694e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0493430511530512,0.00472581750977837,0.0400804488338856,0.0586056534722168,1.9502542358064e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37124,0.0674657633477156,0.00646240504094625,0.054799449467461,0.0801320772279703,2.04828286427902e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.051924862702943,0.00497775843512438,0.0421684561700992,0.0616812692357868,2.15169594558651e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0525843730421154,0.0050424014835155,-0.0624674799498058,-0.042701266134425,2.21756707249896e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BDNF,Brain-derived neurotrophic factor,37437,0.080063369627047,0.00767605691576837,0.065018298072141,0.095108441181953,2.24921848267945e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37368,0.0541089561573353,0.00518924073040718,0.0439380443257372,0.0642798679889334,2.32652699839343e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0455247525540395,0.00438943182518462,0.0369214661766777,0.0541280389314014,4.01038184358591e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.030765548238277,0.00296751183366653,0.0249492250442906,0.0365818714322634,4.18051694492969e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0359349359429065,0.00346626705493361,0.0291410525152367,0.0427288193705764,4.36618418190801e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0231163649684702,0.00223379425235654,0.0187381282338514,0.0274946017030891,5.09448991721332e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0510704839520262,0.00493839930577411,0.041391221312709,0.0607497465913435,5.69687222525566e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAV,Integrin alpha-V,40030,0.0158711643610392,0.00153787819855382,0.0128569230918737,0.0188854056302047,6.82426277354125e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0266332477127367,0.00258477669553991,0.0215670853894785,0.0316994100359949,8.08203812640573e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS1,Nephrin,37056,0.032872914917429,0.00318950930414812,0.0266214766812987,0.0391243531535593,8.17220721855925e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.084905784321242,0.00825180202525176,0.0687322523517485,0.101079316290735,9.42855636173321e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0280478796783283,0.00272750600387187,0.0227019679107395,0.0333937914459172,9.99875220201108e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB6,Integrin beta-6,39587,0.0283317120887251,0.00275887745300036,0.0229243122808444,0.0337391118966058,1.15951137282812e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0316237131874972,0.00307877519864097,-0.0376581125768336,-0.0255893137981609,1.16662065309687e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0837009778979219,0.00816113809407513,0.0677051472335346,0.0996968085623091,1.36786622684025e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRBP,Acrosin-binding protein,37368,0.036581154570778,0.00357492413400587,0.0295743032681264,0.0435880058734295,1.73826608700846e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0637031104144088,0.00622727883122964,0.0514976439051987,0.0759085769236189,1.79968351463528e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0469727640966146,0.00459393364984904,0.0379686541429105,0.0559768740503187,1.88075732575965e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRN1,Secernin-1,39866,0.0533593632431123,0.00522757061656895,0.0431133248346372,0.0636054016515875,2.18445779324856e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0412670180748669,0.00404318015667078,0.0333423849677922,0.0491916511819416,2.21007704078223e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA9,Carbonic anhydrase 9,40030,-0.0410515672246809,0.00402510625864879,-0.0489407754916326,-0.0331623589577293,2.37686198927559e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0462076063851259,0.00453089426722612,0.0373270536213627,0.0550881591488891,2.47081026047965e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRK5,G protein-coupled receptor kinase 5,39585,0.0502410456600753,0.00493153017307414,0.04057524652085,0.0599068447993007,2.67681204497003e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO1A,Coronin-1A,39520,0.0847610791207444,0.00832801562034053,0.068438168504877,0.101083989736612,2.96355579978674e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG2,Bone marrow proteoglycan,37437,-0.0479946532510043,0.004716342033464,-0.0572386836365937,-0.0387506228654148,3.09263712308333e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0543918545342036,0.00534630500697661,0.0439130967205294,0.0648706123478777,3.191297010964e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0268200730712358,0.0026371301211169,0.0216512980338467,0.031988848108625,3.19573010751048e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LARP1,La-related protein 1,37368,0.0606907285412496,0.00596936207010095,0.0489907788838517,0.0723906781986474,3.4003172400293e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2,Brorin,39684,0.0363495875673088,0.00358220055019575,0.0293284744889251,0.0433707006456925,4.03874334468732e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,39788,0.032146432664872,0.00317040064358324,0.0259324474034489,0.0383604179262952,4.36437192475939e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO2,Gamma-enolase,40009,0.0623375631152339,0.00615388656259659,0.0502759454525446,0.0743991807779232,4.80868217651124e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0413030862298686,0.00407862511363194,0.03330898100715,0.0492971914525872,5.13848819885853e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABHD14B,Protein ABHD14B,39687,0.05411898837476,0.00534840984785784,0.0436361050729586,0.0646018716765614,5.399514887914e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40LG,CD40 ligand,40058,0.0730655245947246,0.00723341063923446,0.0588880397418251,0.0872430094476242,6.42943294877688e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0539978100538891,0.00535189959228505,0.0435080868530104,0.0644875332547678,7.24044987913329e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,36874,0.0502764647541578,0.0049841982479245,0.0405074361882258,0.0600454933200898,7.70294625845612e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.085724259627411,0.00850326564222072,0.0690578589686584,0.102390660286164,8.10633975552746e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0560085256876194,0.0055603720166751,0.0451101965349362,0.0669068548403026,8.83940651093459e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUS,RNA-binding protein FUS,39455,0.0367631081865447,0.00365099093892573,0.0296071659462503,0.0439190504268391,8.92207043810265e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB10,Ras-related protein Rab-10,37437,0.0500632633740039,0.00497831313289079,0.0403057696335379,0.0598207571144698,1.04352505162834e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0440803126731022,0.00438493674568607,0.0354858366515575,0.0526747886946469,1.05557947205053e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMB,RGM domain family member B,40009,0.0238131666835602,0.00236969091772118,0.0191685724848267,0.0284577608822938,1.08874845204921e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANPEP,Aminopeptidase N,39891,0.0260459669354511,0.00259776414715381,0.0209543492070297,0.0311375846638726,1.37084936178425e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C5,Complement C5,37453,0.0142131309735598,0.00141742152911395,0.0114349847764965,0.0169912771706232,1.39431375180587e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0599547137508383,0.0059861266391215,0.0482219055381602,0.0716875219635164,1.53268256703753e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDUA,Alpha-L-iduronidase,40030,0.0427274679933285,0.00426787879099188,0.0343624255629844,0.0510925104236726,1.5901442113312e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA4,Annexin A4,39783,0.0673129693842181,0.00673357011842633,0.0541151719521025,0.0805107668163337,1.84902407250343e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.0903889461054314,0.00903971025671641,0.0726711140022672,0.108106778208596,1.86415353794314e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0626851590939285,0.0062808655400136,0.0503746626355018,0.0749956555523551,2.24946396090755e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37382,0.0778542648423558,0.00780677423529103,0.0625529873411854,0.0931555423435262,2.41743701226261e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT2,Angiopoietin-2,40030,-0.0352829340792759,0.00354334614731126,-0.0422278925280059,-0.0283379756305458,2.72871325900017e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO3,Forkhead box protein O3,39477,0.0904067551501257,0.00908229415151541,0.0726054586131555,0.108208051687096,2.83677313937816e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0454158090771807,0.00457250736359051,-0.0543779235098181,-0.0364536946445433,3.51165266832614e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37403,0.0208351216972194,0.00209739139910103,0.0167242345549814,0.0249460088394575,3.56043644847874e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37039,0.073920763753974,0.00744160977032077,0.0593352086041452,0.0885063189038027,3.59222668618846e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0580102920991083,0.00584646828667226,0.0465512142572307,0.069469369940986,3.99369702067248e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0185395286094679,0.00187467414497657,-0.022213889933622,-0.0148651672853139,5.37980257824449e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0825329894995367,0.00834483597108766,0.0661771109962049,0.0988888680028685,5.50782722652691e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0402895588628799,0.00407423471057425,0.0323040588301544,0.0482750588956055,5.5687679742971e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0519425268783255,0.00525412623762597,0.0416444394525786,0.0622406143040724,5.59010265886003e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0220562316947691,0.00223138249319037,0.017682722008116,0.0264297413814222,5.80640722696986e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARK7,Parkinson disease protein 7,39858,0.048219604501335,0.00487979007599397,0.0386552159523869,0.0577839930502832,5.82692876345143e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF2,Fibroblast growth factor 2,39866,0.0611893925713003,0.00619592479906744,0.0490453799651281,0.0733334051774725,6.16800187869055e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0382562486503815,0.0038748261533183,0.0306615893898776,0.0458509079108854,6.35379382869651e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN3,Ataxin-3,37388,0.0563278775268776,0.00571651851741642,0.0451235012327414,0.0675322538210138,7.89885767229702e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA4,Laminin subunit alpha-4,39931,0.0308105881986143,0.00312847695995808,0.0246787733570964,0.0369424030401321,8.07887660629541e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSS,Cathepsin S,36543,0.0224092858974079,0.00227712165157422,0.0179461274603224,0.0268724443344933,9.03899952701045e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR2,Folate receptor beta,40009,-0.026340379226804,0.00268011657353026,-0.0315934077109233,-0.0210873507426847,9.8714921260323e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0598209798351899,0.00609840033208042,0.0478681151843122,0.0717738444860675,1.1879723453268e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0757382994046878,0.00772994296207515,0.0605876111990205,0.090888987610355,1.32881551593685e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0273587402441899,0.00279694449747985,-0.0328407514592505,-0.0218767290291294,1.56044265639386e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0211146408055942,0.00215987554959558,0.0168812847283869,0.0253479968828015,1.65470260785046e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML1,Trem-like transcript 1 protein,37445,0.0482687823820786,0.00493642170081038,0.0385933958484902,0.0579441689156669,1.65886604619414e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTF2,Transcription termination factor 2,37039,0.0447538692816364,0.00458587747788661,0.0357655494249787,0.0537421891382942,2.0093461178358e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0395640772605587,0.00405952849807728,0.0316074014043273,0.0475207531167902,2.28373437339875e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0689105045459552,0.00707445532714075,0.0550445721047593,0.0827764369871511,2.39294706751017e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPCAM,Epithelial cell adhesion molecule,39867,-0.0860678180504557,0.00884438079401637,-0.103402804406728,-0.0687328316941836,2.55547011126849e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCA,Tubulin-specific chaperone A,37124,0.0783844885842859,0.00805663482015393,0.0625934843367842,0.0941754928317876,2.68787251986296e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAP,Prosaposin,37347,0.025322838894251,0.00260345866923647,0.0202200599025475,0.0304256178859545,2.74837900744909e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0515754575944223,0.00531330237234872,0.0411613849446189,0.0619895302442258,3.33139362391807e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.0720453666408746,0.00742406179038082,0.0574942055317282,0.086596527750021,3.42990353581087e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0496103286742136,0.00511529437861968,0.039584351692119,0.0596363056563081,3.53609448880805e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP3,Syntaxin-binding protein 3,39477,0.0398022802828667,0.00411077563052352,0.0317451600470406,0.0478594005186928,4.1321551690495e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0590787352141218,0.0061051049178562,0.0471127295751236,0.0710447408531199,4.35852516623807e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRD2,Protein ZNRD2,37382,0.0612671335480307,0.0063317515795101,0.0488569004521909,0.0736773666438705,4.48882378784871e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK7,Kallikrein-7,36818,0.0350049095493464,0.00363867897801011,0.0278730987524466,0.0421367203462463,7.77047915576956e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0514930467173523,0.00536239847642632,0.0409827457035567,0.0620033477311479,8.92268935993044e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTL1,Cytokine-like protein 1,37437,0.0203916090913591,0.00212933481283476,0.0162181128582029,0.0245651053245152,1.17498435677395e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39477,0.03975822404175,0.00416589687578711,0.0315930661652072,0.0479233819182927,1.57718930127931e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL3,C-C motif chemokine 3,39866,0.0556725090320927,0.00583638729132618,0.0442331899410934,0.067111828123092,1.64722613587328e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40009,0.0405035250207657,0.00424860587865867,0.0321762574985947,0.0488307925429367,1.73431560577018e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMD,Dystrophin,37043,0.0459186970014006,0.00481718798902179,0.0364770085429179,0.0553603854598833,1.80463776273457e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEPD,Xaa-Pro dipeptidase,37445,0.0228047175478498,0.0023926212556699,0.0181151798867368,0.0274942552089628,1.81333206739177e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0245019568067194,0.00257814699983664,0.0194487886870396,0.0295551249263992,2.37134227444285e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0395992958335424,0.00416836853807958,0.0314292934989064,0.0477692981681783,2.39182520068789e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37388,0.0944833074840477,0.00994598001872008,0.0749891866473563,0.113977428320739,2.45453681667562e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL5,Fc receptor-like protein 5,39858,-0.0493200590598607,0.00519722535906538,-0.0595066207636288,-0.0391334973560925,2.63640551589534e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF22,Kinesin-like protein KIF22,37021,0.107224952537835,0.0113132170351603,0.0850510471489208,0.129398857926749,3.0339617240545e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0213856894876022,0.00225732008925081,0.0169613421126706,0.0258100368625338,3.06409399856399e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL1,Chordin-like protein 1,39908,0.0270019642599366,0.00285198089590651,0.0214120817039598,0.0325918468159133,3.24679805406762e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS27,Serine protease 27,39818,0.0353679186408308,0.00373572441820988,0.0280458987811394,0.0426899385005222,3.25862647416148e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0677197394347992,0.00715333633334004,0.0536992002214527,0.0817402786481457,3.28678618990957e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0598225712070031,0.00632455876139733,0.0474264360346644,0.0722187063793419,3.63717141382209e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF7,SLAM family member 7,39866,-0.0506831346173193,0.00536476159134806,-0.0611980673363615,-0.0401682018982771,3.94222078093655e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0331322752771582,0.00351083698059132,0.0262510347951993,0.0400135157591172,4.44814880472192e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0572584396038638,0.0060695311946983,0.0453621584622551,0.0691547207454725,4.59285412528766e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0468469047872562,0.00496776887763277,0.0371100777870959,0.0565837317874164,4.76500469586615e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1F,Protein phosphatase 1F,37437,0.0466551824839437,0.00495472501028202,0.0369439214637909,0.0563664435040964,5.41453623221902e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB4,Ephrin type-B receptor 4,40052,-0.020573174179906,0.00218555241552065,-0.0248568569143265,-0.0162894914454856,5.44205933251727e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0503187801981671,0.00534892589124686,0.0398348854513233,0.060802674945011,5.77304967905374e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0418818550058394,0.00446502118385612,0.0331304134854815,0.0506332965261974,7.63299252458969e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0671263874877689,0.00715710855213482,0.0530984547255847,0.0811543202499531,7.70589916457602e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC13,Mucin-13,39489,0.0441639335371747,0.00470992580019061,0.0349324789688011,0.0533953881055483,7.71515555576741e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRB1,Chymotrypsinogen B,39858,0.0465298269844757,0.00497208932133913,0.036784531914651,0.0562751220543004,9.16389563430111e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADD1,Alpha-adducin,37124,0.0601493211373299,0.00643033458959841,0.0475458653417171,0.0727527769329428,9.77561388581684e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD72,B-cell differentiation antigen CD72,37124,0.0361362004341559,0.00386970581649908,0.0285515770338177,0.0437208238344941,1.13352671303359e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0430813879745884,0.0046216527722376,0.0340229485410027,0.0521398274081741,1.32955753917323e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0315932387821595,0.00339864731863678,0.0249318900376314,0.0382545875266876,1.68581249503595e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXN,"Frataxin, mitochondrial",40030,0.0633412355585922,0.00683117838260869,0.0499521259286792,0.0767303451885052,2.045470261022e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0722827788793905,0.00780516564675175,0.0569846542117571,0.0875809035470239,2.33381333016848e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18,Interleukin-18,39795,0.0391900758775935,0.00423857580915109,0.0308824672916574,0.0474976844635296,2.61836609366327e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD46,Membrane cofactor protein,39777,0.0243842665697156,0.00263808138085691,0.019213627063236,0.0295549060761951,2.6894522811414e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD83,CD83 antigen,39866,0.0281458442236407,0.00305067249365455,0.0221665261360777,0.0341251623112036,3.14965856656813e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0345483363701301,0.00374917005005421,0.0271999630720238,0.0418967096682363,3.5676128667508e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP6,Gastrotropin,39564,0.0463765929623448,0.00503491895770247,0.0365081518052479,0.0562450341194416,3.63183719917013e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC79,Protein unc-79 homolog,36962,0.0486254181665,0.00527870411436015,0.0382791581023541,0.0589716782306459,3.69514959266105e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39477,0.033754042736698,0.00366791504655147,0.0265649292454572,0.0409431562279389,3.93101794561773e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,39788,0.0511618319933494,0.00556009932088641,0.0402640373244121,0.0620596266622868,3.95529172768393e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PER3,Period circadian protein homolog 3,37056,0.100707030675465,0.0109503191396994,0.0792444051616545,0.122169656189276,4.23702305230473e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGXT,Serine--pyruvate aminotransferase,39868,0.0665479418747346,0.00724251771510935,0.0523526071531202,0.0807432765963489,4.46219424051172e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0297247260377502,0.00323742036425528,0.0233793821238098,0.0360700699516905,4.75608378195619e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFAP,Glial fibrillary acidic protein,39453,0.037256232471004,0.00406586642626717,0.0292871342755203,0.0452253306664877,5.65523392873713e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37043,0.0743930957104778,0.00812739516340647,0.0584634011902011,0.0903227902307545,6.32028031469305e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSC2,Desmocollin-2,39673,-0.0283069342113494,0.00309670392159333,-0.0343764738976724,-0.0222373945250265,6.92608641274467e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSD,Cathepsin D,38721,0.0333621679877455,0.00365770181758494,0.026193072425279,0.040531263550212,8.37647679425052e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX9,Sorting nexin-9,39868,0.0587992049040587,0.00644948379601589,0.0461582166638676,0.0714401931442499,8.63124021523811e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.0735050548983033,0.00807957501662555,0.0576690878657172,0.0893410219308894,1.03283365698771e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3BP,Galectin-3-binding protein,37453,0.0255494022659613,0.00280897299649887,0.0200438151928235,0.0310549893390991,1.0691451283842e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS2,Trypsin-2,39931,0.0433473879655006,0.00477773843565552,0.0339830206316157,0.0527117552993854,1.29192019909884e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0224469273508505,0.00247466393189164,0.0175965860443429,0.0272972686573581,1.31741867006546e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRDT,Bromodomain testis-specific protein,37021,0.0309489103584992,0.00341238063190458,0.0242606443199662,0.0376371763970322,1.3619363956531e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0131892734921477,0.00145807582999901,0.0103314448653497,0.0160471021189458,1.65305407394007e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREH,Trehalase,37437,0.0634655562084949,0.00701642045093889,0.0497133721246547,0.0772177402923351,1.6927144617675e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC1,MANSC domain-containing protein 1,39913,-0.0227177774522169,0.00251580711653085,-0.0276487594006174,-0.0177867955038164,1.90787270658142e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF6,SLAM family member 6,39477,0.0317148695143226,0.00351240745454561,0.0248305509034132,0.038599188125232,1.92454072206297e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,39788,0.0297730236114018,0.00330220697019178,0.0233006979498259,0.0362453492729777,2.16679614860191e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOA,Elongin-A,39788,0.0428997998697482,0.00476337004818589,0.0335635945753039,0.0522360051641926,2.37069486821502e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBD,Thrombomodulin,39868,0.022776528019472,0.00252933700177829,0.0178190274959865,0.0277340285429574,2.39638802978113e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5,T-cell surface glycoprotein CD5,40003,0.0275376799800137,0.00305844460352124,0.0215431285571121,0.0335322314029153,2.41876784600098e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLB1,Beta-galactosidase,39749,0.0353368795916337,0.0039246470729965,0.0276445713285605,0.0430291878547068,2.42238548710854e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRK1,Protein BRICK1,39489,0.037246466947912,0.004140146515572,0.0291317797773909,0.0453611541184331,2.59548271458243e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN2,Matrilin-2,39885,0.0249079709105817,0.00276894173525648,0.019480845109479,0.0303350967116844,2.61052522645354e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPLAH,5-oxoprolinase,37043,0.057968154596708,0.00645320824088411,0.0453198664445752,0.0706164427488409,2.99293578577891e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.025180176375013,0.00280840034191028,0.0196757117048689,0.0306846410451571,3.40516996389581e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILP,Rab-interacting lysosomal protein,39984,0.0494091378382866,0.00552331423358757,0.038583441940455,0.0602348337361182,4.09571741695361e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0601940636560884,0.00673454107199425,0.0469943631549797,0.0733937641571971,4.39113548083306e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML2,Trem-like transcript 2 protein,39858,0.0275508480692784,0.00308361616440774,0.0215069603870392,0.0335947357515175,4.52450358731279e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0751056038258924,0.00840582597006522,0.0586301849245645,0.0915810227272202,4.608138718989e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37432,0.0160175959161727,0.00179337503102026,0.0125025808553729,0.0195326109769724,4.73541238479283e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM1,Probable carboxypeptidase X1,39913,0.056394172022888,0.00632314915061246,0.0440007996876876,0.0687875443580885,5.2183366752035e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMM2,Phosphomannomutase 2,37021,0.0500871042766618,0.00561672597747614,0.0390783213608086,0.0610958871925151,5.39201375029508e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0232576586870262,0.00260856518445282,0.0181448709254987,0.0283704464485537,5.46993083672825e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELE,E-selectin,40052,0.0412282841103912,0.0046336866375315,0.0321462583008295,0.0503103099199529,6.30478803286822e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GET3,ATPase GET3,37437,0.0463423560299253,0.00521145477464506,0.036127904671621,0.0565568073882296,6.72627503862409e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.039745460579914,0.00447065419458995,0.0309829783585177,0.0485079428013103,6.87720435895586e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A13,Protein S100-A13,37056,0.0287571288162902,0.00324002790856214,0.0224066741155084,0.035107583517072,7.84441254595017e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPL,Periplakin,37056,0.0264767334517125,0.00299181574570782,0.0206127745901252,0.0323406923132998,9.87952096859608e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK4,Serine/threonine-protein kinase 4,39868,0.0716281977665903,0.00811532564112902,0.0557221595099775,0.0875342360232032,1.19216125656325e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENAH,Protein enabled homolog,39587,0.0394288489618859,0.00446743374609551,0.0306726788195387,0.048185019104233,1.1989979720541e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0232611471936322,0.00263799445614761,0.0180906780595829,0.0284316163276815,1.31243437184602e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME1,Proteasome activator complex subunit 1,39738,0.0302730956374272,0.00344030916018548,0.0235300896834636,0.0370161015913907,1.51314630946148e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OCLN,Occludin,37411,0.0352149020683788,0.00400249125817224,0.0273700192023612,0.0430597849343964,1.55590624756551e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYT1,Synaptotagmin-1,37388,0.0303135780893876,0.00345406467809448,0.0235436113203224,0.0370835448584528,1.89130144947463e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0260576068791488,0.00297849403498477,0.0202197585705787,0.031895455187719,2.41228837205717e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1,Integrin beta-1,39862,0.0176884921888035,0.0020223222353669,0.0137247406074844,0.0216522437701227,2.41380864708292e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0313826367836113,0.00358782116195395,0.0243505073061816,0.0384147662610411,2.44738081739919e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDT,D-dopachrome decarboxylase,37437,0.0326279259487186,0.00373896127555032,0.0252995618486399,0.0399562900487972,2.93056088862461e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0543008707853666,0.00623500395337797,0.0420802630367458,0.0665214785339874,3.42270755772168e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAN,Brevican core protein,39749,0.0269568403759702,0.00309942215496704,0.0208819729522348,0.0330317077997056,3.72416109109883e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0264184584137332,0.00303789468030276,0.0204641848403398,0.0323727319871266,3.7584583661766e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL25,C-C motif chemokine 25,40058,0.0403157492507372,0.00463820140612811,0.0312248744947261,0.0494066240067483,3.89333962112997e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0366772241356765,0.00422180456192091,0.0284024871943115,0.0449519610770415,4.13469159402435e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVALB,Parvalbumin alpha,39971,0.0922482157756237,0.0106243234464419,0.0714245418205975,0.11307188973065,4.22840568472614e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.030755362856489,0.00354327717882804,-0.037700186126992,-0.023810539585986,4.33740276142487e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOE,Apolipoprotein E,37453,0.0585408279882555,0.00676082388809421,0.0452896131675908,0.0717920428089201,5.29789338776192e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0591344755644691,0.00683202122921524,0.0457437139552072,0.072525237173731,5.37339310944959e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLTA,Clathrin light chain A,39585,0.0374432230294887,0.00433603949550298,0.0289445856183028,0.0459418604406745,6.40911093692286e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0278377335430257,0.00322529241620302,0.0215161604072678,0.0341593066787836,6.6461175805605e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGMN,Legumain,39931,0.0288071997700611,0.00334323808251753,0.0222544531283268,0.0353599464117955,7.53279398011423e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0214704692389931,0.00249599713327851,0.0165783148577672,0.026362623620219,8.55345059489823e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.024480111477627,0.00285044366215667,-0.0300669810554541,-0.0188932418997999,9.65415419002432e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF15,Growth/differentiation factor 15,40052,-0.0338465677044911,0.00394718493775318,-0.0415830501824874,-0.0261100852264949,1.08057637790592e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0298287958405611,0.00348013733992033,0.0230077266543173,0.036649865026805,1.11860460195664e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH3,Neurexophilin-3,37056,0.0236679014902888,0.00277000388863731,0.0182386938685597,0.0290971091120179,1.43326694989001e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR3,Toll-like receptor 3,40058,0.0484293387757573,0.00567115212128583,0.037313880618037,0.0595447969334775,1.46506360018952e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0537373561368625,0.0062952962030092,0.0413985755789644,0.0660761366947605,1.5142732058603e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0522726325973909,0.00612354280742995,0.0402704886948283,0.0642747764999536,1.5360950708222e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,39817,0.0314444459739721,0.00368479057348144,0.0242222564499485,0.0386666354979957,1.54492900020717e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOTL2,Angiomotin-like protein 2,37333,0.0385306992283817,0.0045147255249127,0.0296818371995528,0.0473795612572106,1.55753724522543e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0336867433492672,0.0039480864260721,0.0259484939541659,0.0414249927443685,1.584354264732e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCS,Copper chaperone for superoxide dismutase,39749,0.0373864744178192,0.00439661317945851,0.0287691125860805,0.0460038362495578,2.00182968267573e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0416879304750202,0.00490841864207867,0.032067429936546,0.0513084310134944,2.22498555731206e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37169,0.0276632661644096,0.00326362014211621,0.0212665706858619,0.0340599616429574,2.56842092519173e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37169,0.0599876933154193,0.00708369820075097,0.0461036448419474,0.0738717417888912,2.74623391699874e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WDR46,WD repeat-containing protein 46,37368,0.0284638415289078,0.00336283133585942,0.0218726921106233,0.0350549909471922,2.84151280687383e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM1,Intercellular adhesion molecule 1,39822,0.0223878199967749,0.00264611587421681,0.01720143288331,0.0275742071102399,2.88719533351011e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0486156974836196,0.00574913012704391,0.0373474024346136,0.0598839925326257,3.0424022434866e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0369181935040298,0.00436693220831401,0.0283590063757343,0.0454773806323252,3.06002627564713e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0407017384747459,0.00482112875517226,0.0312523261146083,0.0501511508348835,3.43189814251858e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL19,C-C motif chemokine 19,40009,0.0907623661114665,0.0107644888723983,0.0696639679215657,0.111860764301367,3.6929454108525e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOF,Apolipoprotein F,37445,0.0202903840916554,0.00241242103389872,0.0155620388652139,0.0250187293180968,4.47529130793341e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0475603709955228,0.00566423346325804,0.0364584734075371,0.0586622685835086,4.97617345244154e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COLEC12,Collectin-12,39862,0.0193763444307017,0.00231191514032367,0.0148449907556673,0.0239076981057361,5.67576627897913e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTN,Pleiotrophin,39585,0.0392682694903709,0.00469283613322297,0.0300703106692538,0.0484662283114879,6.36391989459892e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0656367879934739,0.0078447567775956,0.0502610647093865,0.0810125112775613,6.48756160852493e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37411,0.0275093480578395,0.00328929735440355,0.0210623252432086,0.0339563708724705,6.69043047833591e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP1,Guanylate-binding protein 1,37376,0.049610659245497,0.00593241766236801,0.0379831206272557,0.0612381978637383,6.72896285094151e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XRCC4,DNA repair protein XRCC4,39489,0.0288979496540845,0.00345776526831592,0.0221207297281853,0.0356751695799837,6.94531874735714e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGRN,Neugrin,37388,0.0166234779854683,0.0019904533133263,0.0127221894913487,0.0205247664795878,7.38427325514948e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0425196389408119,0.00509704970098943,0.0325294215268727,0.0525098563547512,7.90382135515055e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB6,Heat shock protein beta-6,40030,0.0290504245742423,0.00348975835218862,0.0222104982039526,0.035890350944532,9.14019183511524e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MILR1,Allergin-1,39587,-0.038360103931949,0.00460877492899093,-0.0473933027927712,-0.0293269050711267,9.25296529047181e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0430436089659279,0.00518839560893492,0.0328743535724154,0.0532128643594403,1.159481152872e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP6,Bone morphogenetic protein 6,39568,0.0323179244748492,0.00389548985492007,0.0246827643592059,0.0399530845904926,1.16098443086325e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCT,Secretin,37039,0.0341222634557547,0.00411945903605107,0.0260481237450947,0.0421964031664148,1.31417872931926e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0256617287135157,0.003100461352274,0.0195848244630587,0.0317386329639728,1.36354420057974e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40058,0.057135168828507,0.00690368723799022,0.0436039418420461,0.0706663958149678,1.37164368227376e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST2,Bone marrow stromal antigen 2,40009,0.0409275560297966,0.0049539936590275,0.0312177284581026,0.0506373836014905,1.54867455169168e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID2,Nidogen-2,39858,0.0558829275550314,0.00676511799452104,0.0426232962857702,0.0691425588242926,1.56373485363139e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL3,Insulin-like 3,37388,0.055878055047888,0.00676401512720823,0.0426205853985599,0.0691355246972161,1.57687025965463e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0426068333698978,0.00516733554279897,0.0324788557060118,0.0527348110337838,1.79665441864814e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37411,0.0694970457694645,0.00843261347638206,0.0529691233557557,0.0860249681831733,1.85643201098379e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0471371840794196,0.00572769782253147,0.035910896347258,0.0583634718115813,2.0522176858347e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMA,Granzyme A,40058,0.0258790071481953,0.00314674563461843,0.0197113857043432,0.0320466285920474,2.11525104763701e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSNAX,Translin-associated protein X,37021,0.0301030305821603,0.00366251951245812,0.0229244923377423,0.0372815688265782,2.23894676382377e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL1,Follistatin-related protein 1,37043,-0.0175146872638619,0.00213342830599216,-0.0216962067436066,-0.0133331677841173,2.42345063906235e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0370292553323897,0.00451329021759442,0.0281832065059047,0.0458753041588748,2.52344346974836e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACYP1,Acylphosphatase-1,37073,0.0502212368122846,0.00612565752587638,0.0382149480615669,0.0622275255630023,2.6570729290869e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG2,Secretogranin-2,39949,0.0236971200595858,0.00289613298106818,0.0180206994166921,0.0293735407024794,2.99044562856005e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0260284954457662,0.00318330444419766,0.0197892187351388,0.0322677721563936,3.14315256035934e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0533377485951191,0.00652345032653744,0.0405517859551057,0.0661237112351325,3.14528972946708e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIT,Vitrin,37437,0.02800067993646,0.0034239834007835,0.0212896724709243,0.0347116874019956,3.1454752580469e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIPF,Gastric triacylglycerol lipase,37043,0.0454981071494909,0.00557230269762797,0.0345763938621401,0.0564198204368417,3.50347354525192e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN6,Dynactin subunit 6,39489,0.0539439010504301,0.00660809982652023,0.0409920253904504,0.0668957767104097,3.50662615244402e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0242546713962309,0.00297788541755239,0.0184180159778282,0.0300913268146336,4.13409591086616e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17D,Interleukin-17D,39587,0.0255605704519346,0.00315459327731452,0.0193775676283982,0.0317435732754711,5.7695966458528e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX16,Syntaxin-16,39477,0.0439050835218956,0.00542521667216616,0.03327165884445,0.0545385081993413,6.25813260697464e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOB,Apolipoprotein B-100,37445,0.0170626043178546,0.00211174836760536,0.0129235775173481,0.0212016311183611,7.02884303334253e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0568734068272082,0.00704575379766165,0.0430637293837913,0.070683084270625,7.493116238005e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAC1,Cartilage acidic protein 1,40052,0.0226117869618743,0.00280248505793238,0.0171189162483269,0.0281046576754218,7.61319781900885e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0234551134852165,0.00291063680045758,0.0177502653563197,0.0291599616141134,8.26408155242401e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0238792499320117,0.00296965929676591,0.0180587177103505,0.0296997821536729,9.53118144572127e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,39858,0.0392976133198583,0.00489342091112634,0.0297065083340507,0.0488887183056659,1.03612288231322e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R1,Interleukin-1 receptor type 1,39826,-0.0167841117067398,0.00209247586911495,-0.0208853644102051,-0.0126828590032745,1.11957602275275e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0708801509003826,0.00883938164109919,0.0535549628838282,0.088205338916937,1.14292264476371e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0442123663145061,0.00551699102309403,0.0333990639092418,0.0550256687197704,1.18976067134166e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOT,Angiomotin,37124,0.0307920219752873,0.00385478001342876,0.0232366531489669,0.0383473908016077,1.48388936883027e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ING1,Inhibitor of growth protein 1,39453,0.0334368516213493,0.00418854051911924,0.0252273122038756,0.041646391038823,1.52788544542386e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0305203252695866,0.00382654907689776,0.023020289078867,0.0380203614603062,1.61341409111772e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0286167140942918,0.00359439318399584,0.02157170345366,0.0356617247349237,1.81200119992628e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0484165176887121,0.00608392466565427,0.0364920253440298,0.0603410100333945,1.86213345304813e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD27,CD27 antigen,39913,-0.0288374440874612,0.00362476353214169,-0.0359419806104589,-0.0217329075644635,1.89964490035251e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPAG1,Sperm-associated antigen 1,37411,0.0432901072372438,0.00544134377488881,0.0326250734384617,0.0539551410360258,1.92068682811408e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPPK1,Epiplakin,37043,0.0552437489126189,0.0069446388362473,0.0416322567935742,0.0688552410316636,1.93869602477486e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA1,Carboxypeptidase A1,40052,0.0437954165675844,0.00550685329833061,0.0330019841028564,0.0545888490323124,1.94158328044963e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0239702824850864,0.00302128282836408,0.0180485681414928,0.02989199682868,2.29595284644261e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0320966151661436,0.00405032008622696,0.0241579877971388,0.0400352425351485,2.47449782360982e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37124,0.0165806129128497,0.00209649922588595,0.0124714744301132,0.0206897513955861,2.80551973253472e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALCAM,CD166 antigen,40052,0.0142804065709781,0.00180708794391512,0.0107385142009045,0.0178222989410517,2.90977118377311e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIT2,Slit homolog 2 protein,39489,0.0379472251699958,0.00480211565464146,0.0285350784868986,0.0473593718530931,2.92214762171068e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0811461992774128,0.0102938508829321,-0.10132214700796,-0.0609702515468659,3.40299389585381e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX1,Peroxiredoxin-1,39434,-0.0665796834994782,0.00845354012257784,-0.0831486221397308,-0.0500107448592256,3.60352496066691e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECE1,Endothelin-converting enzyme 1,39489,0.0255862614436566,0.0032540432572085,0.0192083366595279,0.0319641862277853,3.99680632417492e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDCP1,CUB domain-containing protein 1,39749,0.0364334672957622,0.00464678774245944,0.0273257633205417,0.0455411712709827,4.76821486353002e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12A_IL12B,Interleukin-12,39788,0.0537545070722646,0.00686936195621113,0.0402905576380908,0.0672184565064384,5.38285392220549e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0296748704176559,0.00379340512104878,0.0222397963804003,0.0371099444549115,5.55957469859304e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0323540837887079,0.00413846034101389,0.0242427015203206,0.0404654660570951,5.70619311517556e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37382,0.0349656332535331,0.00447636227059357,0.0261919632031697,0.0437393033038965,6.0819148734703e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0291630340124648,0.00373765529909792,0.0218372296262329,0.0364888383986967,6.44249843738088e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS4,Galectin-4,39862,-0.0382873892586143,0.00491061393790066,-0.0479121925768996,-0.028662585940329,6.73534156014891e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBKS,Ribokinase,39504,0.0358828250522999,0.00461223985396379,0.0268428349385309,0.0449228151660689,7.70861519634403e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0561822147061678,0.00722302223065303,0.0420250911340879,0.0703393382782477,7.88617408402489e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD276,CD276 antigen,39862,-0.0254554295512281,0.00327621083149846,-0.0318768027809651,-0.0190340563214911,8.33744151850957e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS7_LGALS7B,Galectin-7,39822,0.0294424951026376,0.00378984113064095,0.0220144064865813,0.0368705837186939,8.40341583395711e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG4,Desmoglein-4,39725,0.0355724042908874,0.00458049889645008,0.0265946264538452,0.0445501821279295,8.58945501196265e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0204954307530196,0.00264070445994107,-0.0256712114945041,-0.0153196500115351,8.9099330059624e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0443473582274363,0.00572090063868188,0.0331343929756198,0.0555603234792528,9.60370510107961e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0341686536412621,0.00442344049975607,0.0254987102617402,0.042838597020784,1.19142550983364e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TF,Serotransferrin,37453,0.0157366294228891,0.0020371920342138,0.01174373303583,0.0197295258099481,1.19973801197938e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0338671070197797,0.00438589533013357,0.0252707521727179,0.0424634618668415,1.21606006385887e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMMT,MICOS complex subunit MIC60,37368,0.0315851496870912,0.00409258864832521,0.0235636759363738,0.0396066234378086,1.26791590153208e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0360471581626805,0.00467167615452594,0.0268906728998096,0.0452036434255513,1.269020371669e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37388,0.0468801734286872,0.00607816240489071,0.0349669751151014,0.058793371742273,1.31578396517417e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL1,Fc receptor-like protein 1,39868,0.0314728905125648,0.00408579606799954,0.0234647302192857,0.0394810508058439,1.4065904111677e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB2,Lysosome membrane protein 2,39486,0.0206272324832874,0.00267935496720997,0.0153756967475559,0.025878768219019,1.45791700198048e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGR1,Prostaglandin reductase 1,37437,0.0570846855231242,0.00741590024621751,0.0425495210405379,0.0716198500057106,1.48189005640839e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS53,Serine protease 53,37388,0.0267887637780999,0.00348144275773348,0.0199651359729422,0.0336123915832575,1.51582643835326e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOB,Elongin-B,37021,0.0282146157559631,0.00366731222928252,0.0210266837865694,0.0354025477253569,1.5327752055614e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.051950682859015,0.00676857240274498,0.0386842809496348,0.0652170847683952,1.74546186461737e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL2,C-C motif chemokine 2,39720,0.0369109274151477,0.00481263366837544,0.0274781654251319,0.0463436894051636,1.82529720005071e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMP,Cartilage oligomeric matrix protein,39729,0.0238965510968077,0.00311903396507183,0.0177832445252669,0.0300098576683485,1.94319844721743e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0651741545347506,0.00852579983172601,0.0484635868645677,0.0818847222049336,2.24510984890896e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2orf69,UPF0565 protein C2orf69,37039,0.0416741082661267,0.00545401473352076,0.030984239388426,0.0523639771438274,2.30406222104e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMNL1,Formin-like protein 1,39489,0.0433185791213713,0.00567232393143186,0.0322008242157648,0.0544363340269777,2.35485151465002e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0343518981970852,0.00450781317802501,0.0255165843681562,0.0431872120260143,2.67108917241727e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBI3_IL27,Interleukin-27,40011,-0.0218254336414428,0.00286731611565426,-0.0274453732281251,-0.0162054940547604,2.85195099016846e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0470153392065826,0.00617784313946804,0.0349067666532253,0.05912391175994,2.91446614826722e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM1,Neural cell adhesion molecule 1,39931,0.021231358201388,0.0027903110738287,0.0157623484966837,0.0267003679060922,2.91589442241188e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0382385515685732,0.00503454444828461,0.0283708444499354,0.048106258687211,3.2398648865935e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASSF2,Ras association domain-containing protein 2,39477,0.0389143559438297,0.00513010779339758,0.0288593446687705,0.048969367218889,3.49867611136838e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0387465233664166,0.00511077843586873,0.0287293976321139,0.0487636491007193,3.64850042262321e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0270186009594042,0.00356734104596235,0.020026612509318,0.0340105894094904,3.8247202915985e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3C,Protein FAM3C,39846,0.0203480248945307,0.0026944105498572,0.0150669802168106,0.0256290695722508,4.51945007660992e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH1,Acid ceramidase,37340,0.0332227960130831,0.0044076202024104,0.0245838604163587,0.0418617316098075,5.09281297126155e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0243665547528586,0.00323388770250693,-0.0307049746497722,-0.018028134855945,5.15352691798988e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD101,Immunoglobulin superfamily member 2,37382,0.0295928617430054,0.00393277651154146,0.0218846197803841,0.0373011037056266,5.61864210347507e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0801734893082016,0.0106609777461607,0.0592779729257265,0.101069005690677,5.81013847361349e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0351805503228052,0.00468090918649216,0.0260059683172806,0.0443551323283299,6.0231779287851e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH1,Neurexophilin-1,39489,0.0261871711745237,0.00349446376804151,0.0193380221891624,0.0330363201598851,7.04312919124159e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0208932219408571,0.0027877915516662,0.0154291504995913,0.0263572933821228,7.06426762668045e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0413632546811266,0.00553578754603131,0.0305131110909052,0.0522133982713479,8.38350846619812e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0214255255080366,0.00287104409402211,-0.02705277193232,-0.0157982790837533,8.91176489303562e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SWAP70,Switch-associated protein 70,37382,0.0249876881964487,0.00335100418175806,0.0184197200002029,0.0315556563926945,9.40576187146156e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GC,Vitamin D-binding protein,37453,0.0179862415212694,0.002412277669848,0.0132581772883673,0.0227143057541715,9.44931310095975e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG4A,Cysteine protease ATG4A,39477,0.0406863570271654,0.0054820478765605,0.0299415431891068,0.0514311708652239,1.21538804905072e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37021,0.0350275147202227,0.00472394408291302,0.0257685843177132,0.0442864451227322,1.2916850413239e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNF,Tumor necrosis factor,39555,0.0262456241147609,0.00354128811039222,0.0193046994183921,0.0331865488111296,1.3141624289974e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA12,Carbonic anhydrase 12,39788,-0.0220126629216808,0.00297208573983122,-0.0278379509717499,-0.0161873748716116,1.36196300371412e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL11,C-X-C motif chemokine 11,40009,0.0535547139163351,0.00724655134351053,0.0393514732830545,0.0677579545496157,1.53579312099509e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP8,Caspase-8,39984,0.0423691412357297,0.00574334149933457,0.0311121918970339,0.0536260905744254,1.69656354536428e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0205582885517186,0.00279612182331343,0.0150778897780243,0.026038687325413,2.04050848047282e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDK,Midkine,39843,0.0345932511716458,0.00471362173059371,0.0253545525796821,0.0438319497636094,2.25545097228352e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR2,Complement factor H-related protein 2,37364,0.0385249781489323,0.0052589277268017,0.028217479804401,0.0488324764934636,2.5125198096004e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENR,Density-regulated protein,37056,0.0395150984577085,0.00539495764080272,0.0289409814817351,0.0500892154336818,2.53795675764094e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1A,Meprin A subunit alpha,37382,0.0488998065304106,0.00668236575865734,0.0358023696434422,0.061997243417379,2.66399392922098e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA,Adenosine deaminase,40058,0.0236760708726547,0.00323744523824338,0.0173306782056977,0.0300214635396117,2.7305653954962e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRD1,Natural killer cells antigen CD94,40058,0.0310864032799474,0.00425380621931801,0.0227489430900841,0.0394238634698107,2.83990695755379e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL,Podocalyxin,39788,0.0102377395743484,0.00140288206690437,0.00748809072321579,0.0129873884254809,3.066487834746e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD274,Programmed cell death 1 ligand 1,39749,0.0228093062955488,0.00312605311707091,0.0166822421860899,0.0289363704050078,3.09257795340629e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD59,CD59 glycoprotein,39173,0.0143529954507405,0.00196851154675925,0.0104947128190924,0.0182112780823886,3.22009091463533e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0187427923719353,0.00257083072595853,0.0137039641490566,0.023781620594814,3.23135010481196e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSN,Gelsolin,37383,0.0126648242885622,0.00173889015212706,0.00925659959039317,0.0160730489867312,3.43816598070392e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY75,Lymphocyte antigen 75,39866,0.0261113258648284,0.00359700930914366,0.0190611876189069,0.03316146411075,4.07341373772577e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI1,Neuroserpin,37088,0.0208275769558472,0.0028742090194121,0.0151941272777995,0.0264610266338949,4.51819792122784e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL20,C-C motif chemokine 20,40058,0.0567475488303855,0.00784378794006036,0.0413737244678672,0.0721213731929038,4.87400604599225e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPMT,Thiopurine S-methyltransferase,39477,0.0490231048399738,0.00677761446963305,0.035738980479493,0.0623072292004546,4.9403856244919e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX7,Syntaxin-7,37056,0.0331377107463541,0.00460714434789287,0.024107707824484,0.0421677136682241,6.6957639783114e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0228277809876766,0.00317497283501663,0.0166048342310441,0.0290507277443092,6.8222209840304e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN2,Dynactin subunit 2,39788,0.0635617871661174,0.00884809053222014,0.0462195297229659,0.0809040446092688,7.08670879182521e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REN,Renin,39868,-0.0440623917727466,0.00613661207276166,-0.0560901514353595,-0.0320346321101338,7.26440806951941e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0645499937397682,0.00899814776418167,0.0469136241219721,0.0821863633575643,7.62273874385104e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGED1,Melanoma-associated antigen D1,39477,0.0323474093440357,0.00450966488617202,0.0235084661671385,0.0411863525209328,7.67175197010852e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0404289749273629,0.00563987765233492,0.0293748147287865,0.0514831351259394,7.99074130327772e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0327451096303937,0.0045702263624454,-0.0417027533007866,-0.0237874659600007,8.12398571250238e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCA,Calcitonin,39713,0.040656527551807,0.0056785148513057,0.0295266384432478,0.0517864166603662,8.43951547174251e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMB1,Laminin subunit beta-1,37043,0.0202303219149899,0.00283193361454793,0.0146797320304759,0.0257809117995038,9.56617474177126e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP12,Macrophage metalloelastase,39900,0.0334158271336214,0.00467976915623714,0.0242434795873966,0.0425881746798462,9.69911488124521e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAM,Signal transducing adapter molecule 1,37368,0.0241964004052614,0.0033964478449082,0.0175393626292414,0.0308534381812815,1.10124393415588e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRN,Progranulin,39787,0.0163757427763726,0.00230070036306613,0.0118663700647629,0.0208851154879822,1.14407466986132e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0197129292768598,0.00277021739373469,0.0142833031851398,0.0251425553685798,1.15748282859052e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH17,Cadherin-17,39868,-0.0439949361942323,0.00618413320503577,-0.0561158372761024,-0.0318740351123622,1.17362511873763e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLF4,Krueppel-like factor 4,36991,0.0261427884003264,0.00367909501602749,0.0189317621689125,0.0333538146317403,1.25831784897345e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD302,CD302 antigen,39788,0.0192532076764843,0.00271015536487035,0.0139413031613384,0.0245651121916302,1.26238421090344e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEK,Angiopoietin-1 receptor,39913,0.014325794190038,0.00201907615593173,0.0103684049244118,0.0182831834556642,1.34540317715683e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEPR,Leptin receptor,39868,-0.0203954131219281,0.00287726660465033,-0.0260348556670427,-0.0147559705768135,1.41265619207341e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO2,Amphoterin-induced protein 2,39788,0.0148528955545709,0.00209632337213569,0.0107441017451849,0.0189616893639568,1.44646449523683e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERI1,3'-5' exoribonuclease 1,37169,0.0220472378349016,0.00312193667004417,0.0159282419616151,0.0281662337081882,1.72223969737067e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37411,0.0453149909284305,0.0064294572323716,0.0327132547529821,0.0579167271038788,1.90247761185768e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASN,Vasorin,39642,0.0178766917545565,0.00254557371946866,0.0128873672643979,0.022866016244715,2.26570638963305e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX1,Neuronal pentraxin-1,39858,0.0267029966512676,0.00380454080473114,0.0192460966739946,0.0341598966285407,2.32905382926114e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA1,BolA-like protein 1,36991,0.0359348600270499,0.00512500776356546,0.0258898448104616,0.0459798752436382,2.47010053652001e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0260860956872558,0.00372757005279282,0.0187800583837819,0.0333921329907298,2.71928970643208e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBN,Nibrin,39587,0.0335848096810302,0.00480088897411031,0.024175067291774,0.0429945520702864,2.74894411591177e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0375788843431353,0.00537267187961241,0.027048447459095,0.0481093212271756,2.76895138633966e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX6,Syntaxin-6,39477,0.04439824375447,0.00635304183501191,0.0319462817578466,0.0568502057510933,2.89075365173484e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM2,Junctional adhesion molecule B,40009,0.0162901864961527,0.00233500965950564,0.0117135675635217,0.0208668054287838,3.14381893910858e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK4,Dickkopf-related protein 4,39718,0.0294495748302857,0.00422442015519195,0.0211697113261095,0.0377294383344619,3.26477089025371e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0181859869341937,0.00261253758336956,-0.023306560597598,-0.0130654132707894,3.50876818246429e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0388343312063358,0.00557791582552892,0.0279016161882991,0.0497670462243725,3.5096712354114e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0402430004366932,0.00578316846596776,0.0289079902433964,0.05157801062999,3.59831240479164e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0215487871877608,0.00309724406432693,-0.0276193855538416,-0.0154781888216801,3.6026819778874e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0504056367697142,0.00724838904512183,0.0361987942412754,0.064612479298153,3.71683250031906e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0163185724459314,0.00234738860460474,0.0117176907809061,0.0209194541109567,3.74446059549977e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0368552601599576,0.00531053279397094,0.0264466158837746,0.0472639044361407,4.07328812262079e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0113101002928065,0.00163660266788462,0.00810235906375265,0.0145178415218604,5.00393735591099e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGES2,Prostaglandin E synthase 2,36961,0.0358650276902267,0.00519036137577712,0.0256919193937035,0.0460381359867498,5.07317792843064e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLB,Beta-klotho,39489,-0.0472209027401094,0.00685467900049067,-0.0606560735810711,-0.0337857318991477,5.83889258428462e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37124,0.0162609876116357,0.0023648271605098,0.0116259263770365,0.0208960488462349,6.42294083236873e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRIB,Protein scribble homolog,37043,0.0577914132303575,0.00840632533959612,0.0413150155647491,0.0742678108959659,6.48925638719793e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP9,Caspase-9,37056,0.040547681873288,0.00591102036350294,0.0289620819608222,0.0521332817857538,7.20937062558363e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0284541269254781,0.00415154370052611,-0.0365911525785092,-0.0203171012724469,7.44802373845561e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.0655696337169383,0.00956764414110787,0.0468170512003669,0.0843222162335097,7.53083324828178e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSR,Insulin receptor,37056,0.0106373746042789,0.00155295328429469,0.00759358616706135,0.0136811630414965,7.72465116551737e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM3,Myomesin-3,37124,-0.0596648034562067,0.00874128541070381,-0.0767977228611861,-0.0425318840512272,9.13440019337077e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0161786065430367,0.00237220752685396,-0.0208281332956704,-0.0115290797904029,9.48458622646404e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SF3B4,Splicing factor 3B subunit 4,39788,0.0463981083882449,0.00680677388635057,0.0330568315709978,0.059739385205492,9.66596757852574e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0309884149727771,0.00454789472587474,0.0220745413100626,0.0399022886354916,9.84474265282032e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0244461529309313,0.00358921996903606,0.0174112817916206,0.031481024070242,1.01021625743514e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERMAP,Erythroid membrane-associated protein,37056,0.028288633852179,0.00415881270355559,0.0201373609532101,0.036439906751148,1.07553435402418e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP9,Fatty acid-binding protein 9,39866,0.0350050930853255,0.00514964115793442,0.0249117964157741,0.045098389754877,1.10149695153031e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0409301687039001,0.0060236917552998,0.0291237328635125,0.0527366045442878,1.12331448021326e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELENOP,Selenoprotein P,37453,0.0140886097463325,0.00207404000120867,0.0100234913439635,0.0181537281487015,1.14524735192057e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0298159945024393,0.00439096801742369,0.0212096971882889,0.0384222918165898,1.16561569510674e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRELP,Prolargin,39862,0.0140179860894269,0.00206596322169972,0.00996869817489545,0.0180672740039584,1.19986944019687e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0227527784691789,0.0033631967327276,0.0161609128730328,0.029344644065325,1.37718639262391e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON3,Serum paraoxonase/lactonase 3,39931,-0.017737244243685,0.00262328878367087,-0.0228788902596799,-0.0125955982276901,1.41319256369785e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1A,Protein phosphatase 1A,39477,0.0192158058048454,0.0028445277269787,0.0136405314599671,0.0247910801497236,1.4751567671895e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0225473346010701,0.00333974642956741,0.016001431599118,0.0290932376030223,1.51745945503168e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0466070185100416,0.00690431539734743,0.0330745603312407,0.0601394766888426,1.53529055711527e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0268434651180861,0.00397811044141088,0.0190463686529208,0.0346405615832515,1.55213418809257e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L,Seizure 6-like protein,39913,0.0169034990275916,0.00251014318602402,0.0119836183829845,0.0218233796721986,1.70569876011339e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39453,0.0414775101023718,0.00616172709043142,0.0294005250051262,0.0535544951996174,1.73811493308427e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLC,Galectin-10,39841,-0.0417434505243972,0.00620184359855451,-0.053899063977564,-0.0295878370712303,1.7445638877188e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA2,Apolipoprotein A-II,37445,-0.029874019431275,0.00444165248058866,-0.0385796582932287,-0.0211683805693212,1.81516734919532e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR1,Complement receptor type 1,37420,0.0223548517952655,0.00332485858321101,0.0158381289721719,0.0288715746183591,1.8444789198613e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF23,Fibroblast growth factor 23,40008,0.036566099142376,0.00544122511736328,0.025901297912344,0.047230900372408,1.87550301502383e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0411986736427074,0.00613693462210688,0.0291702817833779,0.0532270655020369,1.96755446135515e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC1,Glypican-1,40030,0.0181051741278236,0.0027013764074473,0.0128104763692269,0.0233998718864203,2.12084486145336e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB1,Carboxypeptidase B,40052,0.0356766009192724,0.00535058420187835,0.0251894558835908,0.046163745954954,2.68070364481225e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39444,0.0175296484607477,0.00263001507217258,0.0123748189192894,0.022684478002206,2.73124688699409e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0642476395102559,0.00965045962964447,0.0453327386361528,0.0831625403843591,2.89331902255122e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37388,0.0136301554855532,0.00204739602674337,0.00961725927313617,0.0176430516979702,2.89634619349379e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD1,Polycystin-1,37437,0.0162481352769983,0.002441052928583,0.0114636715369757,0.021032599017021,2.91788644646205e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QL2,Complement C1q-like protein 2,37056,0.0260562347347771,0.00391650787513194,0.0183798792995185,0.0337325901700357,2.98658359849373e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37382,0.0181930871495947,0.00273669701060482,0.0128291610088092,0.0235570132903801,3.08863965567677e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0228206775282389,0.0034344864656715,0.0160890840555228,0.0295522710009551,3.16077461252898e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0140441979936224,0.0021139883654339,0.00990078079737196,0.0181876151898729,3.16166785087025e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0520092846472833,0.00783010046576756,0.0366622877343789,0.0673562815601877,3.19182459888972e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN1,Ficolin-1,37430,0.03481790727719,0.0052486450762722,0.0245305629276965,0.0451052516266835,3.39796490783578e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0197152871471515,0.00297282145285316,-0.0255420171947437,-0.0138885570995593,3.44365836708581e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0299413860126754,0.00452681310370702,-0.0388139396959412,-0.0210688323294097,3.85336915923807e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.015398001534847,0.00232915428066845,0.0108328591447368,0.0199631439249572,3.96099675503417e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL14,C-C motif chemokine 14,39843,0.023938144688318,0.00362349100626819,0.0168361023160323,0.0310401870606036,4.06278445763662e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPK2,Death-associated protein kinase 2,37056,0.0328398998691094,0.00497034995246849,0.0230980139622712,0.0425817857759477,4.06796347197547e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPS,Colipase,39836,0.0425425739204176,0.00644713926669116,0.0299061809577029,0.0551789668831323,4.27895558765748e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSHB,Thyrotropin subunit beta,39868,0.0458902618003567,0.00697285701621994,0.0322234620485656,0.0595570615521478,4.80929252938246e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00887405491746552,0.00135062478655937,0.00622683033580915,0.0115212794991219,5.20374649021084e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTXR,Neuronal pentraxin receptor,39868,0.0207835463855037,0.00316631442202323,0.0145775701183382,0.0269895226526692,5.40092750235456e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0247839789063595,0.00377942123365316,0.0173763132883993,0.0321916445243197,5.66618024983564e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHI3L1,Chitinase-3-like protein 1,39545,-0.0458717893176223,0.00700852841775823,-0.0596085050164284,-0.0321350736188162,6.12840347373182e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH1,Protocadherin-1,40018,0.0126604000425039,0.00193733678400952,0.00886321994584525,0.0164575801391626,6.55339833064286e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGF,Hepatoma-derived growth factor,40014,0.0571360845854158,0.00874558480891926,0.039994738359934,0.0742774308108975,6.63321207166707e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKZ,Diacylglycerol kinase zeta,39587,0.0218995048514819,0.00335386804444413,0.0153259234843714,0.0284730862185924,6.79545581586762e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIP,Gastric inhibitory polypeptide,37043,0.026512679308659,0.00406222150380465,0.0185507251612019,0.0344746334561161,6.9719800706675e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0426146926508088,0.00653820968434693,0.0297998016694889,0.0554295836321288,7.39460842123583e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX,Glutaredoxin-1,39771,0.0339907356130493,0.00522270073285293,0.0237542421766576,0.044227229049441,7.8294924095467e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0179895768035202,0.00277546708974878,0.0125496613076126,0.0234294922994278,9.39057240666755e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR3,Small proline-rich protein 3,37388,0.0396189148506036,0.00611967048477297,0.0276243607004486,0.0516134690007586,9.87177022543151e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0405796416527923,0.00628070867811129,0.0282694526436942,0.0528898306618904,1.07570075419617e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0209476697105442,0.00324316611037718,-0.0273042752868835,-0.014591064134205,1.08424438770594e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCP1,Plastin-2,37437,0.0282223591234074,0.00437551217912169,0.0196463552523289,0.0367983629944859,1.15586538914602e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37124,0.0170373377122746,0.0026478348223017,0.0118475814605633,0.022227093963986,1.28186560270352e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK1D,Casein kinase I isoform delta,37056,0.0387649439358497,0.00603609648552637,0.026934194824218,0.0505956930474814,1.38934516631203e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN3,Calsyntenin-3,37388,0.0181257082767468,0.00282508525619788,0.012588541174599,0.0236628753788946,1.44572930410079e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXN,Thioredoxin,37289,0.0258319139625894,0.00402775067255147,0.0179375226443885,0.0337263052807903,1.46995261379909e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO1,Roundabout homolog 1,39885,0.0140976461797784,0.00219906267688908,0.00978748333307577,0.018407809026481,1.48851410744441e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0337105518400808,0.00526670988021981,0.0233878004748499,0.0440333032053116,1.59927627006522e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYGD,Gamma-crystallin D,37388,0.0575327152481274,0.0089976274098501,0.0398973655248212,0.0751680649714336,1.66681625508462e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSZ,Cathepsin Z,39865,0.0184488287049455,0.00289044830845391,0.0127835500203758,0.0241141073895151,1.78793441936246e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0239175971491028,0.00375071876323356,0.0165661883731651,0.0312690059250406,1.86874531404816e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPB2,Coatomer subunit beta',37021,0.0254476260052401,0.0039957880851699,0.0176158813583071,0.0332793706521731,1.9708773088816e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0323056066927314,0.00507734430717446,0.0223540118506695,0.0422572015347933,2.04798434957773e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0247435442199946,0.00389574803729299,0.0171078780669004,0.0323792103730889,2.19241635853359e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0145126641913226,0.00228520148166951,-0.0189916590953949,-0.0100336692872504,2.21306885188644e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37056,-0.0716484698877076,0.0112878007259812,-0.0937725593106307,-0.0495243804647845,2.26113150786032e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDM1,Nuclear protein MDM1,37039,0.0185220657808461,0.00292091146783614,0.0127970793038873,0.0242470522578049,2.35432771928709e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFA2,BPI fold-containing family A member 2,36593,-0.0643473098470183,0.010149097648393,-0.0842395412378685,-0.0444550784561681,2.37217741865352e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0228474169608234,0.00360403391471548,0.0157835104879811,0.0299113234336658,2.38153284848413e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0205862473034722,0.00324860782216507,0.0142189759720287,0.0269535186349157,2.40559658939411e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYM,Ketimine reductase mu-crystallin,36991,0.0453000258260613,0.00715615941382667,0.031273953374961,0.0593260982771615,2.52785486263644e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0317781591619512,0.00503693249207576,0.0219057714774827,0.0416505468464197,2.88221550129313e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MET,Hepatocyte growth factor receptor,39879,0.0114526784458784,0.00181882088387718,0.00788778951347911,0.0150175673782777,3.11849004314724e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFAP1,Actin filament-associated protein 1,37124,0.0498257421731018,0.00792159146369302,0.0342994229042635,0.0653520614419401,3.27718420182833e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRH,Corticoliberin,39455,0.0509192985839319,0.00810375355794791,0.035035941610354,0.0668026555575098,3.39992915976688e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0130577604960647,0.00207873430782497,0.00898344125272778,0.0171320797394017,3.45346822478483e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37043,0.0469807801828869,0.00749659552674187,0.0322874529504728,0.061674107415301,3.79656798925154e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0172425794585496,0.0027539137238829,-0.0226402503573601,-0.0118449085597391,3.9378423891811e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0692645728604343,0.011075744542421,0.047556113557289,0.0909730321635795,4.12859386309153e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICOSLG,ICOS ligand,39788,0.0109899805183018,0.00175968865204375,0.00754099076029605,0.0144389702763076,4.33406770132243e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRL,Prolactin,40009,-0.0440960107296369,0.0070622644150348,-0.0579380489831052,-0.0302539724761687,4.37483842420361e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0273153081026205,0.00438818769701475,0.0187144602164715,0.0359161559887694,4.94278732955784e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENSA,Alpha-endosulfine,37368,0.0305125689982895,0.00490331109930187,0.0209020792436578,0.0401230587529212,5.02627830527315e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0200154183316815,0.00322302661815513,-0.0263325505032655,-0.0136982861600974,5.42432471022964e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0273905735449192,0.00441251750064142,0.018742039243662,0.0360391078461764,5.52043282363622e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0154924842536804,0.00249654742045071,0.0105992513095971,0.0203857171977638,5.60885946097739e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.030940828214797,0.0049918415574962,0.0211568187621045,0.0407248376674896,5.87440606149259e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12B,Interleukin-12 subunit beta,40058,0.0301674248966548,0.00487554262725565,0.0206113613472337,0.0397234884460759,6.25948470495429e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0201295632261846,0.00326281160410968,-0.0265246739702396,-0.0137344524821296,7.05593978564815e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX5,Sorting nexin-5,37043,0.0174212109852524,0.00283833161009857,0.0118580810294592,0.0229843409410456,8.60527279323031e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0259975244214055,0.00425501635945527,0.0176576923568732,0.0343373564859378,1.02528840307112e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSTB,Cystatin-B,39619,0.0241340936966256,0.0039558530731111,0.0163806216733279,0.0318875657199234,1.07967747151347e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37339,0.0274635154930439,0.00450301787285908,0.0186376004622401,0.0362894305238477,1.09712193921499e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADM,Pro-adrenomedullin,40030,0.0149423458699254,0.00245307718800909,0.0101343145814276,0.0197503771584232,1.14557064965792e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN4,CCN family member 4,40030,0.0227158297730883,0.00373352135041261,0.0153981279262795,0.030033531619897,1.19644878265097e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX2,Sorting nexin-2,37368,0.045752708132467,0.00752377062944231,0.0310061176987601,0.0604992985661739,1.22589703851911e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,39931,0.0159352914098337,0.0026243392190135,0.0107915865405672,0.0210789962791001,1.29075906620604e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS8,Prostasin,39805,0.0226990865866252,0.00373876565456909,0.0153711059036698,0.0300270672695806,1.29772159827823e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0205025386769317,0.00337907274729119,0.0138795560922409,0.0271255212616224,1.33389154472684e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0176277093210005,0.00291043121711267,0.0119232641354597,0.0233321545065414,1.42594881222267e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39477,0.0308541792796223,0.00509752328175074,0.0208630336473908,0.0408453249118537,1.45624370456794e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPG,Macrophage-capping protein,39739,0.0327375116723129,0.00541324727797982,0.0221275470074725,0.0433474763371533,1.50253002917702e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0284573715610315,0.00470996069322607,0.0192258486023084,0.0376888945197546,1.55712542055451e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX1,Heme oxygenase 1,39691,-0.0267957487878799,0.00443516473436602,-0.0354886716672373,-0.0181028259085225,1.55954396127419e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0160902290065958,0.00266581401857834,0.0108652335301823,0.0213152244830094,1.61660540571185e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39489,0.041360806005015,0.0068654941339259,0.0279044375025202,0.0548171745075098,1.73495294733171e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA6,Corticosteroid-binding globulin,37453,0.00990071409026076,0.00164337096426341,0.00667970700030447,0.013121721180217,1.73867633296097e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0238785405388084,0.00397456429927146,0.0160883945122363,0.0316686865653804,1.92967773636545e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0451352244833469,0.00754156989297173,0.0303537474931223,0.0599167014735715,2.21316430877471e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PZP,Pregnancy zone protein,37453,0.0306906147133921,0.0051389374931017,0.0206182972269128,0.0407629321998714,2.39959536222478e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.020390433036189,0.00341517433714204,0.0136966913353906,0.0270841747369874,2.42403251297363e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.035320220154339,0.0059193807679934,0.023718233849072,0.0469222064596061,2.46935810113332e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LXN,Latexin,39682,-0.0371479602632442,0.00623052228203068,-0.0493597839360243,-0.0249361365904641,2.54072603413438e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37368,0.0161131867758762,0.002712168977168,0.0107973355806269,0.0214290379711254,2.90134247485489e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0309562438504933,0.00521129814560034,0.0207420994851166,0.0411703882158699,2.91749777785622e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0168012962505241,0.00283033211223247,0.0112538453105484,0.0223487471904997,2.98925233925653e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL8,Interleukin-8,39750,0.0365308639091366,0.0061588358491161,0.024459545644869,0.0486021821734042,3.06490704423903e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL32,Interleukin-32,39866,-0.023636538117015,0.00398742833703699,-0.0314518976576075,-0.0158211785764225,3.13395820812183e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0282769991092243,0.00477443045273329,0.018919115421867,0.0376348827965815,3.23561127052704e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.016096184598573,0.00271940403275664,0.01076615269437,0.021426216502776,3.30547724338115e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN3,CCN family member 3,40042,0.0178010147772851,0.00301677738582337,0.0118881311010713,0.0237138984534989,3.69249613801093e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD14,Monocyte differentiation antigen CD14,39564,0.0225356883348255,0.0038242663144026,0.0150401263585965,0.0300312503110546,3.87445273530053e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37043,0.0286971906571707,0.00487502484313234,0.0191421419646313,0.0382522393497101,4.03873760386643e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY96,Lymphocyte antigen 96,39749,-0.019371280766308,0.0032927116412931,-0.0258249955832425,-0.0129175659493735,4.1079736757212e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFIC,Nuclear factor 1 C-type,37411,0.0229974602099601,0.00391744072439998,0.0153192763901362,0.0306756440297841,4.44564206867098e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.035874777441339,0.0061117893635558,-0.0478538845939083,-0.0238956702887696,4.4506786004445e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XCL1,Lymphotactin,40030,0.0300007004716771,0.00511151308288976,0.0199821348292132,0.0400192661141411,4.4635928748468e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGT,Angiotensinogen,37445,0.0122393313590433,0.00209229665235813,0.00813842992042133,0.0163402327976652,5.03760818403752e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0255526000846324,0.00437407482387003,0.0169794134298471,0.0341257867394176,5.26591374174308e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0164604437042854,0.00282184862852231,0.0109296203923817,0.0219912670161891,5.54445040078455e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0183812018394282,0.00315685034928513,0.0121937751548293,0.024568628524027,5.90627589452279e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA4,Ephrin-A4,39720,0.0150038996498112,0.00258013822854964,0.00994682872185388,0.0200609705777685,6.17434956032385e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40030,0.0201583273308543,0.00347240529156388,0.0133524129593891,0.0269642417023195,6.545781709668e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APRT,Adenine phosphoribosyltransferase,39738,0.0259903252213236,0.00448542600362344,0.0171988902542217,0.0347817601884256,6.98673559714795e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0132981209993539,0.00229929339101924,0.00879150595295621,0.0178047360457516,7.44969648244935e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0197676888601922,0.00341887510459434,0.0130666936551873,0.0264686840651971,7.52090946699674e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD1,Bromodomain-containing protein 1,37169,-0.0165639711637814,0.00287118552688411,-0.0221914947964742,-0.0109364475310885,8.1500425813013e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGN,Biglycan,39448,-0.0639007056296333,0.0111137080016554,-0.0856835733128779,-0.0421178379463887,9.10652056194901e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0205763348433957,0.00358556575866137,0.0135486259564194,0.027604043730372,9.75275308369582e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.019545499192071,0.00340672205377648,0.012868323966669,0.0262226744174729,9.82912335467297e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST5,Cystatin-D,39559,0.0289937377538245,0.00505990407563167,0.0190763257655864,0.0389111497420626,1.02214671499984e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA14,Carbonic anhydrase 14,40030,0.0186669576106736,0.00327199374067347,0.0122538498789536,0.0250800653423936,1.1832965730446e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECM1,Extracellular matrix protein 1,37106,0.0192842055535025,0.00338198301305875,0.0126555188479074,0.0259128922590977,1.20909363000776e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCOF1,Treacle protein,37437,0.0161529465045349,0.00283884363705278,0.0105888129759115,0.0217170800331584,1.2968334687495e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MST1,Hepatocyte growth factor-like protein,37271,0.0334682392901754,0.00589126437800447,0.0219213611092866,0.0450151174710642,1.36697433114099e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0181330273481895,0.00319944874001215,0.0118621078177657,0.0244039468786133,1.47322135868479e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1B,Interleukin-1 beta,39478,0.0293869646281833,0.00519906318378523,0.0191968007879642,0.0395771284684023,1.61027786607475e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37411,0.01821162973812,0.00322307204299725,0.0118944085338453,0.0245288509423946,1.63303366593683e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN4B,Sodium channel subunit beta-4,37043,0.0217880419743391,0.00386215232997716,0.0142182234075838,0.0293578605410943,1.72118873075735e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37169,0.0374333451297435,0.00664050631928788,0.0244179527439392,0.0504487375155477,1.76428968458325e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL34,Interleukin-34,39456,0.0187704105669768,0.00333168622464056,0.0122403055666813,0.0253005155672723,1.79216098253832e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0470259262607878,0.00835592812662507,0.0306483071326026,0.0634035453889729,1.85518218463582e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0203828640149964,0.00362293201043558,0.0132819172745427,0.0274838107554502,1.87464887447283e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN5,Contactin-5,39897,0.0188402977639483,0.00335350840191562,0.0122674212961937,0.0254131742317029,1.96293133358952e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL3,Fc receptor-like protein 3,39587,0.0273007490284204,0.00486012554612371,0.017774902958018,0.0368265950988229,1.97257761838526e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL3,Myosin light chain 3,37043,-0.0381229744090767,0.00678619764968064,-0.0514239218024507,-0.0248220270157026,1.97407242202215e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP3,Stromelysin-1,39858,-0.0249443413445976,0.00444244551995283,-0.0336515345637051,-0.01623714812549,1.99826946145007e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYY,Peptide YY,37021,0.0484281460285253,0.0086368803482923,0.0314998605458724,0.0653564315111782,2.0984399375928e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,39698,0.0144198632953131,0.00257232985594347,0.00937809677766394,0.0194616298129623,2.10802482979271e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37437,-0.0121473015612211,0.00216847201453905,-0.0163975067097176,-0.00789709641272453,2.16284925737465e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37021,0.0191486933421159,0.00342045132162342,0.012444608751734,0.0258527779324978,2.20800470185225e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMS,Spermine synthase,36991,0.0334722941650808,0.00598677896947198,0.0217382073849157,0.0452063809452459,2.30221256066984e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR15L,Protein GPR15L,37382,0.0320472951525264,0.00573471033528486,0.0208072628953681,0.0432873274096847,2.3373171877772e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YAP1,Transcriptional coactivator YAP1,37388,0.0133022819822844,0.00238334268299706,0.00863093032361016,0.0179736336409587,2.43239550977724e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC2,Mucin-2,37437,0.0469503265096886,0.00841207237134194,0.0304626646618584,0.0634379883575188,2.43295368705847e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37043,0.0205585381073119,0.00368757881323292,0.0133308836333754,0.0277861925812484,2.52279906409634e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA2,Annexin A2,36879,0.0361939918063099,0.00649508016798218,0.0234636346770649,0.048924348935555,2.5606038877509e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSA,Arylsulfatase A,39858,0.0233547986430852,0.00419157751549328,0.0151393067127184,0.0315702905734521,2.561282727262e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37123,0.027312152643293,0.00490515924294974,0.0176980405271115,0.0369262647594745,2.62616752048854e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0303923709997302,0.00545939887696089,-0.0410927927985736,-0.0196919492008869,2.63428503724035e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0176322903317854,0.00318104324401782,-0.0238671350900604,-0.0113974455735105,3.03002411042171e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM2,Myomesin-2,37021,-0.0266300948914439,0.00481570509192363,-0.0360688768716143,-0.0171913129112736,3.26625786117665e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBP,Lipopolysaccharide-binding protein,39931,-0.0297914158589574,0.00539906794010548,-0.0403735890215642,-0.0192092426963507,3.48413821960299e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LUZP2,Leucine zipper protein 2,37368,0.0224970661483517,0.00407999616124752,0.0145002736723066,0.0304938586243969,3.57224610451192e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0177481539697242,0.00322299069546925,0.0114310922066045,0.0240652157328439,3.71199199533942e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRC,Chymotrypsin-C,39856,0.0316115184242236,0.00575546348779677,0.0203308099881419,0.0428922268603053,4.02471300443596e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0182290994888669,0.00332978830636297,-0.0247554845693383,-0.0117027144083954,4.45219755388249e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37021,-0.0226935618417565,0.0041485974628026,-0.0308248128688496,-0.0145623108146634,4.57799674148645e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NADK,NAD kinase,39868,0.0271988425663268,0.00497342915983286,0.0174509214130543,0.0369467637195992,4.59802030822315e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0258249065012051,0.00473247026060537,0.0165492647904186,0.0351005482119916,4.91532318957865e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LF,CMRF35-like molecule 1,40030,0.0303601237503769,0.00556517245192081,0.0194523857446121,0.0412678617561417,4.95865019748692e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0191119869989007,0.00350519435976268,0.0122418060537659,0.0259821679440356,5.04094986939327e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0205913066027908,0.00379334269212211,0.0131563549262315,0.0280262582793502,5.78844102438426e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0170121017159414,0.00313437665641899,-0.0231554799625226,-0.0108687234693602,5.79525776093557e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0441372015129784,0.00813543367472494,0.0281917515105175,0.0600826515154393,5.88514171376052e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSH,Pro-cathepsin H,39546,0.0365476841677206,0.00674442363219814,0.0233286138486122,0.0497667544868289,6.08352539707316e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0204919221490803,0.00378244953663403,0.0130783210572776,0.027905523240883,6.12876475923113e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCAM,Cell surface glycoprotein MUC18,39931,-0.0164963292697384,0.00304700645299951,-0.0224684619176174,-0.0105241966218594,6.25353018299064e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG4,Regenerating islet-derived protein 4,39885,0.0237007892285639,0.00437969385034556,0.0151165892818866,0.0322849891752412,6.33906779087983e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0195404188579187,0.00361522551884874,-0.0266262608748623,-0.0124545768409752,6.57234846695417e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0302780341032864,0.00560195274053699,0.0192982067318339,0.0412578614747389,6.5793413061181e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,39585,0.0265841614728223,0.0049279318178223,0.0169254151098906,0.036242907835754,6.96743437946296e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0140668336858411,0.00260804336681391,0.00895506868688589,0.0191785986847964,7.02382020183735e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0140412421184371,0.00261294701869051,0.00891986596180369,0.0191626182750705,7.82041935734529e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.022456760554502,0.00418405684161108,0.0142560091449443,0.0306575119640597,8.13113226823857e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLO1,Lactoylglutathione lyase,39585,0.0289572287128078,0.00539819626366309,0.0183767640360282,0.0395376933895875,8.24402056973181e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA1,Ephrin-A1,39826,0.01317610110689,0.00245635631319384,0.0083616427330301,0.01799055948075,8.24946730189241e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITM2A,Integral membrane protein 2A,39866,-0.0294709180988347,0.00550600102992223,-0.0402626801174823,-0.0186791560801871,8.79385451249473e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GM2A,Ganglioside GM2 activator,37178,0.0180202906761964,0.0033734868700108,0.0114082564109753,0.0246323249414176,9.35729810951752e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.023773801423058,0.0044526145745326,0.0150466768569741,0.0325009259891419,9.45853835669624e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0351357509672908,0.00659247082873682,0.0222145081429667,0.048056993791615,1.00006024417043e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0385937906506705,0.00724407246080892,0.024395408627485,0.0527921726738559,1.0113586097766e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLMP,CXADR-like membrane protein,40030,0.010149863662664,0.00190898376413467,0.00640825548496009,0.013891471840368,1.06956531306828e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0182859240151845,0.0034426715390184,0.0115382877987084,0.0250335602316606,1.10150152133305e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0149396639248996,0.00281607080176471,-0.0204591626963584,-0.00942016515344074,1.14082912957467e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37410,0.0239275396781624,0.00451600199292294,0.0150761757720335,0.0327789035842914,1.1865803452166e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17C,Interleukin-17C,39587,-0.0326928186360015,0.00619278688658562,-0.0448306809337093,-0.0205549563382937,1.31490303333631e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP1,Interstitial collagenase,39314,0.0450466356927673,0.00854740428903387,0.0282937232862609,0.0617995480992737,1.38097403706854e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0205403307438839,0.00390042872604576,-0.0281851710469336,-0.0128954904408342,1.4107772242623e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0296625316242957,0.00563365651963538,0.0186205648458104,0.0407044984027811,1.42210156334965e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0118118108463016,0.00224392860127263,0.00741371078780723,0.0162099109047959,1.42866869859708e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37388,0.117504703472461,0.0223386296379112,0.0737209893821548,0.161288417562767,1.46127470139404e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB1,Calbindin,39788,0.0205799787675429,0.00391285801604426,0.0129107770560962,0.0282491804789897,1.46254747699359e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF3,Neurotrophin-3,39866,0.0164614735457733,0.00313553869014509,0.0103158177130889,0.0226071293784577,1.54071083196891e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0483113105167165,0.00922054754713023,0.0302390373243412,0.0663835837090917,1.63474302546872e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0310020640623933,0.00591977848173903,0.0193992982381848,0.0426048298866018,1.65691010249964e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL4,Myosin light chain 4,37043,-0.0253226986387034,0.00483736182226623,-0.0348039278103453,-0.0158414694670616,1.67686308365513e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTB,Lymphotoxin-beta,37368,0.0166824711846562,0.00318955485468506,0.0104309436694734,0.0229339986998389,1.71722028795423e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN5,CCN family member 5,39858,0.0186929110366751,0.00358650517780906,0.0116633608881693,0.0257224611851809,1.89124879504352e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.0090531117679405,0.00173984846826859,0.00564300877013406,0.0124632147657469,1.98531864050436e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN2,Contactin-2,40030,0.0213011164665599,0.00413070728439108,0.0132049301891534,0.0293973027439664,2.54207807118914e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0204507407063578,0.00397656291956418,0.012656677384012,0.0282448040287036,2.73827045133172e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRSF1,G-rich sequence factor 1,36874,0.0388852311274575,0.00756793678234262,0.024052075034066,0.053718387220849,2.81464887646945e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA4,Carboxypeptidase A4,36868,0.0209005835159333,0.0040720489573097,0.0129193675596063,0.0288817994722603,2.89742073442766e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CABP2,Calcium-binding protein 2,37039,0.0315095730834633,0.00614525026648597,0.0194648825611508,0.0435542636057758,2.97828160532779e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA9,Serpin A9,39715,0.0347530633569616,0.00678734263402686,0.0214498717942689,0.0480562549196542,3.08661837721372e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0197657447055139,0.00386332551836213,0.0121936266895241,0.0273378627215037,3.15941048537291e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37124,0.0251298318868604,0.00492800204615355,0.0154709478763994,0.0347887158973213,3.45437710099204e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO3,R-spondin-3,40030,0.0127966640284181,0.00251209254307456,0.00787296264399195,0.0177203654128442,3.5448353207922e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1,Programmed cell death protein 1,39998,0.0194338292215506,0.00381557024118365,0.0119553115488307,0.0269123468942706,3.55856626151013e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0155641647280016,0.00305625539981746,0.0095739041443594,0.0215544253116438,3.58130791830951e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0163446880959267,0.00321332301151209,0.010046574993363,0.0226428011984904,3.68800178962964e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYZL2,Lysozyme-like protein 2,36962,0.0171673078365512,0.00337572175527095,0.0105508931962202,0.0237837224768823,3.71679689650569e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0123129205461038,0.00242267921088258,-0.0170613717994337,-0.00756446929277396,3.77884681130237e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,39866,0.0206117444554596,0.00407210938125253,0.0126304100682047,0.0285930788427146,4.20171012872289e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3B,Protein FAM3B,39788,0.016955175888717,0.00335214546126057,0.0103849707846463,0.0235253809927877,4.28368930958188e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRCAM,Neuronal cell adhesion molecule,39868,0.0130161038484383,0.00257925577404918,0.00796076253130195,0.0180714451655747,4.55010739551938e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK1,Adenylate kinase isoenzyme 1,39868,0.0293474967574319,0.00583566420176043,0.0179095949219815,0.0407853985928824,4.98402299912249e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40052,0.0150030516074644,0.00298414059452097,0.00915413604220331,0.0208519671727255,5.01972383196888e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0207865312205526,0.00413465195650357,0.0126826133858056,0.0288904490552996,5.03723721544955e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA2,Adenosine deaminase 2,39782,-0.0193271508098388,0.0038454541330849,-0.0268642409106852,-0.0117900607089924,5.06318267320423e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39456,0.0239655209143339,0.00476937156077884,0.0146175526552074,0.0333134891734604,5.09321233962083e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB1A1,Uteroglobin,39903,0.0255638735731188,0.0050996916485547,0.0155684779419516,0.035559269204286,5.42076118563827e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP4,Bone morphogenetic protein 4,39720,-0.0214769358436444,0.00428457177560055,-0.0298746965238215,-0.0130791751634673,5.4272232056466e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0114236447777158,0.00227888836648597,-0.0158902659760283,-0.00695702357940332,5.43162998317446e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH5,Cadherin-5,40052,-0.0142425572370895,0.00284238035157756,-0.0198136227261815,-0.00867149174799749,5.47798511228134e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0327469529324184,0.00653587826378597,0.0199366315353979,0.0455572743294389,5.49183322679115e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGA,Chromogranin-A,37437,-0.0366237249724888,0.00731018114152415,-0.0509516800098761,-0.0222957699351015,5.51255157419273e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN2,Prefoldin subunit 2,39489,0.0259657195102851,0.0052000242943803,0.0157736718932997,0.0361577671272704,5.99697297091772e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC16,Mucin-16,39788,0.086701893444101,0.0173722722089659,0.0526522399145277,0.120751546973674,6.07577830777388e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4C,Semaphorin-4C,39788,0.0131971460073764,0.00264534121488401,0.00801227722620378,0.0183820147885491,6.13875002473054e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF4,Neurotrophin-4,39477,0.018484236288749,0.00370655654316891,0.011219385464138,0.0257490871133601,6.20133854334755e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0184145077100014,0.00369331563783613,0.0111756090598426,0.0256534063601602,6.23303211951683e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPP1,Tripeptidyl-peptidase 1,39767,0.0216179047651554,0.00433860294773648,0.0131142429875919,0.0301215665427189,6.33654457583539e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME3,Nucleoside diphosphate kinase 3,39885,0.011062004218764,0.00222114128235785,0.00670856730534266,0.0154154411321854,6.41381371872221e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0206487801058265,0.0041492542040322,-0.0287813183457297,-0.0125162418659234,6.5409301350814e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI2,Serpin I2,37382,0.0266195534059033,0.00535011741488761,0.0161333232727236,0.0371057835390831,6.58765970616308e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBS,Cystathionine beta-synthase,37043,0.0236491222517534,0.00475321935578094,0.0143328123144228,0.0329654321890841,6.59372849385272e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0176069119315042,0.00353902247710028,0.0106704278763876,0.0245433959866207,6.60211877801542e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.0130098056249062,0.00262378914128531,0.00786717890798701,0.0181524323418254,7.18024374652278e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTPN,Myotrophin,39585,0.0149526510847033,0.00302660548745061,0.0090205043293001,0.0208847978401065,7.87624652829494e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CILP,Cartilage intermediate layer protein 1,37437,0.0247495759197567,0.00501555530392848,0.0149190875240569,0.0345800643154565,8.12826637114563e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.025406980637074,0.00515131268560645,0.0153104077732854,0.0355035535008627,8.23096987919907e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHPS,Deoxyhypusine synthase,37368,0.018853691051385,0.00382612431654965,0.0113544873909477,0.0263528947118223,8.42233903965977e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RB,Interleukin-17 receptor B,39644,-0.0246947372341702,0.00501943159518868,-0.03453282316074,-0.0148566513076004,8.74932265304761e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD93,Complement component C1q receptor,39238,-0.0141066303175591,0.00286825537170896,-0.0197284108461087,-0.00848484978900956,8.82494298626198e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.014017885341861,0.00285203143931266,-0.0196078669629138,-0.00842790372080814,8.98326003867879e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37021,0.0209236679216038,0.0042756207862703,0.012543451180514,0.0293038846626936,1.00122434109856e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37021,0.0547327388739918,0.0112044889320054,0.0327719405672612,0.0766935371807225,1.04701918466386e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0245172494403344,0.00503622711406825,0.0146462442967606,0.0343882545839081,1.13899154198064e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA7,Thyroxine-binding globulin,37453,0.00841634785575121,0.00173257792228648,0.00502049512806971,0.0118122005834327,1.20079221324879e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0198764916667823,0.00409713256561013,0.0118461118381864,0.0279068714953781,1.23798018853535e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,39846,0.0309806444645017,0.00639170048692385,0.0184529115101309,0.0435083774188724,1.26512157617475e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA,Lymphotoxin-alpha,39866,0.0178184082300525,0.0036783474485302,0.0106088472309333,0.0250279692291717,1.28354856454948e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,39866,0.022851289930965,0.00472118803092632,0.0135977613903494,0.0321048184715806,1.30946814706802e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0276393017826275,0.00571735438240708,0.0164332871931096,0.0388453163721454,1.35089745165696e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCND2,G1/S-specific cyclin-D2,37169,0.0165943808783527,0.00343377678323179,0.00986417838321836,0.023324583373487,1.36203071154271e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_E,,39866,0.0123094576657016,0.00255085516423049,0.00730978154380982,0.0173091337875933,1.40855101838695e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40052,-0.0113906369680991,0.00236076082443284,-0.0160177281839875,-0.00676354575221079,1.41288656287212e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGB,Secretogranin-1,39952,0.0177106728350275,0.00367810958332443,0.0105015780517117,0.0249197676183434,1.48422115790448e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF3,Trefoil factor 3,39839,-0.0217407648867835,0.0045204534361915,-0.0306008536217188,-0.0128806761518481,1.52747713413603e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN1,Prorelaxin H1,37411,-0.0361649352301647,0.00753466642370295,-0.0509328814206225,-0.0213969890397069,1.60514678573366e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPQ,Carboxypeptidase Q,37430,0.0168841811403382,0.00352224781618318,0.00998057542061912,0.0237877868600572,1.65567419511366e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0234581614430351,0.00489632604671924,0.0138613623914654,0.0330549604946048,1.67734107209738e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN1,Calsyntenin-1,39489,0.0224183801739462,0.0046912445561083,0.0132235408439739,0.0316132195039184,1.77974330648607e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40030,0.0260549466830936,0.00546564586745505,0.0153422807828817,0.0367676125833055,1.88580630865401e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA7,Carbonic anhydrase 7,37169,-0.0149782455543304,0.00314319329787966,-0.0211389044181745,-0.00881758669048622,1.9056998539597e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0212309555325979,0.00445799361120308,0.0124932880546399,0.0299686230105559,1.93299612907802e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN2,Alpha-actinin-2,37021,-0.0262853959413413,0.0055229193434727,-0.0371103178545478,-0.0154604740281348,1.96302703336526e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40058,0.0112228216224714,0.00236273161389248,0.00659186765924216,0.0158537755857007,2.05225940647072e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP8,GTPase IMAP family member 8,36962,0.0220406868535295,0.00464153062180122,0.0129432868347992,0.0311380868722599,2.07018058183326e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0268778315885483,0.00568684423629539,0.0157316168854094,0.0380240462916873,2.30991553217151e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHCY,Adenosylhomocysteinase,39868,0.0298419125687944,0.00631560482614157,0.017463327109557,0.0422204980280319,2.31948211922141e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL2,Fc receptor-like protein 2,39990,0.0203769754946241,0.00431451281077231,0.0119205303855103,0.0288334206037378,2.34472610333286e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGCR6,Protein DGCR6,36991,0.0190980190886814,0.00404548518554571,0.0111688681250119,0.027027170052351,2.37319401871849e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG3,Desmoglein-3,39964,0.0146099433505131,0.00310903881031884,0.00851622728228817,0.020703659418738,2.63364294116985e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0158063022217607,0.00336509082189334,0.00921072421084978,0.0224018802326717,2.66492856946793e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVR,Poliovirus receptor,40009,0.0162583027931779,0.00346739339479766,0.00946221173937448,0.0230543938469813,2.76907685506374e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH17,Protocadherin-17,39868,-0.0152558921685063,0.00325834954246673,-0.0216422572717411,-0.00886952706527145,2.86291871228324e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0166108593295871,0.00354926091794605,0.00965430793041284,0.0235674107287614,2.89576465298747e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0122722904817918,0.00262430390753009,-0.0174159261405508,-0.00712865482303286,2.94359345870985e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST1,Cystatin-SN,35640,0.0440285531513758,0.0094318515749515,0.0255421240644709,0.0625149822382808,3.07395557223303e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0251343595210597,0.00538951259073586,0.0145709148432174,0.035697804198902,3.1334738263476e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37124,-0.0172244392534156,0.00369572649433908,-0.0244680631823202,-0.00998081532451105,3.18301137505137e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK4,Kallikrein-4,40030,-0.0261378329022264,0.00560970999602738,-0.03713286449444,-0.0151428013100127,3.19674290483846e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0170116673660631,0.00366223306241992,-0.0241896441684061,-0.00983369056372003,3.42536585777087e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0124267319176595,0.00268056742755113,0.0071728197596593,0.0176806440756597,3.58258784534921e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY2,Protein canopy homolog 2,39585,0.0260338935554853,0.00562256367145288,0.0150136687594377,0.037054118351533,3.68141455831847e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0146058364019168,0.00315802679096282,0.00841610389162965,0.0207955689122039,3.78096273185277e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCOR1,REST corepressor 1,39585,0.0193521313282881,0.00419361345959658,0.0111326489474788,0.0275716137090974,3.96835472034375e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0166512315405615,0.00361259179960481,0.00957055161333605,0.0237319114677869,4.07879753222579e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS22,Brain-specific serine protease 4,37056,0.0144834635583448,0.00314250076576385,0.0083241620574476,0.0206427650592419,4.08604522415079e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0114561803200999,0.0024943988652162,0.00656715854427618,0.0163452020959237,4.41349073675401e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40052,-0.0133986905469405,0.00291938554797789,-0.0191206862209771,-0.00767669487290383,4.47521171612361e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXT,Oxytocin-neurophysin 1,40009,0.0592397481628775,0.0129180286066911,0.033920412093763,0.084559084231992,4.55604255161892e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP10,Bone morphogenetic protein 10,37124,0.0121067362271975,0.00264139985957522,0.00692959250243005,0.0172838799519649,4.61531389764371e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0088594321074776,0.00193394498507639,0.00506889993672788,0.0126499642782273,4.6623170051281e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIFR,Leukemia inhibitory factor receptor,39866,-0.010396313769169,0.00227262345827001,-0.0148506557473782,-0.00594197179095976,4.80740994440843e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC5D,Netrin receptor UNC5D,37056,0.0113497843222442,0.0024851703243762,0.00647885048646684,0.0162207181580215,4.99220528348332e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSB,Cathepsin B,39847,-0.0218325376897824,0.00478600747583505,-0.0312131123424191,-0.0124519630371457,5.11076928042775e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDA,Cytidine deaminase,37422,0.0197070110411151,0.00432716902776373,0.0112257597466982,0.028188262335532,5.30306642698659e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS4,Thrombospondin-4,39892,0.0189618293243822,0.00416670270627959,0.0107950920200742,0.0271285666286902,5.38348647264331e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0164781960152791,0.00362195175580494,0.00937917057390136,0.0235772214566567,5.41692071608446e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0165796893761717,0.00365640997477053,-0.0237462529267219,-0.00941312582562141,5.82569113249573e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPR,Nucleoprotein TPR,37021,0.0199585695867929,0.00440296966616026,0.0113287490411188,0.028588390132467,5.86703375674245e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0148640868496491,0.00328292679796303,0.00842955032564161,0.0212986233736567,6.00718090313004e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB8,Serpin B8,40058,0.0232127823670132,0.00513238959675445,0.0131532987573745,0.0332722659766519,6.14594514313131e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39489,0.0356323643361863,0.00790511330733192,0.0201383422538157,0.0511263864185568,6.60696792534653e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37388,0.0150389876930008,0.00334191890383096,0.00848882664149213,0.0215891487445095,6.84862273300655e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDHB15,Protocadherin beta-15,37368,-0.0166976994193205,0.00371054286606187,-0.0239703634368017,-0.00942503540183922,6.84987742946903e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0170516832002684,0.00379409939678582,-0.0244881180179686,-0.00961524838256817,7.0302908836628e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFA,Protransforming growth factor alpha,39866,0.0192082427866462,0.00427519158798572,0.0108288672741942,0.0275876182990982,7.07335801478928e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD3,Bromodomain-containing protein 3,37021,0.0194620664484183,0.00433817554912907,0.0109592423721253,0.0279648905247112,7.31076783239127e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPL14,60S ribosomal protein L14,37043,0.0168830946466587,0.00377264288685458,0.00948871458842373,0.0242774747048937,7.70020631619293e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0175146724538681,0.00391840505612081,0.0098345985438713,0.0251947463638649,7.8912701776403e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTG,Protogenin,40030,0.0103544255646154,0.00232122531507197,0.00580482394707438,0.0149040271821565,8.22207957670421e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0270176376652843,0.00609036191026831,-0.0389547470094102,-0.0150805283211584,9.22022888306275e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIGR,Polymeric immunoglobulin receptor,39677,0.0150394291084796,0.00339210606679882,0.00839090121755389,0.0216879569994053,9.32726839972826e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37325,-0.011124604069741,0.00250946782042937,-0.0160431609977826,-0.00620604714169945,9.36429448585746e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNLY,Granulysin,39858,0.0209955656528064,0.00474981595105406,0.0116859263887404,0.0303052049168723,9.92171389960249e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37411,0.0147259987546106,0.00333295725582525,0.00819340253319309,0.0212585949760281,1.00253171134827e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0122660388960129,0.0027763709414965,0.00682435185067976,0.017707725941346,1.00412522353734e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG3,Proteasome assembly chaperone 3,39866,0.0204417787979043,0.00462997322746246,0.0113670312720778,0.0295165263237307,1.01626146006162e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NINJ1,Ninjurin-1,39477,0.0232181176693178,0.00526101481229503,0.0129065286372195,0.033529706701416,1.02517776919139e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0290391046456662,0.00658892325224276,-0.041953394220062,-0.0161248150712704,1.0536195327195e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS2,Growth arrest-specific protein 2,37169,0.0217747001433367,0.0049444327459198,0.0120836119613339,0.0314657883253395,1.07160393908876e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0267496574818528,0.00608279668842487,-0.0386719389911655,-0.01482737597254,1.10319609820887e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0195531253529715,0.00444721156498448,0.0108365906856019,0.0282696600203411,1.10738130340559e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37382,0.020771149591689,0.00472770831687125,0.0115048412906214,0.0300374578927567,1.12393188068801e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0138610864104682,0.00315617895357016,0.00767497566147068,0.0200471971594657,1.13167430174408e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.00810711134025837,0.00184898204976778,-0.0117311161578032,-0.00448310652271352,1.16925041539159e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0141317848910106,0.00322783947071208,0.00780521952841492,0.0204583502536063,1.20480873463574e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0190708181071888,0.00436815603932519,-0.0276324039442662,-0.0105092322701114,1.27403227855366e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0239837243157836,0.00549470710954988,0.0132140983810658,0.0347533502505013,1.28134273257544e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRUNE2,Protein prune homolog 2,37169,0.0115889103273104,0.00266080317143917,0.00637373611128966,0.0168040845433312,1.33806598144114e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEO1,Neogenin,37411,0.00878609465058357,0.00201861267120424,0.00482961381502326,0.0127425754861439,1.35554670154366e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0289538497130035,0.00669997147375179,0.01582190562445,0.042085793801557,1.56105201450102e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC4A1,Band 3 anion transport protein,37437,-0.0188016226090301,0.00435201141085352,-0.027331564974303,-0.0102716802437572,1.56985583959663e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPH,Hephaestin,37437,0.0106068850583836,0.00245543279616214,0.00579423677790585,0.0154195333388614,1.5730740562326e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00895166340602247,0.00207293083325952,0.00488871897283382,0.0130146078392111,1.58139365365081e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.024351119031799,0.00564393045113795,-0.0354132227160294,-0.0132890153475686,1.6108051951991e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0227172419865486,0.00528826836245507,0.0123522359961366,0.0330822479769605,1.75124509893102e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0165855880505354,0.00386730132288208,0.00900567745768653,0.0241654986433843,1.80793428244384e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0238603071406019,0.00557343749635842,0.0129363696477394,0.0347842446334644,1.8709404168595e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB2,Lamin-B2,37388,0.0109377510535729,0.00255696793458687,0.00592609390178265,0.0159494082053632,1.90194976431277e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP2,Retinol-binding protein 2,39788,-0.0305057164933723,0.00713650492638703,-0.0444932661490909,-0.0165181668376537,1.92592815149688e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37411,0.01115078387382,0.002613973034139,0.00602739672690759,0.0162741710207325,2.00505060352598e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0227120661399193,0.00532624606267041,0.0122726238570852,0.0331515084227533,2.0181772424114e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0245913832520713,0.0057861036373144,0.0132506201229351,0.0359321463812075,2.1512950912507e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0175237530161868,0.00414398457010557,0.00940154325877987,0.0256459627735937,2.36571205525812e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37124,0.0163971954946801,0.00387880652522688,0.00879473470523544,0.0239996562841248,2.38009720991883e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF16,Fibroblast growth factor 16,37056,0.0190525488583497,0.00451138953878016,0.0102102253623406,0.0278948723543588,2.42461486176307e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGBL1,Integrin beta-like protein 1,37437,-0.0140659113989446,0.00333281750033675,-0.0205982336996046,-0.00753358909828456,2.45425695832295e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POSTN,Periostin,37437,-0.0146244363469254,0.00346861745624456,-0.0214229265611648,-0.00782594613268607,2.50046024884444e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MENT,Protein MENT,37124,-0.00874898351547081,0.00207688677184032,-0.0128196815882778,-0.00467828544266378,2.54175361377833e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAX,Apoptosis regulator BAX,39456,0.0358853901004031,0.00853052722089289,0.019165556747453,0.0526052234533531,2.60571821627334e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN2,Calsyntenin-2,40058,-0.0154417838429867,0.00367233690067983,-0.0226395641683192,-0.00824400351765426,2.62608555661159e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBB,Inhibin beta B chain,37124,0.019421067812862,0.00462344332865165,0.0103591188887048,0.0284830167370193,2.67991561517092e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0120260980644923,0.00286559776062133,-0.0176426696753101,-0.00640952645367447,2.72465739573367e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK2,Protein AHNAK2,37043,0.0114669810147662,0.00273573896219407,0.00610493264886587,0.0168290293806666,2.78864760618276e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0122286601613721,0.0029265871204533,0.00649254940528367,0.0179647709174606,2.95364764777266e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0265162700657641,0.0063678277958938,-0.0389972125457159,-0.0140353275858122,3.14514063443148e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37043,0.00938949881550056,0.002256780332858,0.00496620936309888,0.0138127882679022,3.19463326316294e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0121692582387499,0.00292603990463968,0.00643422002565613,0.0179042964518437,3.21733900295008e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CX3CL1,Fractalkine,39749,-0.012850457364094,0.00309426205540112,-0.0189152109926802,-0.00678570373550782,3.29864505936724e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22,Interleukin-22,37368,-0.0252244184791485,0.00611296688732225,-0.0372058335783002,-0.0132430033799969,3.70729506439359e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRNN,Cornulin,39397,0.0247412531825152,0.00602897880553338,0.0129244547236698,0.0365580516413606,4.08630917043828e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37388,0.022952968577797,0.00559608952833201,0.0119846331022662,0.0339213040533277,4.1268898006354e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0135662637287169,0.00331276932826397,-0.0200592916121143,-0.00707323584531957,4.23960647276501e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWF,von Willebrand factor,40052,-0.0278878844847078,0.00681326017600606,-0.0412418744296797,-0.014533894539736,4.27564843263431e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0172480236472141,0.00421626591901137,-0.0255119048484764,-0.0089841424459518,4.31932243434889e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB37,Ras-related protein Rab-37,39587,0.0317763861365868,0.00777279814998286,0.0165417017626203,0.0470110705105532,4.36982791714055e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0151382561738209,0.00370420867966206,-0.0223985051859586,-0.0078780071616833,4.39932268757661e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0710152124775593,0.0174043448629277,0.036902696546221,0.105127728408898,4.5193584449557e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAP,Cartilage-associated protein,37039,0.0188115237694378,0.00461680762609539,0.00976258082229086,0.0278604667165848,4.63687290353655e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00876509948740194,0.00215981380977683,0.00453186442023935,0.0129983345545645,4.96747986513699e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A12,Protein S100-A12,39615,0.0282874302861393,0.00697414696037034,0.0146181022438135,0.0419567583284652,5.01516704380695e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0141245088221527,0.00350211697009998,-0.0209886580835486,-0.00726035956075671,5.53478911156905e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPO,Lactoperoxidase,39344,-0.0224866234188697,0.00558024698094145,-0.033423907501515,-0.0115493393362245,5.61191743208649e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0100558693587287,0.00249849168835955,-0.0149529130679134,-0.00515882564954395,5.72938121077681e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0232472637896665,0.00578425898469821,-0.034584411399675,-0.011910116179658,5.86990928659597e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE3,Eosinophil cationic protein,39791,0.0402032201042021,0.0100228833127929,0.0205583688111281,0.0598480713972761,6.07012464939317e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37368,0.0223935440959404,0.00558431739462924,0.0114482820024671,0.0333388061894137,6.10253958945441e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK14,Kallikrein-14,40030,0.0168762977204709,0.00420893758161428,0.0086267800605069,0.0251258153804349,6.10860958470835e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON1,Spondin-1,39885,0.0119007903974324,0.00296974289550313,0.00608009432224627,0.0177214864726185,6.16822269869994e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0158874603534684,0.00396587107927892,0.00811435303808173,0.0236605676688551,6.20824375542998e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0375497365034699,0.00937367584419698,0.0191773318488438,0.055922141158096,6.2128691930748e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0169385658407918,0.00423533600625923,0.00863730726852376,0.0252398244130599,6.38027992216888e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA2,GDNF family receptor alpha-2,39788,0.0077729688054404,0.00194430144758755,0.00396213796816881,0.011583799642712,6.42164963470872e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD1,Leiomodin-1,37411,-0.0131281191460619,0.00329127202710632,-0.0195790123191903,-0.00667722597293355,6.67664644859426e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0141016196269475,0.00354042730263611,0.00716238211378073,0.0210408571401143,6.84090119194904e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300E,CMRF35-like molecule 2,39991,0.0142685507490012,0.00358741468075373,0.00723721797472389,0.0212998835232785,6.99797208905675e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37445,0.00947577044330283,0.00238825092178939,0.00479479863659562,0.01415674225001,7.29542925037485e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0194822006936975,0.00491311890470675,0.00985248764047228,0.0291119137469227,7.36683611408382e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0137528192085826,0.00347892415649824,0.00693412786184606,0.0205715105553192,7.74505419516843e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0136836258587597,0.00346952417125571,0.00688335848309848,0.0204838932344209,8.05655633871015e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37388,0.0145010933932003,0.00367954488813724,0.00728918541245126,0.0217130013739492,8.1550030321181e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.00971807831299931,0.00247477631340269,0.00486751673873004,0.0145686398872686,8.64277147891022e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKLR,Pyruvate kinase PKLR,39881,-0.0233888371943386,0.00596173960211709,-0.0350738468144881,-0.0117038275741891,8.77610448215906e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.00910763434453141,0.00232864094886678,0.00454349808475251,0.0136717706043103,9.22402710525896e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSG,Basigin,40040,0.00709011026889572,0.00181309381937555,0.00353644638291964,0.0106437741548718,9.2479738816711e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0142840491745351,0.0036540081905689,0.00712219312102002,0.0214459052280501,9.30755806633518e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0178098566587128,0.0045580816599096,-0.0267436967121357,-0.00887601660529004,9.37113267941835e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM5,Intercellular adhesion molecule 5,39868,0.016064076421228,0.00411232634805789,0.00800391677903454,0.0241242360634215,9.40961373623011e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0093624589338818,0.00239843253830146,0.00466153115881093,0.0140633867089527,9.52414984761611e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR2,Interferon gamma receptor 2,39749,0.0189000558051335,0.00485614957358477,0.00938200264090734,0.0284181089693597,9.98337684568733e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0211221797384405,0.00544991329120675,0.0104403496876752,0.0318040097892057,0.000106832741365095
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37056,0.0115617973581795,0.00298336506734116,0.00571440182619083,0.0174091928901682,0.000106955255203336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSE,Cathepsin E,37124,0.0190881694260897,0.0049366927376271,0.0094122516603406,0.0287640871918388,0.000110894198946104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0215780496710524,0.0055948050884013,0.0106122316977859,0.032543867644319,0.000115426439160537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK3,Dickkopf-related protein 3,40052,-0.0103042031646514,0.00267851136133139,-0.0155540854328609,-0.0050543208964419,0.000120036879418187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH6,Cadherin-6,39868,-0.0136102805493235,0.00354507812943087,-0.020558633683008,-0.00666192741563902,0.000123908516977851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0181453373797697,0.00472923137417531,0.00887604388638613,0.0274146308731533,0.00012520620384921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIT,Citron Rho-interacting kinase,37039,0.0162375006401495,0.00423469941703868,0.00793748978275365,0.0245375114975453,0.000126460675453892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0115466544569333,0.00301332475591321,-0.0174527709785232,-0.00564053793534344,0.000127673463851294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UMOD,Uromodulin,40012,-0.0187611859595156,0.00491501819802545,-0.0283946216276454,-0.00912775029138566,0.000135525543223983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0131107263281878,0.00343618609348126,0.00637580158496456,0.0198456510714111,0.000136519717631602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHB,Lutropin subunit beta,39477,0.0314500433959602,0.00824992189951578,0.0152801964729092,0.0476198903190111,0.000138285348696928
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,39617,0.0103778115225623,0.00272661360235353,0.00503364886194936,0.0157219741831752,0.000141699572742874
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0501653778000341,0.0131822409251201,0.0243281855867987,0.0760025700132696,0.000142041940439794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK8,Kallikrein-8,39315,0.012345840769695,0.00324589776510066,0.00598388115009767,0.0187078003892923,0.000143202782123108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.021763818275365,0.00572469465301111,0.0105434167554632,0.0329842197952667,0.000144315371752477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OBP2B,Odorant-binding protein 2b,39701,-0.0222491984405194,0.00587356445427926,-0.0337613847709067,-0.010737012110132,0.000152412065641927
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0192952477723329,0.00509838722383141,0.00930240881362331,0.0292880867310425,0.000154544596343539
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGN,Secretagogin,39587,-0.0152065939541517,0.00401947454844607,-0.023084764069106,-0.00732842383919736,0.00015538039683528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0124065743841367,0.00328300442442475,0.00597188571226419,0.0188412630560092,0.00015813455252695
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0144098262030145,0.00381808984773508,-0.0218932823045753,-0.00692637010145376,0.000161295774031621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB6,Ephrin type-B receptor 6,39713,0.0106264696375128,0.00282001032596469,0.00509924939862199,0.0161536898764036,0.000164999496472705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0205137454652353,0.00545273755872988,0.00982637985012472,0.0312011110803459,0.000169224935328677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.00953390431649263,0.00254068470390603,0.00455416229683681,0.0145136463361484,0.000175717164238906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAA4,Serum amyloid A-4 protein,37453,0.0115691235349957,0.00308365522995772,0.00552515928427861,0.0176130877857129,0.000176329756192339
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0137057058397438,0.0036596538771011,0.00653278424062569,0.020878627438862,0.000181102344135628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.00965591531672011,0.00258143096164805,-0.0147155200015503,-0.00459631063188993,0.000184404667068593
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO4,Roundabout homolog 4,37043,-0.00622019389456955,0.00166317543735491,-0.00948001775178516,-0.00296037003735393,0.00018483590220602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA4,Carbonic anhydrase 4,40052,-0.00815953029227913,0.00218390264069329,-0.012439979468038,-0.00387908111652029,0.000187452298561797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.010441608037008,0.00279756497264836,0.00495838069061724,0.0159248353833988,0.000190343057931421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0295270167444501,0.00793903450560388,-0.0450875243754337,-0.0139665091134665,0.000200667615851814
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0167390182650229,0.00451219046404716,0.00789512495549051,0.0255829115745554,0.000208331065731272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLN,Mesothelin,39766,0.018167935991956,0.00490257489448503,0.00855888919876533,0.0277769827851466,0.000211443316877584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0113518251370693,0.00306609803388568,-0.0173613772834853,-0.00534227299065339,0.000214441484096812
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK3,NT-3 growth factor receptor,40009,0.00735467205586001,0.00198751912927911,0.00345913456247295,0.0112502095492471,0.000215950621087608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0188274393917016,0.00509828346999936,0.00883480379050283,0.0288200749929003,0.00022245399826087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1A,Lithostathine-1-alpha,39804,-0.0159594123366432,0.00432996877499803,-0.0244461511356393,-0.00747267353764706,0.000228738056789982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0125981497446206,0.0034181897197892,0.00589849789383375,0.0192978015954074,0.000228912626873195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2,Ataxin-2,36991,0.0382880271201824,0.01039447222688,0.0179148615554976,0.0586611926848672,0.000230977983547525
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37056,0.0376295992169312,0.0102383302866241,0.0175624718551479,0.0576967265787145,0.000238450848697954
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0158606965047116,0.00431873199407781,-0.0243254112131041,-0.00739598179631909,0.000240941700261815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0124731608263968,0.00339989087862663,0.00580937470428863,0.019136946948505,0.000244729460287238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L1CAM,Neural cell adhesion molecule L1,39913,0.0097587975206734,0.0026673995082213,0.00453069448455965,0.0149869005567872,0.000254464437765406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST6,Cystatin-M,39524,0.0159332843585217,0.00436725110066288,0.0073734722012224,0.0244930965158209,0.000264781081875445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39489,0.0191725306069794,0.00525670783594053,0.00886938324853596,0.0294756779654228,0.000265922816956558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD209,CD209 antigen,39885,0.0131856151310261,0.00362392866057093,0.00608271495630705,0.0202885153057451,0.000275106495965536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POF1B,Protein POF1B,37056,-0.0153306645994226,0.00422639674963364,-0.0236144022287046,-0.00704692697014069,0.000287413314033237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAM,Integrin alpha-M,39858,-0.0106533113550621,0.00294055222124097,-0.0164167937086944,-0.00488982900142984,0.000292226257566681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFD,Complement factor D,37453,0.00614406988594006,0.00170623061940579,0.0027998578719047,0.00948828189997541,0.000318172584981355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37368,0.0200518295379729,0.00557586162347215,0.00912314075596747,0.0309805183199783,0.000324070135927552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABO,Histo-blood group ABO system transferase,37445,0.0480240015875517,0.0133945868529033,0.0217706113558612,0.0742773918192421,0.000337834038523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEFL,Neurofilament light polypeptide,39438,0.0144978456605523,0.00405087658287238,0.00655812755812248,0.0224375637629822,0.000346038062913216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.021671202845242,0.00606391223165197,0.00978593487120415,0.0335564708192799,0.000352878753817806
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00639604830537609,0.00179041554492344,-0.00990526277342602,-0.00288683383732615,0.000354971995588796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTN3,Myeloblastin,39421,-0.0153975229676914,0.00431105554863421,-0.0238471918430144,-0.0069478540923683,0.000355828191881726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0134941367724486,0.00378103201948472,0.00608331401425853,0.0209049595306386,0.000359552955258695
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.0132344804796287,0.00371469252930643,-0.0205152778370693,-0.00595368312218813,0.000368302797409346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAU,Urokinase-type plasminogen activator,39858,0.0094873340211395,0.00266705170822058,0.00425991267302717,0.0147147553692518,0.000375860029286836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0133866279807914,0.00378493630837502,0.00596815281637636,0.0208051031452064,0.000406145587714313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXTL1,Exostosin-like 1,37021,0.015776614087672,0.00446596238474006,0.00702332781358147,0.0245299003617625,0.000412849551084632
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA12,Serpin A12,39405,0.0388149644105971,0.0110056931617173,0.0172438058136312,0.060386123007563,0.0004218138576709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0121187729373789,0.00343709149739,-0.0188554722722633,-0.00538207360249454,0.000423471717245685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0189449799932537,0.00537539213639245,0.00840921140592454,0.0294807485805829,0.000425642977546262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.021256058442317,0.00603332825418354,0.00943073506411726,0.0330813818205167,0.00042794981308252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PREB,Prolactin regulatory element-binding protein,39587,0.00938102575694993,0.00266902421367884,0.00414973829813941,0.0146123132157604,0.000441360419549958
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSPN,Claspin,39453,0.0112602461045387,0.00320960385883909,0.00496942254121408,0.0175510696678633,0.000452254141199617
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,39913,0.0133181896304792,0.00381147717542843,0.0058476943666395,0.020788684894319,0.000476707031139282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37043,0.0118088258236466,0.0033809994530045,0.00518206689575773,0.0184355847515354,0.000479725505358391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPS,Calcyphosin,37388,0.028385776116301,0.0081348629074625,0.0124414448176745,0.0443301074149275,0.000485649846999584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.022476221207196,0.00645242106647213,0.00982947591691067,0.0351229664974814,0.000496696571769059
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0194308950513931,0.00558362681369349,0.00848698649655381,0.0303748036062323,0.000503087165643243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBP1,Z-DNA-binding protein 1,37056,0.0133738626672869,0.00385147857488822,0.00582496466050595,0.0209227606740678,0.000517485262331933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0163324140048183,0.00470705891685866,0.0071065785277753,0.0255582494818613,0.000522568862850214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1B,Lithostathine-1-beta,40052,-0.0175682376761654,0.00506660911623531,-0.0274987915439866,-0.00763768380834418,0.000526776374592552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.00703921375329698,0.00203032774319441,0.00305977137663594,0.011018656129958,0.000527865750468657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNC,Tenascin,39931,-0.0152149423817084,0.00438964906707378,-0.023818654553173,-0.00661123021024378,0.000529455238104003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX18,Sorting nexin-18,37382,0.0146239257508186,0.00422701101993427,0.00633898415174744,0.0229088673498898,0.000542570878981043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL15,C-C motif chemokine 15,40052,0.0139769284853733,0.00404293002949146,0.00605278562756999,0.0219010713431765,0.000547366315141873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.015783402721175,0.004566317811972,0.00683341980970991,0.0247333856326402,0.000548727275592436
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0138778995377218,0.00401739705214164,0.00600380131552423,0.0217519977599195,0.000552868775042641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL6,Fc receptor-like protein 6,39866,-0.0212133802728257,0.00614623104594339,-0.0332599931228748,-0.00916676742277668,0.000559032218736239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37043,0.0310804090824263,0.00900938885656892,0.0134220069235512,0.0487388112413013,0.000562799324648939
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMOD4,Tropomodulin-4,36962,-0.0131671904328594,0.00382177181806146,-0.0206578631962599,-0.00567651766945895,0.000572191177260515
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40038,0.0167454693157007,0.00487492289335132,0.0071906204447321,0.0263003181866693,0.000593991518393506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0377615096300086,0.0109983134893858,0.0162048151908125,0.0593182040692048,0.000597609579654224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EP300,Histone acetyltransferase p300,37056,0.00947395416981757,0.00276479054536568,0.00405496470090083,0.0148929436387343,0.000612951734470204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00723189598471045,0.00211099471443708,0.00309434634441378,0.0113694456250071,0.000614459141043401
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB2,Plexin-B2,39984,0.00754246952672909,0.00220230629853541,0.00322594918159969,0.0118589898718585,0.000616772730050175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00959007549142634,0.00281085581153311,0.00408079810082143,0.0150993528820312,0.000646980642013315
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARTN,Artemin,39587,0.0142296148269567,0.00417939989530937,0.00603799103215036,0.0224212386217631,0.000664014944218054
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR2,TGF-beta receptor type-2,39913,0.00946625231389903,0.00278047181877193,0.00401652754910604,0.014915977078692,0.000664355460782765
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERC2,ERC protein 2,37039,0.0238545072993968,0.00700676689783986,0.0101212441796307,0.0375877704191629,0.000664838898353786
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFC1,Cryptic protein,39477,0.0147517061314573,0.00435307637374008,0.00621967643892679,0.0232837358239879,0.000703726380245105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR1,Cadherin-related family member 1,39489,0.0134504535440642,0.00397998296100739,0.00564968694048975,0.0212512201476387,0.000727886012980591
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.00926952369453278,0.00274714948308096,0.00388511070769409,0.0146539366813715,0.000742348750878133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.021950306285721,0.00650642738920494,0.00919770860287926,0.0347029039685626,0.000743567703523723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0191704642755409,0.00572828045356589,0.00794303458655175,0.03039789396453,0.000819904735075151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN1,Nectin-1,37056,0.00998440848796472,0.00299773440749255,0.00410884904927932,0.0158599679266501,0.000868806987614255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0130849251166628,0.0039338303285912,0.00537461767262401,0.0207952325607015,0.000882547146064137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP29,Dual specificity phosphatase 29,37039,-0.0206480449105791,0.00621007169672512,-0.0328197854361603,-0.00847630438499784,0.000886825726658204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3,Granulocyte colony-stimulating factor,39587,0.0148701004373348,0.00447328664315715,0.0061024586167468,0.0236377422579228,0.000888751263060013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR2,Complement receptor type 2,39931,0.0140567643514962,0.00422874960181242,0.0057684151319439,0.0223451135710486,0.000889043805038636
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO6,Unconventional myosin-VI,37411,0.0118422149682229,0.00356627358115419,0.00485231874916064,0.0188321111872851,0.000900572101473711
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0240649139042376,0.00725494910945151,-0.0382846141587625,-0.00984521364971262,0.000911811044734353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0111486151506501,0.00336558225068272,0.00455207393931197,0.0177451563619882,0.000926564083808626
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC1,Syndecan-1,39868,0.0122527035828476,0.00370322690709058,0.00499437884495008,0.0195110283207452,0.000939517939392036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPACAM2,HEPACAM family member 2,37388,-0.0129487197053211,0.00391700690541023,-0.0206260532399252,-0.00527138617071709,0.000949626661919589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP4,Guanylate-binding protein 4,39489,0.0150578727001976,0.0045561508875284,0.00612781696064191,0.0239879284397532,0.00095205489629547
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC4,MANSC domain-containing protein 4,37021,0.0192237639797721,0.00582780877291651,0.00780125878485578,0.0306462691746885,0.000974169626284622
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FEN1,Flap endonuclease 1,39477,0.0191810437036595,0.00581701088444673,0.00777970237014394,0.0305823850371751,0.000978004183325534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37411,-0.0235092154760259,0.00713231220113561,-0.0374885473902517,-0.00952988356180009,0.000982694105877432
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN3,Matrilin-3,39720,-0.00962757401724004,0.00292206789132699,-0.0153548270842409,-0.00390032095023914,0.00098714329405443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00914308935206581,0.00277751923630349,0.00369915164891097,0.0145870270552207,0.00099803268426983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37382,0.0152747286035496,0.00464902392977148,0.00616264170119751,0.0243868155059017,0.00102032568026264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KITLG,Kit ligand,39868,-0.0113457794343462,0.00345443790336734,-0.0181164777249462,-0.00457508114374625,0.00102416692060509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAM,Basal cell adhesion molecule,39858,-0.00720541181103998,0.00219528476312597,-0.0115081699467669,-0.00290265367531309,0.00103213217737287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A11,Protein S100-A11,39703,0.0138893773423036,0.00423371796824598,0.00559129012454146,0.0221874645600657,0.00103789248685953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF1,Trefoil factor 1,39789,-0.0229697183827352,0.00701743959557888,-0.0367238999900698,-0.00921553677540058,0.00106551130062268
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTN,Neuroplastin,39477,0.0254332068458477,0.00782872567999946,0.0100889045130488,0.0407775091786467,0.00116177362067052
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAL,Galanin peptides,39931,0.0194994695435037,0.00600338099222276,0.00773284279874707,0.0312660962882603,0.00116424518063045
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL2,Chordin-like protein 2,39868,-0.0170432732476488,0.00524985947645056,-0.0273329978214918,-0.00675354867380566,0.00117104710450124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39489,0.011952432242816,0.00369086153104191,0.00471834364197383,0.0191865208436581,0.0012045918710884
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF2,Scavenger receptor class F member 2,40009,-0.00849305295781937,0.00262334326773877,-0.0136348057625874,-0.00335130015305139,0.00120828631899488
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGF,Beta-nerve growth factor,39749,0.00370818022161051,0.00114672125991202,0.00146060655218295,0.00595575389103808,0.0012243693884104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA2,Carboxypeptidase A2,39933,0.0193563631522977,0.00600875587897611,0.00757920162950451,0.0311335246750909,0.00127837920509207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ULBP2,UL16-binding protein 2,39749,0.0109265317359348,0.00340675738594507,0.00424928725948244,0.0176037762123871,0.0013424734085576
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0090447514339985,0.00282183759515566,0.0035139497474934,0.0145755531205036,0.00135198348187537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR1,Interferon gamma receptor 1,39931,0.00602087928452926,0.00188302276066594,0.00233015467362402,0.00971160389543449,0.00138914878389415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC1,Hamartin,37056,0.0228140531095651,0.00713976737504303,0.00882010905448072,0.0368079971646494,0.00139990186406024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA6C,Semaphorin-6C,37056,0.00778560364543152,0.00244574268771047,0.00299194797751899,0.012579259313344,0.00145929958310694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR101,Probable G-protein coupled receptor 101,36991,-0.0186130632117825,0.00585195649571908,-0.0300828979433919,-0.00714322848017311,0.0014728341285495
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.00922942056674233,0.00290578112871084,0.00353408955446907,0.0149247515790156,0.00149486634401329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0208933205289366,0.00658540873125338,0.00798591941567995,0.0338007216421932,0.00151332264093569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,39868,0.00936934845757558,0.00295499472162584,0.00357755880318895,0.0151611381119622,0.0015236822458523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAYN,Layilin,39713,-0.00952848630216106,0.00300863922435383,-0.0154254191818946,-0.00363155342242755,0.00154290049971527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELL,L-selectin,37453,0.00669083408277491,0.00211490889392449,0.00254561265068291,0.0108360555148669,0.00156146477761322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0265677687447482,0.00839792518370923,0.0101078353846781,0.0430277021048183,0.00156178347369052
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSV,Cathepsin L2,39967,0.0120232347337635,0.00382034411583719,0.00453536026672263,0.0195111092008044,0.00165165148797621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39489,0.011268169341004,0.00358525157466979,0.00424107625465123,0.0182952624273568,0.00167582552568829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHPK,Sedoheptulokinase,37169,-0.0122878681377948,0.00391080907166477,-0.0199530539182578,-0.00462268235733189,0.00168150445895793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.0208359677119024,0.00664674526804312,0.00780834698653788,0.0338635884372669,0.00172367290866818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC1,Sialoadhesin,39931,-0.0122041817152795,0.00389656886032649,-0.0198414566815195,-0.00456690674903963,0.00173912016559038
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.00773909319357008,0.0024782626486402,0.00288169840223529,0.0125964879849049,0.00179461698704747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0104882111166422,0.0033604611417684,-0.0170747149545083,-0.00390170727877611,0.00180522377576575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAG,S-arrestin,36991,-0.0154467246910414,0.00496305683505993,-0.0251743160877588,-0.00571913329432391,0.00186008459032101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0178972789035657,0.00576258799836776,0.00660260642676488,0.0291919513803665,0.00190187832479654
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN10,Ataxin-10,39489,0.0211777228933008,0.00681943280338308,0.00781163459866998,0.0345438111879317,0.00190299832142983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0134790140511679,0.00437155871872754,-0.0220472691398738,-0.00491075896246189,0.00205112086373263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0127078213663795,0.00413914273625435,0.00459510160332095,0.020820541129438,0.00214305771654974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTN,Titin,37021,-0.0195912358445145,0.00639871301471832,-0.0321327133533624,-0.00704975833566661,0.00220493646730517
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RETN,Resistin,39790,-0.011617200249503,0.00380389717374213,-0.0190728387100376,-0.00416156178896847,0.00226165335550528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMB,Granzyme B,39866,0.0182344804415444,0.00597209000879887,0.00652918402429859,0.0299397768587902,0.00226723940375467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDN1,Endothelin-1,37043,0.00798701015545417,0.00261948596394984,0.00285281766611249,0.0131212026447958,0.00230002060621611
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0166834749468627,0.00547293954113107,-0.0274104364474796,-0.00595651344624584,0.0023046732549178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM25,Transmembrane protein 25,37411,-0.0127500513910901,0.00418266217340253,-0.020948069250959,-0.00455203353122112,0.00230575841121507
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0179793555463811,0.00590160886300791,0.00641220217488563,0.0295465089178766,0.00231886365378336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.00661480515720803,0.00217156545748332,0.00235853686054073,0.0108710734538753,0.0023220475560449
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171B,Protein FAM171B,37368,0.00785871601503831,0.00258892273580728,0.00278442745285604,0.0129330045772206,0.00240581773545059
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCA2A,Guanylin,39796,-0.0091171680563814,0.00300591914631988,-0.0150087695831684,-0.00322556652959444,0.00242467633018452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF9,Fibroblast growth factor 9,36931,0.0115005694751443,0.00379537240732564,0.00406163955678602,0.0189394993935025,0.00244905502010794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRC1,Macrophage mannose receptor 1,37445,0.00778878968126907,0.00257173736393771,0.00274818444795116,0.012829394914587,0.0024614280467321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37021,0.0124618563959129,0.00412452316324594,0.00437779099595089,0.020545921795875,0.00252087641129759
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL2,Podocalyxin-like protein 2,39913,0.00774231122569599,0.00256408584920944,0.00271670296124548,0.0127679194901465,0.00253572500380168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD55,Complement decay-accelerating factor,39315,0.00714497082356194,0.00236782069906303,0.00250404225339839,0.0117858993937255,0.00255258453149522
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0106257955325952,0.0035338694108113,0.00369941148740506,0.0175521795777853,0.00264471754153713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0123815024222478,0.00412919404715748,-0.0204747227546765,-0.00428828208981919,0.00271705134703035
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0195238760790081,0.00651623118168944,-0.0322956891951194,-0.00675206296289682,0.00273870275655708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.00733412786200463,0.00245155090403346,0.00252908809009905,0.0121391676339102,0.00277915371845369
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00757662629726096,0.00253285763224692,-0.0125410272564649,-0.00261222533805698,0.00278182124239397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.00733909849264964,0.00246013023256604,-0.0121609537484791,-0.0025172432368202,0.00285762593742712
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY6D,Lymphocyte antigen 6D,39761,0.0100658702802929,0.00337432731524149,0.00345218874241954,0.0166795518181662,0.00285801430660479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0188801335954606,0.00635986957303532,0.00641478923231134,0.0313454779586098,0.00299666622026652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0148959377665018,0.00502799046873934,0.00504107644777267,0.0247507990852309,0.00305500773520007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA2,Carbonic anhydrase 2,39821,0.0187274017178149,0.00633144920003412,0.00631776128574806,0.0311370421498818,0.00310258865483642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.010172402869468,0.00344018335763854,0.00342964348849647,0.0169151622504395,0.00311174028911453
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.0128931751683212,0.00436633463849047,0.0043351592768799,0.0214511910597625,0.00315383551000118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.0103748840875566,0.00351761055121374,0.00348036740717767,0.0172694007679355,0.0031885893173967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.00868051866338801,0.00294633529344074,0.00290570148824416,0.0144553358385319,0.00322159335305759
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLNS1A,Methylosome subunit pICln,37039,-0.00927198235987676,0.00314757635006914,-0.0154412320060123,-0.00310273271374124,0.00322733055062061
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0194602230610988,0.00661335523828709,0.00649804679405611,0.0324223993281415,0.00325968905864802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.0106401379475468,0.0036371990097492,0.00351122788843836,0.0177690480066552,0.00344638901393431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0115786636264002,0.00396503752255176,0.00380719008219875,0.0193501371706016,0.00350303861153678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0103192383542098,0.00353965466604914,-0.0172569614996661,-0.00338151520875346,0.00355920640857252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD48,CD48 antigen,39908,-0.00786461061415905,0.00269967716394279,-0.0131559778554869,-0.00257324337283119,0.0035827658924982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS1,"Nitric oxide synthase, brain",39489,-0.0146505935263041,0.00503121806657186,-0.024511780936785,-0.00478940611582326,0.00359702194899879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.032732951632385,0.0113027989264388,0.0105794657365649,0.054886437528205,0.00378468129364982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APLP1,Amyloid-like protein 1,39868,-0.0138207391161093,0.00477342962587767,-0.0231766611828296,-0.00446481704938909,0.00379250737279551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0174250647250587,0.00602125000529264,-0.0292267147354323,-0.00562341471468516,0.00381074361230552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0229379423294575,0.00794190653799949,-0.0385040791439365,-0.00737180551497846,0.00387970150866157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MELTF,Melanotransferrin,37437,0.00781171631686904,0.00271015635788319,0.00249980985541799,0.0131236227783201,0.00395295232518501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF2,Trefoil factor 2,39908,-0.0152464701891051,0.00532122526898717,-0.0256760717163199,-0.00481686866189023,0.00417263471215047
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK15,Kallikrein-15,37351,0.0134827542376934,0.00470557800245067,0.00425982135289012,0.0227056871224968,0.00417296756762738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.00845953180293005,0.00295761470236857,-0.0142564566195724,-0.00266260698628765,0.00423852414769555
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40030,-0.0159986443357151,0.00559372497667739,-0.0269623452900028,-0.00503494338142745,0.00424042205339615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00692090606675489,0.00242482184486867,0.0021682552508123,0.0116735568826975,0.00432138834983481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0192858096422038,0.00678315503228434,-0.0325807935054812,-0.00599082577892653,0.00447208673653027
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0162891802730759,0.00572951744582262,0.00505932607926361,0.0275190344668883,0.00447459463669874
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0102879355721045,0.00362042722814211,0.00319189820494595,0.017383972939263,0.00449398672955202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300A,CMRF35-like molecule 8,37124,0.00765106451180344,0.00270351745304061,0.00235217030384384,0.012949958719763,0.00466120109750302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0129039038352131,0.00456118029259918,0.00396399046171873,0.0218438172087075,0.00467520315611456
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.00891617975090737,0.0031537444439658,-0.0150975188610803,-0.00273484064073441,0.00470320308150507
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP152,Centrosomal protein of 152 kDa,36962,0.0110265589343473,0.00391086290357997,0.00336126764333051,0.018691850225364,0.004817528103368
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD7,FERM domain-containing protein 7,37039,0.00885333871093087,0.00314172345386091,0.0026955607413635,0.0150111166804982,0.00483975914388139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.0103880421452117,0.00368781636261385,0.00315992207448852,0.0176161622159348,0.00485666203324933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17A,Interleukin-17A,39558,-0.0111031546603258,0.00395075757782562,-0.018846639512864,-0.00335966980778755,0.00495433371813448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC2,Stanniocalcin-2,39831,-0.00692451482748838,0.00246701700660739,-0.0117598681604389,-0.0020891614945379,0.00500911357989368
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37021,-0.0086672457114214,0.0030932690274959,-0.0147300530053134,-0.00260443841752943,0.00508658572635101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN2,Nectin-2,39846,0.00734080590193294,0.00262916790571959,0.00218763680672255,0.0124939749971433,0.00524351251185534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0183492769661391,0.00657204036504323,0.00546807785065441,0.0312304760816239,0.00524532646769145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SATB1,DNA-binding protein SATB1,37411,0.00781708563982086,0.00280407586148378,0.00232109695131264,0.0133130743283291,0.0053148059295893
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPO,Myeloperoxidase,39858,0.0117501445776583,0.00422667654337379,0.00346585855264564,0.0200344306026709,0.00544230321016503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0136470349970288,0.00492083202331697,-0.0232918657627301,-0.00400220423132759,0.00555660486737535
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD109,CD109 antigen,39858,-0.00866878331065136,0.00314597752885313,-0.0148348992672035,-0.00250266735409924,0.00586663980497898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0179694617985026,0.00652924713001227,0.00517213742367861,0.0307667861733267,0.00592738173162171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37043,0.0150383875323233,0.00546774124947596,0.00432161468335039,0.0257551603812961,0.00596066640077053
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA10,Ephrin type-A receptor 10,39489,0.0164067995408985,0.00597928478450073,0.00468740136327711,0.02812619771852,0.00607758530273074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37437,0.0125540117862169,0.00457654759243839,0.00358397850503768,0.0215240450673962,0.00609385720534881
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.00918747499251359,0.00335226978984305,0.00261702620442121,0.015757923780606,0.00613807797452777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0111140379966669,0.00406047528188908,0.00315550644416429,0.0190725695491695,0.00620483610367642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0222627357766794,0.00815166863979784,0.00628546524267563,0.0382400063106832,0.00632141313889823
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD70,CD70 antigen,39866,0.0107188771802796,0.00393738649216364,0.00300159965563887,0.0184361547049203,0.00648929647253554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM1,Myomesin-1,36991,0.0120222251964504,0.00442647285379529,0.00334633840301165,0.0206981119898892,0.00661657806782376
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0177622444285541,0.00656115184932579,0.00490238680387556,0.0306221020532326,0.00679432651820335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP9,Matrix metalloproteinase-9,39843,-0.0152879505713331,0.0056494531817151,-0.0263608788074947,-0.00421502233517145,0.00681520425474636
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0137401058119207,0.00508173314939676,-0.0237003027847384,-0.00377990883910305,0.00686194342793542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLGN,Calmegin,37039,0.0110138222143417,0.00408037958473641,0.00301627822825831,0.019011366200425,0.00695918717082026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSF,Cathepsin F,39913,0.0101762223387744,0.00377456048138494,0.00277808379525991,0.0175743608822889,0.00702504162207631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00771791630304081,0.00286507221181922,0.00210237476787513,0.0133334578382065,0.00707172985091572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPTC,Opticin,39788,0.0110798028720848,0.00412112449542375,0.00300239886105423,0.0191572068831153,0.00718401606646515
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RA,Interleukin-17 receptor A,39858,0.011046048376383,0.00410909882403356,0.00299221468127726,0.0190998820714888,0.00719143519632176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARCL1,SPARC-like protein 1,39871,0.00682239993603558,0.00254048932406397,0.00184304086087021,0.011801759011201,0.00725031992031062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSPN,Persephin,39866,0.0235614738438661,0.0087826301470483,0.00634751875565147,0.0407754289320808,0.0073097722605485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JCHAIN,Immunoglobulin J chain,39587,-0.015147537936265,0.00564770077774698,-0.0262170314606491,-0.00407804441188096,0.00732442180441944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSMB,Beta-microseminoprotein,39780,0.0167585995446596,0.00625994161955313,0.00448911397033547,0.0290280851189837,0.00743346939654979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,39931,-0.00652572495978197,0.00244390706971509,-0.0113157828164235,-0.0017356671031404,0.0075881943854293
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0106784357481987,0.00399965845128997,-0.018517766312727,-0.00283910518367035,0.00759814959857991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.00851074081500369,0.00319948905666324,0.00223974226394374,0.0147817393660636,0.00782126411362947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO1,Alpha-enolase,39830,0.0195665694712466,0.00736774798206709,0.00512578342639508,0.0340073555160981,0.00792212549276253
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.00900979193927523,0.0033983139440964,-0.0156704872697042,-0.00234909660884627,0.00802750957602552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPME1,Protein phosphatase methylesterase 1,39788,0.0148039024154625,0.0055960915521291,0.00383556297328946,0.0257722418576355,0.00816744274691973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37056,-0.00722030977382826,0.00273031373989636,-0.0125717247040251,-0.0018688948436314,0.00819089761384642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOSB,Protein fosB,39489,0.00961221478555296,0.00364148528396786,0.00247490362897595,0.01674952594213,0.00830762238606023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL19,Interleukin-19,39419,-0.0168626234754172,0.00638942572915909,-0.029385897904569,-0.00433934904626537,0.00831981577228618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0165839504129475,0.00631054993325111,0.00421527254377528,0.0289526282821196,0.00859926313130286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0238599886637866,0.00908310473389982,0.00605710338534293,0.0416628739422302,0.0086260572684602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR4,Proline-rich protein 4,37031,-0.0171124211804171,0.0065253449267262,-0.0299020972368005,-0.00432274512403378,0.00873993619313948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00682992135013061,0.00261686854188022,-0.0119589836922158,-0.00170085900804539,0.00906368689692311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB5,Integrin beta-5,39913,0.00920820896233081,0.00354156670873501,0.00226673821321019,0.0161496797114514,0.00932987349246795
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB1,Lamin-B1,37348,0.0140842586528818,0.00541960345109155,0.00346183588874241,0.0247066814170213,0.00936624671257468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00642550489119116,0.00247787956270149,-0.0112821488340861,-0.00156886094829625,0.00952072986340393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00769998841849544,0.00297807610709789,0.00186295924858357,0.0135370175884073,0.00973106313889283
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WIF1,Wnt inhibitory factor 1,40030,0.00807985229687147,0.00312639983505631,0.00195210862016111,0.0142075959735818,0.00976367947957171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.00764522694024272,0.00296548498542823,0.00183287636880339,0.013457577511682,0.00994424017895705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFLAM,Pikachurin,37382,0.00738580385254304,0.00286538773370047,0.00176964389449013,0.013001963810596,0.00995959484342171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB2A2,Mammaglobin-A,37021,-0.00757080892057918,0.00293889680860497,-0.0133310466654449,-0.00181057117571345,0.0100037938419054
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNR,Tenascin-R,39749,0.0100810279564048,0.00391446377702598,0.00240867895343389,0.0177533769593757,0.0100234653893869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D1,DCN1-like protein 1,36991,-0.0179767443426917,0.00700252467043769,-0.0317016926967495,-0.00425179598863379,0.0102638970664572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GKN1,Gastrokine-1,39123,0.00671547366052056,0.00261844115666938,0.00158332899344857,0.0118476183275925,0.0103364612385062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL4,Delta-like protein 4,37043,0.0205911316187577,0.00802975843929521,0.0048528050777391,0.0363294581597763,0.0103478242923651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK11,Kallikrein-11,39779,0.00696221268650279,0.00271656417884887,0.00163774689595901,0.0122866784770466,0.0103900696931408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,36962,-0.00980433183061204,0.00382584858110271,-0.0173029950495733,-0.00230566861165073,0.0103985782809493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00891131530871633,0.00348043432635007,-0.0157329665883625,-0.00208966402907019,0.0104661863853679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00708279324398712,0.00276765324829005,0.00165819287733863,0.0125073936106356,0.0105024659913741
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRAXIN,Draxin,39749,0.0100392667610673,0.00392294267807989,0.00235029911203072,0.0177282344101039,0.0105030388221468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLASP1,CLIP-associating protein 1,36962,0.0175328840290471,0.0068631726927598,0.00408106555123786,0.0309847025068563,0.0106412009722079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM26,Tripartite motif-containing protein 26,36962,0.0133091913879786,0.0052343493941431,0.00304986657545808,0.023568516200499,0.0110125027692512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDAN1,Codanin-1,37388,0.00535884833119492,0.00210776486643652,0.00122762919297934,0.00949006746941049,0.0110194585443583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX9,Transcription factor SOX-9,37039,0.0064186762731759,0.00252549794858914,0.0014687002939412,0.0113686522524106,0.0110476102589464
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00704941947376396,0.00277731873320224,-0.0124929641908404,-0.00160587475668756,0.011151435519578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37247,-0.00191039783555889,0.000756537524602679,-0.00339321138378014,-0.000427584287337638,0.0115751616659252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0196961411833309,0.00782160910107482,-0.0350264950214375,-0.00436578734522421,0.011808099529847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM19,Probable RNA-binding protein 19,37021,-0.0111934594714292,0.00444809201446055,-0.0199117198197719,-0.00247519912308654,0.0118657236852894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0109170749121281,0.00436095350283453,-0.0194645437776838,-0.00236960604657244,0.0123116071352582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00873206473474471,0.00349124699439609,0.00188922062572838,0.015574908843761,0.0123918039468231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROCR,Endothelial protein C receptor,37021,-0.00855013447814729,0.00341935639675596,-0.015252073015789,-0.00184819594050561,0.0124135304553146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCP2,Non-specific lipid-transfer protein,39477,0.0181631075373272,0.00727153639161064,0.00391089620977036,0.0324153188648841,0.0125055924332899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELB,Transcription factor RelB,37056,0.0114470918071957,0.00459601262632548,0.00243890705959774,0.0204552765547936,0.0127629075248245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA1,Annexin A1,37072,0.0101638202110907,0.00408860486814863,0.00215015466951943,0.0181774857526621,0.0129350711643148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE,Angiotensin-converting enzyme,37445,-0.00594479805039755,0.00239505505413947,-0.0106391059565109,-0.00125049014428419,0.0130725645916064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00588514157850952,0.00237130920810838,0.00123737553061709,0.0105329076264019,0.0130841116359854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.00851448759693182,0.00343224068864461,-0.0152416793466753,-0.00178729584718838,0.0131234793182488
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGA4,Pepsin A-4,37445,0.0144081371508372,0.00580971278873689,0.00302110008491289,0.0257951742167615,0.0131499509722162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFB,Vascular endothelial growth factor B,37056,0.00652444335510919,0.00265008765904674,0.00133027154337758,0.0117186151668408,0.0138302106554538
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKCQ,Protein kinase C theta type,39587,0.00994984968503407,0.00404592127480624,0.00201984398641384,0.0178798553836543,0.0139342385463322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPA,Apolipoprotein(a),37186,0.0404125651859763,0.0164395248979529,0.00819109638598868,0.072634033985964,0.0139739809704027
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKAP12,A-kinase anchor protein 12,37124,0.0048136024005033,0.00197093232641482,0.000950575040730258,0.00867662976027635,0.0146070927718665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,39991,0.00578443760634016,0.00236983095382535,0.00113956893684247,0.0104293062758379,0.0146628078698902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.00747920210684134,0.00306551767624736,-0.0134876167522862,-0.00147078746139652,0.0147068085558985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNN,Tenascin-N,37437,0.00976644984449429,0.00401144339952421,0.00190402078142685,0.0176288789075617,0.0149191055889647
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI16,Peptidase inhibitor 16,37445,0.00541305879303106,0.00222970074247794,0.00104284533777429,0.00978327224828782,0.0152075416970215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOC,Brother of CDO,39585,0.00530453278504627,0.00218662648570255,0.00101874487306927,0.00959032069702326,0.0152817362502827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSC,Dipeptidyl peptidase 1,39856,0.00967967786244836,0.00399027186132255,0.00185874501425616,0.0175006107106406,0.0152848657469539
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPO,Erythropoietin,39866,-0.0173667837351513,0.00719436675499759,-0.0314677425749466,-0.00326582489535603,0.0157921262049397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.00986512549630208,0.00408829418091058,0.00185206890171735,0.0178781820908868,0.0158344847182701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0154213590678331,0.00639114951600561,0.00289470601646214,0.0279480121192041,0.0158386545154832
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.00948531196742838,0.00393548549161178,0.00177176040386929,0.0171988635309875,0.0159551266334382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXDNL,Peroxidasin-like protein,37368,0.0133837408067934,0.00555982230276684,0.00248648909337039,0.0242809925202164,0.0160876093705344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100P,Protein S100-P,39585,0.0118253446088279,0.0049175134228005,0.00218701830013896,0.0214636709175169,0.0161954293403561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEG1,Protein LEG1 homolog,36703,-0.0157106262341612,0.00654086068048768,-0.028530713167917,-0.0028905393004053,0.0163233726295871
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.00964198360799157,0.00401630308163563,-0.0175139376479974,-0.00177002956798573,0.0163745420486773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA1,Carbonic anhydrase 1,39531,0.0132623617932424,0.00553218214743266,0.00241928478427434,0.0241054388022104,0.0165275269340322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH12,Protocadherin-12,37411,0.005666608497313,0.00236557988466056,0.0010300719233783,0.0103031450712477,0.0166138435356382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0126485532215435,0.0052933128578124,-0.0230234464228558,-0.00227366002023121,0.0168812444977488
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10,Interleukin-10,39587,-0.0176227327818575,0.00738438544255847,-0.0320961282492721,-0.0031493373144429,0.0170220045968161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP8,Neutrophil collagenase,39985,-0.0159045966935718,0.0066799985251637,-0.0289973938028927,-0.00281179958425093,0.0172806200582638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSB,Lupus La protein,39489,0.0134628492384056,0.00565876188632416,0.00237167594121027,0.024554022535601,0.0173661625761307
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00592533250902313,0.0024971770094128,-0.0108197994474722,-0.00103086557057404,0.017665032652318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40052,-0.00547474089405528,0.00230893959470229,-0.0100002624996718,-0.000949219288438784,0.0177465707687201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL5,Insulin-like peptide INSL5,37382,0.0214765014367919,0.00906097096537099,0.00371699834466474,0.039236004528919,0.017791414466247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP2,Guanylate-binding protein 2,39587,0.0130572932227191,0.00553096984670463,0.00221659232317801,0.0238979941222601,0.018249652849174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37021,0.0087129914438816,0.00371740255564259,0.00142688243482212,0.0159991004529411,0.0191012269237033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.00841533582727537,0.00359557382126678,0.00136801113759248,0.0154626605169583,0.0192717448798286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROS,Uroporphyrinogen-III synthase,37039,0.0149951797538361,0.00640725688935018,0.0024369562507097,0.0275534032569624,0.0192808666411524
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37169,0.0150180556304595,0.00641980058466902,0.00243524648450818,0.0276008647764107,0.0193328818169635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,39788,0.00568544675753461,0.00243304570270729,0.000916677180228322,0.0104542163348409,0.0194639338808641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0116671495778172,0.00501890560245219,-0.0215042045586235,-0.00183009459701092,0.0201059401493542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.0100524292159034,0.00433456605635398,0.0015566797454496,0.0185481786863572,0.0204003145604628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX1B,Syntaxin-1B,37039,0.00921235097939932,0.00397239908964064,0.00142644876370366,0.016998253195095,0.0204053698987661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37056,-0.0120074002761683,0.00518056327373825,-0.0221613042926952,-0.00185349625964132,0.0204765562851637
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH7B,Myosin-7B,36962,-0.00955507242758534,0.00412286467832828,-0.0176358871971088,-0.00147425765806191,0.020487438181351
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TK1,"Thymidine kinase, cytosolic",37169,0.00997341118493228,0.00430352794975135,0.00153849640341963,0.0184083259664449,0.0204917901792917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA5,Protein disulfide-isomerase A5,36962,0.0133060901951248,0.00575567399627221,0.00202496916243126,0.0245872112278183,0.0208029598925141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMS1,PMS1 protein homolog 1,37039,0.0107350550019482,0.00465018273512529,0.00162069684110261,0.0198494131627938,0.0209854498677898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.006406920351332,0.00277557023792942,0.000966802684990342,0.0118470380176737,0.0209964060639747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0258604810178777,0.0112234359849516,0.00386254648737268,0.0478584155483828,0.0212272798772286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.00933432007593796,0.00405683962067922,0.00138291441940668,0.0172857257324692,0.0214136649053023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39477,-0.00993492728706347,0.00433406663753226,-0.0184296978966267,-0.00144015667750025,0.0219022883114001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD177,CD177 antigen,39844,-0.0266657162941029,0.0116389484696289,-0.0494780552945755,-0.0038533772936303,0.0219719646189614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCNA,Proliferating cell nuclear antigen,36962,0.0137064928985116,0.00599075191670185,0.00196461914177595,0.0254483666552472,0.0221567536941523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37039,0.0112277653391296,0.00492420731836296,0.00157631899513817,0.020879211683121,0.0226166916048589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT1A1,Sulfotransferase 1A1,40009,-0.0273825997492545,0.0120304926967275,-0.0509623654348405,-0.00380283406366854,0.0228530810837729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1A,Interleukin-1 alpha,39587,0.0113198163556766,0.00498105552218176,0.00155694753220038,0.0210826851791529,0.0230653093713129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99,CD99 antigen,39858,0.00401738409159954,0.00178526613864361,0.000518262459858061,0.00751650572334102,0.0244434466914224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,36962,0.00898814008574192,0.00399713749298539,0.00115375059949056,0.0168225295719933,0.0245516888240922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTO1,Protein LTO1 homolog,39587,0.00844890329547428,0.00376419316774483,0.00107108468669441,0.0158267219042542,0.0248111623460183
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD2,Sushi domain-containing protein 2,39858,-0.00587779539965604,0.0026279334877491,-0.0110285450356443,-0.000727045763667805,0.0253222521861058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAT,Catalase,37252,0.0110261142050276,0.00493518161788446,0.00135315823397406,0.0206990701760812,0.0254872672859256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.00754628729155836,0.00338392120427403,0.000913801731181256,0.0141787728519355,0.0257582854506132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.0066136302487331,0.00296823288350814,-0.012431366700409,-0.000795893797057156,0.025888171879409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB116,Beta-defensin 116,36991,-0.0160934865796247,0.00722881865511811,-0.0302619711436562,-0.00192500201559324,0.0260112947225599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.00868683652729519,0.0039029177772683,0.00103711768384932,0.0163365553707411,0.0260462236150076
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.0070512750827619,0.00316920942771321,0.000839624604443999,0.0132629255610798,0.0260995947339128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.00685390624433252,0.00308802972107239,-0.0129064444976344,-0.000801367991030638,0.0264661383994157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.0100153971090265,0.0045130309264007,-0.0188609377247719,-0.00116985649328112,0.0264888948410284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.00752788470646084,0.00340795267128077,0.000848297470750536,0.0142074719421711,0.0271975521415778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00831906704767408,0.00376718918355586,-0.0157027578474436,-0.000935376247904584,0.0272406616250948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH2,Growth hormone variant,39477,0.033775884272149,0.0153278170450372,0.00373336286387617,0.0638184056804219,0.0275692947056966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1,Methionine aminopeptidase 1,39489,0.00624542960613757,0.00284149169290691,0.000676105888040023,0.0118147533242351,0.0279679598703287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEBP1,Heme-binding protein 1,39585,-0.0109788441937994,0.00501461051548673,-0.0208074808041533,-0.00115020758344537,0.0285845115769059
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPS10,40S ribosomal protein S10,37021,-0.00878581427668641,0.00401646431578959,-0.016658084335634,-0.00091354421773881,0.0287272319963687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00964417069802234,0.00441213184992268,-0.0182919491238708,-0.000996392272173883,0.0288455715756239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00518844468795296,0.00237878759797326,-0.00985086837998056,-0.00052602099592537,0.0291909109520219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37437,0.00681820310417589,0.00313055284752822,0.000682319523020575,0.0129540866853312,0.0294265413718371
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX3,Syntaxin-3,37388,0.00770269780642065,0.00355522471806062,0.000734457359021825,0.0146709382538195,0.0302838858586472
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL3,Follistatin-related protein 3,39803,-0.00605582069045704,0.00279597252697783,-0.0115359268433336,-0.000575714537580491,0.0303329530836689
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.00832493601126166,0.00384481495873609,0.000789098692138925,0.0158607733303844,0.0303874110122775
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM4,Intercellular adhesion molecule 4,39866,-0.0105587965166274,0.00488711503712585,-0.0201375419893941,-0.00098005104386077,0.0307458551236112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37382,-0.0160126662968399,0.00741565594176112,-0.0305473519426917,-0.00147798065098812,0.0308440053676917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.00841595770156865,0.00389808621526636,0.000775708719646583,0.0160562066834907,0.0308678700014272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0107116568984269,0.00496150686509833,0.00098710344283418,0.0204362103540196,0.0308718539473009
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37056,0.0130962606876255,0.00606682219575236,0.00120528918395084,0.0249872321913001,0.0308938310132281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFD,Vascular endothelial growth factor D,40024,-0.00713005902978219,0.00331141190914915,-0.0136204263717145,-0.000639691687849848,0.0313194441710171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX5,Syntaxin-5,37056,0.00818103519889826,0.00380526697187452,0.000722711934024202,0.0156393584637723,0.0315793360306495
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0135719579676589,0.00632007662219209,-0.0259593081471554,-0.00118460778816242,0.0317768209565523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.019562222363099,0.00911288794535131,-0.0374234827359876,-0.00170096199021045,0.0318390141283879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39489,0.0115791537812801,0.00540779883238866,0.000979868069798374,0.0221784394927619,0.0322737064203647
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL28,C-C motif chemokine 28,39815,0.0118755633193097,0.00555196225106154,0.000993717307229079,0.0227574093313903,0.0324520275263836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC2,MAM domain-containing protein 2,37437,-0.00659129073293336,0.00308392954435728,-0.0126357926398736,-0.000546788825993096,0.0325911976789817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00798755595079556,0.00375170056085166,0.000634222851526314,0.0153408890500648,0.0332652753056566
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37039,-0.00636134674390907,0.00299695126574258,-0.0122353712247645,-0.000487322263053608,0.0338054741801999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37169,0.0102517760089476,0.00484649906659601,0.000752637838419418,0.0197509141794758,0.0344233279858544
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAP1,Antigen peptide transporter 1,37169,-0.0115953526925151,0.00549452367635014,-0.0223646190981614,-0.000826086286868824,0.0348470688834948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37388,0.00528633920044401,0.00250733202590991,0.000371968429660594,0.0102007099712274,0.0350188675166424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00675684615455752,0.0032266137794662,-0.0130810091623113,-0.000432683146803775,0.0362703554764591
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN1,Contactin-1,40052,0.00519768362161311,0.00248513217234305,0.000326824563820746,0.0100685426794055,0.0364977385021078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.00809137262155086,0.00387397567714977,-0.0156843649487644,-0.000498380294337304,0.0367551637319762
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00974923357994677,0.00469270400871927,0.000551533722857002,0.0189469334370365,0.037772007840577
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200,OX-2 membrane glycoprotein,39866,0.00497521190469673,0.00239783953859589,0.000275446409048788,0.00967497740034468,0.0380142693091083
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37169,0.00891275416215636,0.00430898586185548,0.000467141872919609,0.0173583664513931,0.0386206519971878
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.00872770887355146,0.0042336908207594,0.000429674864863042,0.0170257428822399,0.0392754610600938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D2,DCN1-like protein 2,36962,-0.0155333915576068,0.00753548969966998,-0.03030295136896,-0.000763831746253668,0.0392879550505887
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX2,Neuronal pentraxin-2,37437,-0.00648408916825749,0.00314639938618633,-0.0126510319651827,-0.000317146371332286,0.0393414521805772
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN15,Lipocalin-15,37411,-0.0118381034292285,0.00579534248651997,-0.0231969747028076,-0.000479232155649342,0.0411021836359002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20,Interleukin-20,39587,0.00927985067568854,0.00455506169951183,0.000351929744645355,0.0182077716067317,0.041640575651895
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSG1,Tryptase gamma,37056,0.00511435665052746,0.00251382872033654,0.000187252358667843,0.0100414609423871,0.0419222782844413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.00629159657421251,0.00310213414747287,0.000211413645165687,0.0123717795032593,0.0425613437915705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.00499430965708093,0.00246698205714795,0.00015902482507094,0.00982959448909091,0.0429392887389318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.00910300432514511,0.00451164203480367,0.000260185936929927,0.0179458227133603,0.0436453245277569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00970075546438311,0.00481019023189906,0.000272782609860956,0.0191287283189053,0.0437456059806336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0121174565468804,0.00602447267498897,-0.0239254229898587,-0.000309490103901961,0.04430648304425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00970440179923196,0.00482543477865089,-0.0191622539653877,-0.000246549633076217,0.0443358777562665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0109550008689242,0.00545047923729887,0.000272061563818383,0.02163794017403,0.0444572141840283
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40030,0.0104818400542327,0.0052295232583347,0.00023197446789667,0.0207317056405687,0.0450483021368713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF5,Fibroblast growth factor 5,39587,0.00617196860199788,0.00308941153459233,0.00011672199419692,0.0122272152097988,0.045757567384195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEF,Thyrotroph embryonic factor,37021,0.0079244758357049,0.00396866199366698,0.00014589832811762,0.0157030533432922,0.0458715371484245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.00669962254193654,0.00335564331122145,0.000122561651942495,0.0132766834319306,0.0458974193691653
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOD,Apolipoprotein D,36780,-0.00810337500362612,0.00406268035018625,-0.0160662284899912,-0.000140521517261074,0.0461087662878247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF12,Fibroblast growth factor 12,37056,0.00867320011439722,0.0043790253900169,9.03103499640991e-05,0.0172560898788303,0.0476542553996974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPF,Centromere protein F,37169,0.009969130568778,0.0050403846008005,8.99767512090241e-05,0.019848284386347,0.0479660928542118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS5,Transmembrane protease serine 5,39667,0.00701084540425497,0.00354978057394728,5.32754793182988e-05,0.0139684153291916,0.0482846001881883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.00772515846352954,0.00391741731261856,-0.0154032963962619,-4.70205307971658e-05,0.0486263582673797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYAL1,Hyaluronidase-1,39747,0.00418903632614533,0.00212573245341511,2.26007174517172e-05,0.00835547193483894,0.0487833218146748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00730526878872198,0.00371433963065953,2.51631126293086e-05,0.0145853744648147,0.0492301814356006
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A14,Protein S100-A14,37411,0.00938198693353873,0.00477590202180092,2.12189708089297e-05,0.0187427548962685,0.0494991539009457
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.0054050812122034,0.00275305791460884,9.08769957008466e-06,0.0108010747248367,0.0496322116665911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP7,GTPase IMAP family member 7,37124,-0.00598614442352919,0.00304941206467879,-0.0119629920702996,-9.29677675875519e-06,0.0496613793219219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDSN,Corneodesmosin,39992,0.00769021999457161,0.00394526865015963,-4.25065597412615e-05,0.0154229465488845,0.0512857549857854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALB,Ras-related protein Ral-B,37056,0.0053164495380977,0.00273344593931651,-4.11045029626526e-05,0.0106740035791581,0.0518007187470687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00484090500870319,0.00249909577113602,-5.73227027234067e-05,0.00973913272012979,0.0527551069776444
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_DRA,,39799,-0.00640261073709216,0.00330609774150551,-0.012882562310443,7.73408362586443e-05,0.0528111018923136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1B,Protein phosphatase 1B,37056,0.0115241807778384,0.00595766010168439,-0.000152833021462972,0.0232011945771398,0.0530918531925555
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00878809607360069,0.00456392031687632,-0.000157187747476903,0.0177333798946783,0.0541804778028905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCP11,T-complex protein 11 homolog,37169,-0.0107089475416905,0.00556219754566022,-0.0216108547311845,0.0001929596478035,0.0542120287578507
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0109381562197443,0.00568905856708113,-0.0220887110112233,0.000212398571734737,0.0545436083948454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,39866,0.00733655958105727,0.00381892592450106,-0.000148535230964805,0.0148216543930793,0.0547361498195404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A3,Protein S100-A3,37368,0.00808377242654386,0.00421674450979922,-0.000181046812662608,0.0163485916657503,0.0552507720734048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNU13,NHP2-like protein 1,37021,0.0110867497940522,0.00579255145139865,-0.000266651050689203,0.0224401506387935,0.0556460931521799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPT,Microtubule-associated protein tau,39489,0.00938012685211529,0.00490854200147641,-0.000240615470778461,0.019000869175009,0.0560253928857921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0105042749709964,0.00550439241909871,-0.000284334170437049,0.0212928841124299,0.0563682448999037
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF1,Formylglycine-generating enzyme,37056,0.0121901489720959,0.0063890004370324,-0.000332291884487612,0.0247125898286794,0.0564141888492529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAST,Gastrin,37388,0.0206976510212119,0.0108636940324027,-0.000595189282297442,0.0419904913247213,0.0567735713790033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0127468346088641,0.00670452876908436,-0.0258877109962695,0.000394041778541243,0.0572940380804492
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0105318779314616,0.00553957771801009,-0.000325694395838221,0.0213894502587613,0.0572961983689767
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D17,TBC1 domain family member 17,39489,0.0077882508410507,0.00410014903770154,-0.000248041272844312,0.0158245429549457,0.0575165900903678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.00496664313852287,0.00261505857880664,-0.000158871675938144,0.0100921579529839,0.0575497873193859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37039,-0.00769220990207005,0.00405082652031242,-0.0156318298818824,0.000247410077742281,0.0575963456499672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WNT9A,Protein Wnt-9a,39587,0.00498202397900484,0.00262398231474745,-0.000160981357900169,0.0101250293159099,0.0576287977116483
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0180952435593781,0.00954267632705702,-0.000608402041653668,0.0367988891604099,0.057945899147521
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL1,Delta-like protein 1,39913,-0.00502495524739531,0.00265226098833049,-0.0102233867845231,0.000173476289732448,0.0581642897735581
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.00633152686352024,0.00334932957608098,-0.000233159105598475,0.012896212832639,0.0587282586290149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15,Interleukin-15,39866,-0.00571848404770639,0.00302565203344017,-0.0116487620332491,0.000211793937836345,0.0587759360816772
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0106160341004424,0.00562147930418182,-0.0216341335366387,0.000402065335753994,0.0589838623709248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2B,Sodium channel subunit beta-2,37039,-0.00507937124485303,0.00269456549716268,-0.0103607196192919,0.000201977129585819,0.059446043125518
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR4,Toll-like receptor 4,37056,0.00485479054370227,0.00257651877594135,-0.000195186257142783,0.00990476734454733,0.0595539143740381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGN,Mimecan,39858,-0.00692246751949434,0.00368233616840805,-0.0141398464095741,0.000294911370585424,0.0601382446826056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MBL2,Mannose-binding protein C,37257,-0.018872391742925,0.0100402346577056,-0.0385512516720279,0.000806468186177998,0.0601738834869099
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL6B,Myosin light chain 6B,37039,-0.0162120552174751,0.00864253659380571,-0.0331514269413342,0.000727316506384128,0.0606987143472804
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A14,Zinc transporter ZIP14,39489,0.00570657142514816,0.0030442383024166,-0.00026013564758838,0.0116732784978847,0.0608735419359594
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOC,Myocilin,39858,0.00801841817086748,0.00428479983687224,-0.000379789509402109,0.0164166258511371,0.0613129457495679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MN1,Transcriptional activator MN1,37039,-0.0103337622212362,0.00553181139703473,-0.0211761125594243,0.000508588116951826,0.0617757151135161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.00600135162788908,0.00321301106396595,-0.000296150057484188,0.0122988533132623,0.0618042173548315
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3G,Semaphorin-3G,37124,0.0076287807976886,0.00409583265029238,-0.000399051196884471,0.0156566127922617,0.0625446815458336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.00791336437115613,0.00425225759468453,-0.000421060514425538,0.0162477892567378,0.0627657129573074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00475268724083547,0.00255474260452868,-0.000254608264040742,0.00975998274571168,0.0628556991831914
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00455541588192204,0.00245937797345023,-0.00026496494604041,0.00937579670988449,0.0640104810881652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC51B,Organic solute transporter subunit beta,37021,-0.0131030108272046,0.00709283857364253,-0.027004974431544,0.000798952777134761,0.0647177256474836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0084740528826796,0.00458772900536888,-0.000517895967843414,0.0174660017332026,0.0647531049701403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.00877234512277801,0.00475659748762765,-0.000550585952972176,0.0180952761985282,0.0651695761985138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00663243482845848,0.00360161860925352,-0.000426737645678424,0.0136916073025954,0.0655679977593794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAFB2,Scaffold attachment factor B2,37411,0.00471554002296548,0.00256186484082176,-0.000305715065045159,0.00973679511097612,0.065692225589631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB39B,Ras-related protein Rab-39B,37021,0.0152754129037611,0.00830194522603676,-0.000996399739270919,0.0315472255467932,0.0657936831858052
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.0101225787966954,0.00551314333787416,-0.000683182145537954,0.0209283397389288,0.0663644117767657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPE,Coatomer subunit epsilon,39489,0.00809558436336178,0.00441074969410818,-0.000549485037090259,0.0167406537638138,0.0664622659787252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THY1,Thy-1 membrane glycoprotein,40009,-0.0046050983421339,0.00251835247748422,-0.00954106919800296,0.000330872513735168,0.0674756653983896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,H2AP,Huntingtin-interacting protein M,36962,-0.00858250395780561,0.00469485596691464,-0.0177844216529583,0.000619413737347092,0.067562457413488
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL4,Early placenta insulin-like peptide,37368,-0.00910458330484275,0.00499444848063728,-0.0188937023268918,0.000684535717206322,0.0683344690675107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0133263393014593,0.00731994294676654,-0.00102074887420315,0.0276734274771217,0.06869393011166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME2,Proteasome activator complex subunit 2,39666,-0.00614380392723926,0.00337691502767379,-0.0127625573814799,0.000474949527001376,0.0688763470173388
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00389636120104481,0.00214313665463844,-0.000304186642046528,0.00809690904413616,0.0690730588094371
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRND,Prion-like protein doppel,37388,-0.00860121418320961,0.00475056286455297,-0.0179123173977334,0.000709889031314213,0.0702300204359818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL12,Stromal cell-derived factor 1,39587,0.00671957863639005,0.00371928968596322,-0.000570229148097864,0.014009386420878,0.070830775334412
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31,Interleukin-31,37056,-0.00959627440578352,0.00536912460715565,-0.0201197586358086,0.000927209824241545,0.0739108136965715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00820492609658059,0.0045910500070909,-0.0172033841104787,0.000793531917317576,0.0739310526510813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00420344709197473,0.00237092029671883,-0.00885045087354363,0.000443556689594169,0.0762648053680273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL9,C-X-C motif chemokine 9,39931,0.0107491844659687,0.00608020128770587,-0.00116801005793482,0.0226663789898722,0.0770966867165423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNG,Uracil-DNA glycosylase,37368,0.00571397765267173,0.00324057513305679,-0.000637549608119567,0.012065504913463,0.0778791947929646
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.028200466462126,0.0160086876349441,-0.00317656130236445,0.0595774942266164,0.0781608899128184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00466166018629747,0.00265651061867943,-0.000545100626314217,0.00986842099890916,0.0793152040433384
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD9,COMM domain-containing protein 9,37368,0.00643123514229919,0.00366745217086385,-0.000756971112593948,0.0136194413971923,0.0795221692787444
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALY,RNA-binding protein Raly,37368,0.00796501491391819,0.00454882467521632,-0.000950681449505802,0.0168807112773422,0.0799677395959218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIM,Vimentin,39585,0.0191046748196583,0.0109438004402999,-0.00234517404332957,0.0405545236826462,0.080881315790638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN8,Tetraspanin-8,37382,0.0159784590222003,0.00916275337500717,-0.00198053759281373,0.0339374556372144,0.0812081344094943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSAP,Gamma-secretase-activating protein,39477,0.01430820941778,0.00820641076587971,-0.00177635568334419,0.0303927745189043,0.0812589264392064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM132A,Transmembrane protein 132A,37043,0.0100294417438872,0.00584914538475965,-0.00143488321024174,0.0214937666980161,0.0864265012879599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH23,Cadherin-23,37388,-0.0043067948377462,0.00251181181557516,-0.00922994599627351,0.000616356320781105,0.0864384029214847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD9,Enhancer of filamentation 1,37056,0.00534869443005329,0.00312148319652522,-0.000769412635136135,0.0114668014952427,0.086642138416223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDK2,Protein sidekick-2,37124,0.0059473582887575,0.00347357723150352,-0.000860853084989396,0.0127555696625044,0.086888529841835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00861409448678715,0.00503203261733314,-0.0012486894431858,0.0184768784167601,0.0869438077532571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00598127452398779,0.00350269134426344,-0.000884000510768557,0.0128465495587441,0.0877299340109553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RYR1,Ryanodine receptor 1,37021,-0.00539815910032688,0.0031673009548351,-0.0116060689718037,0.000809750771149915,0.0883411077948579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0135091816220578,0.00795598015747927,-0.0020845394866016,0.0291029027307171,0.0895289603652615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00440265493743085,0.00259614150569562,-0.000685782413732561,0.00949109228859427,0.0899387282490008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR2,Toll-like receptor 2,37169,-0.00359523577084171,0.00212008719471553,-0.00775060667248415,0.000560135130800721,0.089947874349246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0132432008042142,0.00782348049554881,-0.0285772225754899,0.00209082096706144,0.0905267361243062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRLF1,Cytokine receptor-like factor 1,39931,0.0041019416821128,0.00243421493215426,-0.000669119584909543,0.00887300294913515,0.0919850415186419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00768616622730557,0.00456441999051563,-0.00126009695410507,0.0166324294087162,0.0922194471203695
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP164,Centrosomal protein of 164 kDa,39587,0.00945420287758888,0.00564948612414147,-0.00161878992572841,0.0205271956809062,0.0942561802544719
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.0102128305256283,0.00611945592319752,-0.0222069641350954,0.00178130308383886,0.0951584355834411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCARE,Photoreceptor cilium actin regulator,36991,-0.0132851138216477,0.00796604017437505,-0.0288985525634228,0.00232832492012739,0.0953954347719297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOBR,Apolipoprotein B receptor,37043,-0.00661760868768195,0.00396825936894268,-0.0143953970508096,0.0011601796754457,0.0954119332339817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00915353449230732,0.00549159476380107,-0.0199170602293574,0.00160999124474278,0.0955728009980406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.00647115301851962,0.00388504299120209,-0.0140858372812757,0.00114353124423649,0.0958053472199847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOH,Beta-2-glycoprotein 1,39858,0.00551462823301633,0.00331130061233815,-0.000975520967166454,0.0120047774331991,0.095853270280796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37039,0.00776290365734517,0.00466872188933389,-0.00138779124574925,0.0169135985604396,0.096386854568972
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00477450980722673,0.00287768874707401,-0.0104147797514918,0.000865760137038328,0.0971099204887188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GL3,Endophilin-A3,37083,0.0127783303194225,0.00770789381139363,-0.00232914155090905,0.027885802189754,0.0973767432568054
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00416116334326638,0.00251097503612389,-0.000760347727536451,0.00908267441406921,0.0975009661212521
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD7,T-cell antigen CD7,37037,0.00662077085704195,0.00399925191965378,-0.00121776290547946,0.0144593046195634,0.0978464576321905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00715876657938227,0.00433375245936554,-0.00133538824097419,0.0156529213997387,0.0985862797104288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.00853669367608374,0.00517241224348755,-0.00160123432115185,0.0186746216733193,0.0988786547463811
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPJ,Centromere protein J,37169,0.0111484102209389,0.00678348399196908,-0.00214721840332046,0.0244440388451983,0.100310635060793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLFM4,Olfactomedin-4,36654,0.0188971722327712,0.0115134242398094,-0.00366913927725531,0.0414634837427976,0.100756329248071
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP4,Caspase-4,37169,-0.0251821939303963,0.0153988487455788,-0.0553639374717307,0.00499954961093807,0.102003609173521
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.00363182947483445,0.00222204230117614,-0.00798703238513968,0.000723373435470774,0.102182830611294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A16,Protein S100-A16,39456,-0.00942266081514281,0.00579134032623482,-0.0207736878545631,0.00192836622427744,0.103751794691298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAP1A,Ras-related protein Rap-1A,37056,-0.0103278964810657,0.00635432610227482,-0.0227823756415244,0.00212658267939292,0.104115484715935
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00856127045345994,0.00527340943303946,-0.0017746120352974,0.0188971529422173,0.104510958318105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN2,Prorelaxin H2,37095,-0.0214923389826046,0.0132686918015717,-0.0474989749136851,0.0045142969484758,0.105303735386852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39477,0.00778272193332372,0.00480861079750744,-0.00164215522979086,0.0172075990964383,0.105575736389238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00825762022270041,0.00510290706275804,-0.00174407762030536,0.0182593180657062,0.105635502546885
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA5,Annexin A5,39415,0.00456261813508159,0.00282059184490072,-0.000965741880923817,0.010090978151087,0.105766906000869
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.00782244038737982,0.00485579956437312,-0.0173398075335511,0.00169492675879149,0.107210793982335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP1,"Fatty acid-binding protein, liver",39862,0.0140562256599584,0.00873450180817978,-0.00306339788407398,0.0311758492039907,0.107575692262989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L2,Seizure 6-like protein 2,39788,0.00360614118853886,0.00224387664355694,-0.00079185703283273,0.00800413940991046,0.108051567166828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00522245963938051,0.00325123233298941,-0.00114995573327874,0.0115948750120398,0.108230904626815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCN,Decorin,39585,-0.00325572692090806,0.00202853398663399,-0.00723165353471068,0.000720199692894554,0.108521493908891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLON5,IgLON family member 5,36962,0.0138643413993404,0.00864286045092196,-0.00307566508446666,0.0308043478831474,0.108707726920419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX33,Testis-expressed protein 33,37169,-0.00593465390112845,0.00370915631811308,-0.0132046002846301,0.00133529248237318,0.109622092363825
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0215884665486107,0.0134937499227459,-0.0480362163971926,0.00485928329997117,0.109647905082062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300C,CMRF35-like molecule 6,40009,0.00495258903451546,0.00310143854941685,-0.00112623052234156,0.0110314085913725,0.110314624001318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00545321578790366,0.00341977471818662,-0.0121559742355494,0.0012495426597421,0.110822909551254
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.0116206492283991,0.00731718947332783,-0.0259623405961216,0.00272104213932345,0.112280665960588
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.0198819792795675,0.0125549431139617,-0.0444896677829324,0.00472570922379737,0.113308584467963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF20B,Kinesin-like protein KIF20B,36991,0.0110920232911114,0.007016326342234,-0.00265997633966726,0.02484402292189,0.113927826037769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.00582895547670862,0.00368766298696052,-0.001398863977734,0.0130567749311512,0.113978204868852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESR1,Estrogen receptor,37056,0.008771731117509,0.00555539984547831,-0.00211685257962849,0.0196603148146465,0.114370151492096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME1,Nucleoside diphosphate kinase A,37056,-0.00321759982317793,0.0020403457130194,-0.00721667742069595,0.000781477774340088,0.11482235629524
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCC1,Regulator of chromosome condensation,37368,0.00745757755554088,0.00473215397801439,-0.00181744424136731,0.0167325993524491,0.115063691429562
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.00847933470936555,0.00539220956618069,-0.0190480654590797,0.0020893960403486,0.115855017151809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,36991,0.0134452024072901,0.0085634636818576,-0.00333918640915075,0.030229591223731,0.11642387283577
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37043,0.00486400976753263,0.00311325745470931,-0.00123797484369762,0.0109659943787629,0.118228656247534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOPH1,Enolase-phosphatase E1,37368,0.00813748761379813,0.00521366072247943,-0.00208128740226156,0.0183562626298578,0.118594104092154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA7A,Semaphorin-7A,40002,-0.00391107193918519,0.00251278343691752,-0.00883612747554353,0.00101398359717315,0.119615984633515
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.0047662164366182,0.00306338560335006,-0.00123801934594791,0.0107704522191843,0.119764087658527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00435639688741989,0.0028092405578168,-0.00986250838074081,0.00114971460590104,0.120988568522403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN1,Transcobalamin-1,37235,0.00493819498120289,0.00319748698900886,-0.00132887951725446,0.0112052694796603,0.122515415745573
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTP1,Glutathione S-transferase P,39393,-0.00998716857887688,0.00647040699798467,-0.0226691662949268,0.00269482913717307,0.12272630517322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR1,TGF-beta receptor type-1,37056,0.00313866139315369,0.00203504056466719,-0.000850018113594013,0.00712734089990139,0.123022499742656
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN2,Transcobalamin-2,40012,0.00418541253897807,0.00272950763674022,-0.00116442242903276,0.0095352475069889,0.125198219909903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT1,Diamine acetyltransferase 1,37021,-0.00709633520773114,0.00464815008785961,-0.016206709379936,0.00201403896447369,0.126859418573377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00554603708763179,0.00363672063973243,-0.0126740095415074,0.00158193536624378,0.12728032561833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.00882436145434021,0.00579154105675219,-0.00252705901689408,0.0201757819255745,0.127612826011543
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC44A4,Choline transporter-like protein 4,37039,-0.00962534562039402,0.00633828744294313,-0.0220483890085626,0.00279769776777452,0.12888631206741
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRLB,Fc receptor-like B,39477,0.00818672224303586,0.00539826680417947,-0.0023938806931559,0.0187673251792276,0.129401479910714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.00997581158604776,0.00658337572168852,-0.0228792280005573,0.00292760482846174,0.129718963031266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEB,Nebulin,37021,-0.00530094664369281,0.00351312221283435,-0.0121866661808481,0.00158477289346251,0.131348596497919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTTG1,Securin,37169,0.00587331345439612,0.00389827394910592,-0.0017673034858515,0.0135139303946437,0.131925508612551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD2,Leiomodin-2,36991,-0.00901754236461926,0.00599132335806615,-0.0207605361464289,0.00272545141719038,0.132322353702168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVPL,Envoplakin,37169,0.00461398257469322,0.00307472120618222,-0.00141247098942394,0.0106404361388104,0.13347806518863
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0360632851213216,0.0240864537949477,-0.0832727345594191,0.011146164316776,0.134353864963312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00736637232043302,0.00493741953800012,-0.0170437146149133,0.00231096997404721,0.135736958335836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.00459709442769649,0.00308629730448205,-0.00145204828908833,0.0106462371444813,0.136370602268128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00442376939792626,0.0029705202854467,-0.00139845036154927,0.0102459891574018,0.136448509906429
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6,Seizure protein 6 homolog,37039,0.00428394160552372,0.00290638785016603,-0.0014125785808017,0.00998046179184914,0.140512339353287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBN,Ameloblastin,39587,-0.00391718155589493,0.00266233372267211,-0.00913535565233227,0.0013009925405424,0.141220878545711
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC8,Histone deacetylase 8,37056,0.00868170824469078,0.00590538682746704,-0.00289284993714463,0.0202562664265262,0.141549385583519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA3,Carbonic anhydrase 3,40017,-0.00825406248985509,0.00561931624897604,-0.0192679223378481,0.00275979735813796,0.141886680323819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00434914381181846,0.00296352292291963,-0.00145936111710403,0.0101576487407409,0.142248032856926
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00790469666353994,0.00538948958199045,-0.00265870291716135,0.0184680962442412,0.142485049563833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37169,0.00718522412064811,0.00492440517957654,-0.00246661003132191,0.0168370582726181,0.144559815924569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESPL1,Separin,36962,-0.00735578302449922,0.00504250078102573,-0.0172390845553097,0.00252751850631122,0.14465598885877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.00694765705894711,0.00476504701425135,-0.00239183508898553,0.0162871492068798,0.144851152015636
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0399492077865195,0.0274259798150251,-0.0138057126509298,0.0937041282239688,0.145241155341003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G15,Phospholipase A2 group XV,39913,0.00359681060752426,0.00246969837540372,-0.00124379820826702,0.00843741942331554,0.145308133424506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL11,Interleukin-11,39587,0.0084500884077539,0.00580553648526766,-0.00292876310337071,0.0198289399188785,0.145544653199104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL2,Interferon lambda-2,36991,-0.00841117909362759,0.00578815026711996,-0.0197559536171827,0.00293359542992752,0.146199843788372
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBR1,T-box brain protein 1,37039,-0.0065237948764083,0.0045060946771376,-0.015355740443598,0.0023081506907814,0.147704788884421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,39866,0.00619200179847083,0.0042878751664994,-0.002212233527868,0.0145962371248097,0.148738208985191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00637940307326217,0.00442698112057925,-0.0150562860695975,0.00229747992307315,0.149600606213905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37437,0.00391857350258038,0.00272220070237474,-0.00141693987407412,0.00925408687923488,0.150035543374435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.00497916446808142,0.00345965407968431,-0.00180175752809982,0.0117600864642627,0.150114481069064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.00984172285256099,0.00684596847608626,-0.00357637536056809,0.0232598210656901,0.15057234519817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00302101420295662,0.00210548941979404,-0.00110574505983969,0.00714777346575293,0.151359946891062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYMP,Thymidine phosphorylase,39764,0.00904828543051902,0.00631406268252225,-0.00332727742722459,0.0214238482882626,0.15186692079178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G1B,Phospholipase A2,40031,0.00543744236349035,0.00381093723120267,-0.00203199460966689,0.0129068793366476,0.153657075632361
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00653221173216401,0.00458264554924326,-0.00244977354435278,0.0155141970086808,0.154058466468238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.00456001178290899,0.00321409148251702,-0.00173960752282436,0.0108596310886424,0.155989712173668
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00640275949372968,0.00451764217515208,-0.0152573381570278,0.0024518191695684,0.156425005045294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFASC,Neurofascin,40058,0.00362939018875031,0.00258299339989691,-0.00143327687504764,0.00869205725254826,0.160007710117584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.00376475300740646,0.00268498054514432,-0.00902731487588932,0.0014978088610764,0.160892566069615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00389897419876493,0.00278432377861083,-0.00935624880484215,0.00155830040731229,0.16143714898733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37388,0.00578784463541407,0.0041539807395097,-0.00235395761402494,0.0139296468848531,0.163544467853405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00857439565350306,0.00616511453573493,-0.0206580201435435,0.0035092288365374,0.164311896226306
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00662972465246919,0.00477280861591673,-0.015984429539666,0.00272498023472761,0.164837522762642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00531176825739817,0.0038522244252041,-0.0128621281307982,0.00223859161600186,0.167954145183988
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.0034611290005184,0.00251424607817422,-0.00838905131373988,0.00146679331270307,0.16865278899791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.00313602420243975,0.00227850953775282,-0.00132985449155578,0.00760190289643529,0.168732658559663
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB1,Scavenger receptor class B member 1,39489,0.00729681627667677,0.00531273499194373,-0.00311614430753294,0.0177097768608865,0.169629833292182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX101,Testis-expressed protein 101,37039,0.00618630339563099,0.00454565642120507,-0.00272318318993094,0.0150957899811929,0.173560250444189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR1B,Cornifin-B,37169,0.0111084979943447,0.00818834961497822,-0.00494066725101264,0.027157663239702,0.174924250964493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37437,-0.00402295521884513,0.00296597916129262,-0.00983627437497865,0.0017903639372884,0.175005093187937
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00687847021962504,0.0050716549750641,-0.0168189139707507,0.00306197353150059,0.175040287360799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA11,Serpin A11,40052,-0.00517251846994503,0.003815970586364,-0.0126518208192185,0.00230678387932841,0.17527968960965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00583560179968446,0.0043306338672042,-0.0143236441794047,0.00265244058003576,0.177837102685715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMA,Repulsive guidance molecule A,40009,-0.00388276461725019,0.00288743417441091,-0.00954213559909556,0.00177660636459519,0.17873745322757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEL1L,Protein sel-1 homolog 1,37043,0.00392944729034181,0.002922288853658,-0.00179823886282787,0.00965713344351149,0.178762353292297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37169,-0.00555348199415087,0.00413496840733347,-0.0136580200725245,0.00255105608422273,0.17927769388374
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00647952731820725,0.00484028485847777,-0.00300743100440917,0.0159664856408237,0.180703468074859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDRG1,Protein NDRG1,39489,0.0085910369219615,0.00645794800004408,-0.00406654115812489,0.0212486150020479,0.183437394274269
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00613736156635475,0.00461358788564875,-0.0029052706895168,0.0151799938222263,0.183445596456064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00707601712024368,0.005320616352078,-0.00335239092982919,0.0175044251703165,0.183566356248779
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.00380944162638763,0.0028745503926335,-0.00182467714317403,0.0094435603959493,0.185113747418602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP1,Caspase-1,39489,0.00823045646920611,0.006234139731381,-0.00398845740430064,0.0204493703427129,0.186779812355746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX2,Transcription factor SOX-2,37391,0.00292826120297146,0.00222103219433661,-0.0014249618979283,0.00728148430387122,0.187384209537713
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK1,Cyclin-dependent kinase 1,36962,0.0044713230960029,0.00339276663923069,-0.00217849951688925,0.0111211457088951,0.187560567837131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.00877322685306587,0.00666983632176763,-0.0218461060437304,0.00429965233759868,0.188412364991165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA4,Apolipoprotein A-IV,37453,0.00435091778070854,0.00330911176113738,-0.00213494127112074,0.0108367768325378,0.188589390497879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSM,Oncostatin-M,39785,-0.00873836819950607,0.00666406537618075,-0.0217999363368203,0.0043231999378082,0.189786520312568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00385909399840821,0.00294825794965137,-0.00963767957972489,0.00191949158290848,0.190573109441101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.00441883812358075,0.00337780527783796,-0.0110393364681432,0.00220166022098165,0.190828385773863
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00634788247637582,0.0048643200368921,-0.0031861847959327,0.0158819497486843,0.191919271942405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMH,Granzyme H,39585,0.00915029940532516,0.00703102504288201,-0.00463050967872359,0.0229311084893739,0.19313463495381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2BP,LRP2-binding protein,37039,-0.00969044290519026,0.00745405548345277,-0.0243003916527577,0.00491950584237717,0.193615852773852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,36962,0.00898737138822198,0.00693685963623804,-0.00460887349880458,0.0225836162752485,0.195137344501245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.00784659149521837,0.00606116184804659,-0.00403328572695295,0.0197264687173897,0.195491052727441
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF7,Fibroblast growth factor 7,36962,-0.00964707782888769,0.0074588610108603,-0.0242664454101739,0.00497228975239851,0.195905424297286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.00483337882205469,0.00373749511986302,-0.00249211161287682,0.0121588692569862,0.195956386567076
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAGLN3,Transgelin-3,36962,-0.00723450923669964,0.00560478643572948,-0.0182198906507294,0.00375087217733013,0.196805040207052
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00389832921337889,0.00302802901942923,-0.00983326609146017,0.00203660766470239,0.197972457705138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17F,Interleukin-17F,39587,-0.00930813073573982,0.00723048378846038,-0.0234798789611222,0.00486361748964252,0.197992837363688
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00611388736694708,0.00475400771266408,-0.0154317424837687,0.00320396774987452,0.198448549201458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA8,Carbonic anhydrase-related protein,37056,0.00313175706908881,0.00243772216037213,-0.00164617836524057,0.00790969250341819,0.1989174792139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF6,Fibroblast growth factor 6,37056,0.00492037975237061,0.0038302050107164,-0.00258682206863354,0.0124275815733748,0.198945667045865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.00752762458502945,0.0058652800751208,-0.0190235735322662,0.00396832436220732,0.199367129214807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0174492422142193,0.0136249837989175,-0.009255726031659,0.0441542104600977,0.200328105775282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTF,Ciliary neurotrophic factor,36991,0.00404988726422003,0.00317000769723994,-0.00216332782237026,0.0102631023508103,0.201425837324428
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37056,0.0113266177468236,0.00894040859834851,-0.00619658310593948,0.0288498185995867,0.205212844204241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF75D,Zinc finger protein 75D,37169,0.00699186901513309,0.00552968484967202,-0.00384631329022406,0.0178300513204902,0.206099844953396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.00644508232293465,0.00510031951675972,-0.0035515439299144,0.0164417085757837,0.206370051670812
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO6,Coronin-6,36991,-0.00445452269012249,0.00354083497559669,-0.011394559242292,0.00248551386204703,0.208398572039756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENND2B,DENN domain-containing protein 2B,37021,-0.00605950074353841,0.0048251531035068,-0.0155168008264117,0.00339779933933493,0.209205262767909
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPN1,Epsin-1,37169,0.00505134444537872,0.00402317191441041,-0.00283407250686569,0.0129367613976231,0.209296617932977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN2,Neuroligin-2,36991,-0.00552814709271655,0.00440323521303195,-0.0141584881102592,0.00310219392482607,0.209329100469839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00621528672104435,0.00495789072810878,-0.00350217910604887,0.0159327525481376,0.210004305544044
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIF,Leukemia inhibitory factor,39489,0.00595847081738106,0.00478782574085964,-0.00342566763470384,0.015342609269466,0.213332595560334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.00311280575442174,0.0025074120012768,-0.0018017217680808,0.00802733327692427,0.214460750596896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,36962,0.00382206897725119,0.00308257233954017,-0.00221977280824755,0.00986391076274993,0.21503608582936
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKIV2L,Helicase SKI2W,37021,0.00466910096547116,0.0037674022452185,-0.00271500743515711,0.0120532093660994,0.215240859359022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH4,Myosin-4,37021,-0.00553775180351673,0.00447144587176231,-0.0143017857121709,0.00322628210513739,0.215563908883807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KEL,Kell blood group glycoprotein,39489,-0.00409447507268052,0.00330824038045457,-0.0105786262183715,0.00238967607301045,0.215860942046948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00559955352439862,0.00458996395443296,-0.00339677582628997,0.0145958828750872,0.222503509770793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX2,Peroxiredoxin-2,37249,-0.00692600242255055,0.00568694483016793,-0.0180724142896797,0.00422040944457859,0.223291971317821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.00578455062615868,0.00475087005169935,-0.0150962559274894,0.00352715467517205,0.223406547061041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI4,Protein-arginine deiminase type-4,39456,0.0079767797454194,0.00655382880211986,-0.00486872470673553,0.0208222841975743,0.22357792875259
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0104132680506081,0.00856512078874136,-0.0272009047965412,0.00637436869532495,0.224092179267529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAVL4,ELAV-like protein 4,36991,0.00956037137989046,0.00789371156320379,-0.00591130328398897,0.0250320460437699,0.225864445191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP2,Neuropilin-2,39858,0.0032107378350371,0.00266028970759052,-0.00200342999184033,0.00842490566191453,0.227483553210703
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00386007231349326,0.00320104008174997,-0.00241396624673668,0.0101341108737232,0.227884947427817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.00677306742051989,0.00562067340020959,-0.0042434524438909,0.0177895872849307,0.228210536396017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN3,Perilipin-3,39868,-0.00481029225375008,0.00400412953383646,-0.0126583861400695,0.00303780163256937,0.229639894800756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP15,Matrix metalloproteinase-15,37437,0.00553646876380031,0.00462180737464399,-0.0035222736905019,0.0145952112181025,0.230976380147022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00579792568739655,0.00484252925974996,-0.0152892830365065,0.00369343166171336,0.231213992183578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00323107941335215,0.00270132398140157,-0.00206351559019493,0.00852567441689923,0.231672463958604
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK12,Kallikrein-12,39477,-0.0152473816204805,0.0128470555253793,-0.0404276104502238,0.00993284720926291,0.235309336419896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMR1,Synaptic functional regulator FMR1,39477,0.00392373803768252,0.00332094128898728,-0.00258530688873256,0.0104327829640976,0.237416656882944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALLD,Palladin,37056,0.00449432240436895,0.0038068344317404,-0.00296707308184224,0.0119557178905801,0.237785691427292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0042207582925043,0.00357819789693276,-0.00279250958548392,0.0112340261704925,0.238186296166598
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL9,Interleukin-9,37169,-0.00628894054429807,0.00534951689304695,-0.0167739936546701,0.00419611256607396,0.239772161693653
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.00469920418220499,0.00400049292168268,-0.00314176194429307,0.012540170308703,0.240149813119577
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00358707268293534,0.00305748923753015,-0.00240560622262376,0.00957975158849443,0.240732818379756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00326380798777272,0.00278251831248452,-0.00871754388024238,0.00218992790469694,0.240828817009725
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCF2,Neutrophil cytosol factor 2,39843,0.00904014377712367,0.00773928227517812,-0.00612884948222545,0.0242091370364728,0.242789682645585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40058,0.00623514840204821,0.0053389736159077,-0.00422923988513088,0.0166995366892273,0.242882344333181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOS,Proto-oncogene c-Fos,36931,-0.00385267063825583,0.00331137241390919,-0.0103429605695178,0.00263761929300617,0.244661549168492
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5A,Cytochrome b5,36962,0.00781062844474758,0.00671670511996704,-0.00535411359038781,0.020975370479883,0.244905027297533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37039,0.00393099625799062,0.0033969621811141,-0.00272704961699302,0.0105890421329743,0.247207828690798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39017,0.00386714303702596,0.0033440879641453,-0.00268726937269881,0.0104215554467507,0.247530952264508
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.00461029644390578,0.00403937815860359,-0.0125274776347688,0.00330688474695726,0.253749762405196
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHD,SH2 domain-containing adapter protein D,37002,0.00888134284560345,0.00778342196486067,-0.00637416420552347,0.0241368498967304,0.253866208367684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA6,Carbonic anhydrase 6,39817,-0.00674039362470772,0.00592889872749322,-0.0183610351305944,0.00488024788117898,0.255609246453418
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YY1,Transcriptional repressor protein YY1,37056,0.0029470856729193,0.00259485691055948,-0.00213883387177728,0.00803300521761587,0.256085555660164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,39928,0.00849728973123049,0.00750972112712899,-0.00622176367794233,0.0232163431404033,0.257859334124378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCLRE1C,Protein artemis,36962,-0.00326843282072453,0.00290863570061907,-0.00896935879393791,0.00243249315248884,0.261161067489755
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.00722612583632112,0.00643076830765518,-0.00537818004668302,0.0198304317193253,0.261166056283557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00321270507124295,0.0028610254053008,-0.00882031486563252,0.00239490472314663,0.261488254547808
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37186,0.00440861536439192,0.00393065779685205,-0.0032954739174381,0.0121127046462219,0.262053889153614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM2,Neural cell adhesion molecule 2,39858,-0.00279251259639216,0.00249236314013005,-0.00767754435104705,0.00209251915826274,0.262548383548216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00401623493054673,0.00358688144560429,-0.0110465225639311,0.00301405270283767,0.262861581879845
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPA33,Cell surface A33 antigen,39788,-0.013685629526263,0.0122690327204608,-0.0377329336583662,0.0103616746058402,0.264669680275709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2,T-cell surface antigen CD2,37021,-0.00399735935997467,0.00359169631575853,-0.0110370841388614,0.00304236541891205,0.265752509777425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00647110314208914,0.00584249295920588,-0.00498018305795437,0.0179223893421327,0.268057955613067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37056,-0.00794912743870703,0.00718107035889267,-0.0220240253421367,0.00612577046472261,0.268333219384298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSND,Barttin,36962,-0.00349409757019186,0.00316026658945433,-0.00968822008552235,0.00270002494513863,0.268905353727654
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39477,-0.00477908396912876,0.00433469459246554,-0.0132750853703612,0.00371691743210371,0.270253010446423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGM2,Phosphoglucomutase-2,37039,0.00621088049231212,0.00566010106514822,-0.00488291759537839,0.0173046785800026,0.272526336075923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36G,Interleukin-36 gamma,37021,0.0068850213779934,0.00630466170731424,-0.00547211556834252,0.0192421583243293,0.274830030087829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAN,Versican core protein,40009,-0.00298058324952648,0.00275714211611421,-0.00838458179711034,0.00242341529805738,0.279695087266341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0171909602205559,0.015922137727513,-0.0483983501664813,0.0140164297253695,0.280299860165769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSP90B1,Endoplasmin,39405,0.00677088117852797,0.00628541832329113,-0.00554853873512265,0.0190903010921786,0.281391400286941
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN1,Neuroligin-1,37039,-0.00676729447014189,0.00628928060130274,-0.0190942844486953,0.00555969550841147,0.281944923762758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00727242984990132,0.0067587585063226,-0.0205195965222936,0.00597473682249097,0.281946384027628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00589224331240878,0.0055087256040595,-0.0166893454963654,0.00490485887154783,0.284809986483933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00489067522363207,0.00457253048023165,-0.0138528349648861,0.00407148451762197,0.284829280204702
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00763667668264937,0.00718785450815693,-0.00645151815333822,0.021724871518637,0.288054658975462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,39866,-0.00599421271901215,0.00564807661794563,-0.0170644428901856,0.00507601745216129,0.2885769182119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00549529850557948,0.00517887353631719,-0.0156458906367612,0.00465529362560222,0.288664271437339
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.00265006180047354,0.00250986921512552,-0.00756940546211955,0.00226928186117248,0.291052554102846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB7,Integrin beta-7,40030,0.004464882513121,0.00424458235407125,-0.00385449890085865,0.0127842639271007,0.292860466169315
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37161,-0.00969080912660391,0.00923784777473178,-0.0277969907650782,0.00841537251187037,0.294181893053803
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDNRB,Endothelin receptor type B,37056,0.0045655275869681,0.00435902777630858,-0.00397816685459672,0.0131092220285329,0.29494680611643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.00829284344498131,0.00795664898926565,-0.023887875463942,0.00730218857397937,0.297313414993035
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TG,Thyroglobulin,37368,0.0105657518828706,0.0101531255337496,-0.00933437416327862,0.0304658779290198,0.298061132486247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN15,Tetraspanin-15,37021,-0.00480192560927916,0.00462053292241322,-0.0138581701372091,0.00425431891865076,0.298703873946084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00613789679475945,0.00597014334533333,-0.0178393777516128,0.00556358416209388,0.303922366942342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.00510553771953035,0.00498670659963515,-0.00466840721575455,0.0148794826548153,0.305934111040208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNW1,Interferon omega-1,37021,0.00339199030529198,0.00331387429693459,-0.00310320331669981,0.00988718392728378,0.306056094829152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00285849423440149,0.00280487082162229,-0.00835604104478117,0.00263905257597819,0.308165743799865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF8,SLAM family member 8,39477,-0.0049448340183459,0.00485305384085638,-0.0144568195464244,0.00456715150973261,0.308260606170861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAND5,DAN domain family member 5,37056,0.00511239465247503,0.00501836327357097,-0.00472359736372407,0.0149483866686741,0.308346300256656
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BEX3,Protein BEX3,36962,-0.00446864641390153,0.00438661889802633,-0.0130664194540331,0.00412912662623008,0.308364466895297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSTN,Osteocrin,37039,-0.00398189892890426,0.00390964807242328,-0.0116448091508539,0.00368101129304538,0.308468528723903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.00582578675595954,0.00572060309619801,-0.0170381688245076,0.00538659531258856,0.308512929249046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0110614240233562,0.0108834962202279,-0.0102702285682904,0.0323930766150028,0.309482231648488
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN8,Septin-8,37357,0.00302397372519754,0.00298105043044042,-0.00281888511846568,0.00886683256886076,0.310410720998473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.00309964914739612,0.00305820516680434,-0.00909373127433263,0.00289443297954038,0.310812019599921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPLX2,Complexin-2,36962,-0.00283648653741889,0.00281146530310611,-0.00834695853150686,0.00267398545666908,0.313041364361503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.00339181099319391,0.00338783861083813,-0.0100319746704366,0.00324835268404882,0.316761756775313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00596183173776715,0.0059575138079609,-0.0176385588013705,0.00571489532583622,0.316978278809013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2B,Alpha-amylase 2B,38832,0.00448681592010015,0.00449228314420134,-0.00431805904253446,0.0132916908827348,0.317915977045284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRN1,Neuritin,37411,-0.0032744482579213,0.00329139569185566,-0.00972558381395839,0.00317668729811579,0.319826506873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2A,Pancreatic alpha-amylase,39246,0.00435620320054385,0.00438869862232518,-0.00424564609921351,0.0129580525003012,0.320922650748858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTNNA1,Catenin alpha-1,36991,-0.00324340879069431,0.0032812455227507,-0.00967465001528568,0.00318783243389706,0.322941325712476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00340401196718172,0.0034472606394544,-0.0101606428205123,0.0033526188861489,0.32343818222152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHH,Sonic hedgehog protein,37056,-0.00402438916397071,0.00407887233668421,-0.0120189789438718,0.00397020061593034,0.323835973545331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00552159643446325,0.00561835778798632,-0.00549038482998994,0.0165335776989164,0.325734904536526
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.00481299899414593,0.0049285684234952,-0.00484699511590466,0.0144729931041965,0.328806452656421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00184260419975069,0.00188740908262009,-0.0018567176021847,0.00554192600168607,0.328953000552068
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP2,Dipeptidase 2,39788,0.00264322124234925,0.00271733651410594,-0.0026827583252984,0.0079692008099969,0.330704753239881
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1,Huntingtin-interacting protein 1,37021,0.00303519062140212,0.00313892647707514,-0.00311710527366516,0.00918748651646941,0.33358589530141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00596341839209526,0.00617560096901541,-0.0180675962913655,0.00614075950717494,0.334241277912572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.00555580163647346,0.00575437291006773,-0.0168343725402062,0.00572276926725928,0.334316167273082
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC3,Membrane primary amine oxidase,39931,0.00268853918118503,0.0028031684042356,-0.00280567089111675,0.00818274925348681,0.337519139487998
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37021,0.00339887228456141,0.00354456785507038,-0.00354848071137653,0.0103462252804993,0.337628705525045
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA10,Annexin A10,39489,-0.00690804754489995,0.00730575568816168,-0.0212273286936969,0.00741123360389695,0.344386471097999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF830,Zinc finger protein 830,37368,-0.00707830423880722,0.00752994610602272,-0.0218369986066118,0.00768039012899731,0.34722381778984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNXB,Tenascin-X,39858,0.00225062919570708,0.00239858483037079,-0.00245059707181966,0.00695185546323383,0.348096489540742
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.00715415875208002,0.00763124103460867,-0.022111391179913,0.00780307367575297,0.348527443723574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00676545845184694,0.00722455634436121,-0.0209255888867949,0.00739467198310104,0.349056618531007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.00260581305780066,0.00278344491204646,-0.00284973896981039,0.00806136508541172,0.349196245219211
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.00574347717915853,0.006158726977896,-0.0178145820558347,0.00632762769751763,0.351055891062668
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL33,Interleukin-33,39587,0.00340225266385476,0.00365200559037246,-0.00375567829327526,0.0105601836209848,0.351551318754429
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00291188352814664,0.00313078834475528,-0.009048228683867,0.00322446162757371,0.35234673983782
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37368,0.00326234505241191,0.0035212961666995,-0.00363939543431911,0.0101640855391429,0.354222788760573
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBLN2,Fibulin-2,37437,-0.00261143916539047,0.00282580284226334,-0.00815001273622662,0.00292713440544568,0.355429535347541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRXN3,Neurexin-3,37039,0.00302502383489833,0.0032798449542691,-0.0034034722754691,0.00945351994526577,0.356385367627181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00482869284169423,0.00523883791608795,-0.00543942947383815,0.0150968151572266,0.356696443817824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACHE,Acetylcholinesterase,37124,-0.00280740024615872,0.00305676128102622,-0.00879865235697012,0.00318385186465268,0.35841408904337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00994468790144466,0.0108407295910508,-0.0311925178999042,0.0113031420970149,0.358978750633953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.0042997057145435,0.0046980343551784,-0.0135078530506932,0.00490844162160617,0.360096262514016
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSCA,Prostate stem cell antigen,37382,0.021632782122342,0.0237288821368591,-0.0248758268659019,0.0681413911105859,0.361961550347342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00369322014289852,0.00406246535358435,-0.00426921195012681,0.0116556522359238,0.363309531729334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00651394334960741,0.00717047724646004,-0.0205680787526691,0.00754019205345428,0.363662840827606
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6,Interleukin-6,39788,-0.00600196161755221,0.00661707904855392,-0.0189714365527179,0.00696751331761347,0.364398868249799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB2,Beta-crystallin B2,37388,0.00478484517611783,0.00531119278265259,-0.00562509267788125,0.0151947830301169,0.367658370046726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTA2,"Actin, aortic smooth muscle",39585,-0.00363228321708804,0.00403230117242691,-0.0115355935150448,0.0042710270808687,0.367710266901872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3A,Uroplakin-3a,36991,0.00399322872865561,0.00445905433680925,-0.00474651777149053,0.0127329752288017,0.370518838167966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR5,Proline-rich protein 5,37056,0.00398416128994686,0.00444941707103023,-0.00473669616927239,0.0127050187491661,0.37057122920612
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0017470364062406,0.00195379201169972,-0.00208239593669084,0.00557646874917205,0.371243375937652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,36991,0.00501986562460741,0.0056269302710222,-0.0060089177065961,0.0160486489558109,0.372347954957907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL21R,Interleukin-21 receptor,37056,-0.00450083871621499,0.00508061990216504,-0.0144588537244585,0.00545717629202849,0.37569630521681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPEP,Glutamyl aminopeptidase,37021,0.00343407904599556,0.00392006987098413,-0.00424925790113333,0.0111174159931244,0.381032453746144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE6,Ribonuclease K6,37386,0.00225551228429918,0.0025808295133194,-0.00280291356180684,0.0073139381304052,0.382161773884651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPEP,Aspartyl aminopeptidase,37388,0.00481922574964263,0.00552751370878707,-0.00601470111958004,0.0156531526188653,0.383299475528159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSD1,Tryptase delta,37411,-0.00297468102939909,0.00341977070310932,-0.00967743160749335,0.00372806954869518,0.384398831664162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00442687658430326,0.00510989191497393,-0.00558851156904565,0.0144422647376522,0.386322481628245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.0051877081017835,0.00600472876432016,-0.016956976479851,0.00658156027628402,0.387635346894046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37056,0.00161824277786636,0.00188277513434259,-0.00207199648544512,0.00530848204117783,0.390081050958166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36A,Interleukin-36 alpha,37056,-0.00472620833373737,0.00549983722097591,-0.0155058892868501,0.00605347261937541,0.390170756435723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRTN,Neurturin,39587,0.00397955543189419,0.00463187812087471,-0.00509892568502024,0.0130580365488086,0.390261648424256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00279079222653943,0.00325372089195161,-0.00358650072168573,0.00916808517476459,0.391058432607351
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD8,Frizzled-8,36991,0.0033998208652721,0.00397660499325631,-0.00439432492151028,0.0111939666520545,0.392591304748303
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00389620549965508,0.00456791620785781,-0.0128493212670564,0.00505691026774623,0.393702423628068
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2,Interleukin-2,39587,0.00247603461966429,0.0029072851635608,-0.00322224430091488,0.00817431354024346,0.394412713826336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTR,Methionine synthase,37021,0.00513003782480133,0.00602697021913098,-0.00668282380469539,0.016942899454298,0.394684736130574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL1,Interferon lambda-1,39489,-0.00355361136320473,0.00418555013425972,-0.0117572896263538,0.00465006689994431,0.395883753887405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.00317532687754478,0.00374285136918696,-0.0105113155611512,0.00416066180606166,0.396244033607779
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JUN,Transcription factor AP-1,39587,0.00409878845723636,0.00484307763457416,-0.00539364370652899,0.0135912206210017,0.397387707031834
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP7,Dipeptidyl peptidase 2,39754,0.0047222653682729,0.00560495100539134,-0.00626343860229412,0.0157079693388399,0.39951141923323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI2B,Protein EVI2B,36962,0.00325596111891282,0.0038648054120107,-0.00431905748862815,0.0108309797264538,0.39954341532218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMI,N-myc-interactor,37311,0.00567490583384791,0.00673894308310624,-0.00753342260904033,0.0188832342767362,0.399743476177008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00449245602071561,0.00533706084436983,-0.0149530952756805,0.00596818323424925,0.399942039572241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00347690612337671,0.00414886704125792,-0.00465487327748882,0.0116086855242422,0.402024475996306
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMCN2,Hemicentin-2,37100,-0.00443852466664322,0.00530924041456408,-0.0148446358791888,0.00596758654590238,0.403170023669504
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00593147685302095,0.00709640365622881,-0.0198404280192294,0.00797747431318753,0.403258636796769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLGAP5,Disks large-associated protein 5,37411,-0.00409657049662263,0.00490486279966828,-0.0137101015839725,0.0055169605907272,0.403616496116437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPP1,Osteopontin,40012,-0.00350434583922052,0.00420002930362771,-0.0117364032743308,0.0047277115958898,0.404089230718405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.00648943448707534,0.00778537381495818,-0.0217487671643934,0.00876989819024268,0.404551673216468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.00197546568355172,0.00238292445483603,-0.0026950662479269,0.00664599761503033,0.407111672784997
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00527364791196051,0.00636848300842796,-0.00720857878455828,0.0177558746084793,0.407637122349005
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00307815284558957,0.00371946832662901,-0.0103683107657824,0.0042120050746033,0.407924161990723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHIT1,Chitotriosidase-1,39906,0.0116441948254048,0.0140734736912364,-0.0159398136094187,0.0392282032602282,0.408030628511336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39364,-0.00772621627950428,0.00934149987306641,-0.0260355560307144,0.0105831234717059,0.408201501922163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH1,Cadherin-1,39315,0.00311414115536917,0.00376681182336624,-0.00426881001842865,0.010497092329167,0.408402151819365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC1A4,Neutral amino acid transporter A,37039,-0.00395937686455315,0.00479884073378494,-0.0133651047027716,0.00544635097366533,0.409347098631603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP7,Retinoid-binding protein 7,37382,-0.00464963763821119,0.00563709019799782,-0.0156983344262869,0.00639905914986454,0.409483011486465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN1,Tetraspanin-1,39585,0.00310295211896792,0.00376875312916723,-0.00428380401419986,0.0104897082521357,0.41032913227408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.00260944655597098,0.00317476410490558,-0.00361309108964395,0.00883198420158591,0.41112676478085
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC9,Histone deacetylase 9,36991,-0.00493116667175884,0.00600033894900166,-0.0166918310118021,0.0068294976682844,0.411197295092943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA3,GDNF family receptor alpha-3,39709,0.00211481063816719,0.00258011180451319,-0.00294220849867867,0.00717182977501305,0.412423125237354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA2,Ephrin type-A receptor 2,39248,-0.00224506817558948,0.00274298135930389,-0.00762131163982511,0.00313117528864615,0.413097331624944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD2,Glutamate decarboxylase 2,37056,0.00355890782880553,0.00435380249829675,-0.00497454506785611,0.0120923607254672,0.413700243879242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD4,Sushi domain-containing protein 4,37368,0.00318823907821257,0.00390086579021105,-0.00445745787060109,0.0108339360270262,0.413762419021069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPE,Carboxypeptidase E,39906,0.0029410399090217,0.00360141181084321,-0.00411772724023099,0.00999980705827439,0.414149016046126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.00704405738112173,0.00868859929039929,-0.00998559722806088,0.0240737119903043,0.41753882014549
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRAL,GDNF family receptor alpha-like,36942,-0.00471249748367973,0.00582223717536445,-0.016124082347394,0.00669908738003459,0.418301925297986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF3,Fibroblast growth factor 3,37056,0.00230847607796953,0.00287679892128254,-0.00333004980774425,0.00794700196368331,0.422309405842907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B2M,Beta-2-microglobulin,37453,0.0022911163648672,0.00287856467506995,-0.0033508703982699,0.00793310312800429,0.426090583333016
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPB41L5,Band 4.1-like protein 5,37039,-0.00477203629518093,0.00600381673096223,-0.0165395170878669,0.00699544449750505,0.426724516629737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00461813749031304,0.00583650073917986,-0.0160576789391056,0.00682140395847949,0.428811592017019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00405830825137809,0.00515297484177491,-0.0141581389412569,0.00604152243850073,0.430964701189911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00260597247322602,0.00331007461358872,-0.00388177376940787,0.00909371871585991,0.431129120764005
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100G,Protein S100-G,37411,0.00329416359071115,0.00420057451814193,-0.00493896246484704,0.0115272896462693,0.432926269807105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOP56,Nucleolar protein 56,37021,0.00809795562079993,0.0103269718692217,-0.0121429092428746,0.0283388204844744,0.432962767849435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAPPA,Pappalysin-1,39587,0.00346899784827237,0.00442759599158273,-0.00520909029522978,0.0121470859917745,0.433348482667496
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF174,Zinc finger protein 174,37056,0.00278975135983633,0.00356883398734359,-0.0042051632553571,0.00978466597502977,0.43440594226644
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00242438199258748,0.00310239345417266,-0.00850507316276589,0.00365630917759093,0.434546286330793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_A,,37411,0.00235796920032882,0.00301864306742656,-0.00355857121182725,0.00827450961248489,0.434736462407624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.00347457141573791,0.0045015808332671,-0.00534852701746561,0.0122976698489414,0.440211490135088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL24,Interleukin-24,39587,-0.00338358427219615,0.00440537191861371,-0.012018113232679,0.00525094468828673,0.442463837848242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD248,Endosialin,37437,-0.00284318955866167,0.00370328022389371,-0.0101016187974933,0.00441523968017,0.442649691592007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00268953886124563,0.00350840437609326,-0.00418693371589717,0.00956601143838842,0.443333685489708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPE4,NXPE family member 4,37021,-0.00248527664329992,0.00327030649552912,-0.00889507737453699,0.00392452408793715,0.447296765139098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L15,Bcl-2-like protein 15,37056,-0.00401081174927925,0.00528594004572822,-0.0143712542389066,0.00634963074034806,0.448003817441816
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MB,Myoglobin,40052,-0.00364452517202848,0.00483680531590497,-0.0131246635912022,0.00583561324714526,0.45116141523893
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.00591844276852431,0.00791487073268177,-0.00959470386753196,0.0214315894045806,0.454616824849325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00407955865534635,0.00546463354646962,-0.00663112309573411,0.0147902404064268,0.455353260109056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCIN,Adseverin,36991,-0.00513060378172226,0.00690623128724569,-0.0186668171047238,0.00840560954127928,0.457558622841303
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.00517119475686791,0.00696144475708401,-0.0188156264807526,0.00847323696701675,0.457593630830014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPGN,Epigen,37368,-0.00345777029632849,0.00466310337082126,-0.0125974529031382,0.00568191231048118,0.458392935667657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJP3,Tight junction protein ZO-3,36991,-0.00295989415306763,0.00405945803810016,-0.0109164319077439,0.00499664360160869,0.465931908221745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00429333567187256,0.00590674155456001,-0.00728387777506506,0.0158705491188102,0.467328499694959
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROK1,Prokineticin-1,39866,0.00438435434733554,0.00603668014039273,-0.00744753872783421,0.0162162474225053,0.467674275775236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHP1,Calcineurin B homologous protein 1,36991,0.00492334631610205,0.0067801391904575,-0.00836572649719464,0.0182124191293987,0.46776444167962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00382277581925621,0.0052697497600675,-0.0141514853489885,0.00650593371047608,0.468208038913395
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASA1,Ras GTPase-activating protein 1,39489,0.0022062948305103,0.00304403180664874,-0.00376000751052123,0.00817259717154183,0.468589501225415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00315839692427768,0.00436995660071925,-0.00540671801313204,0.0117235118616874,0.469844816419037
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBH,Dopamine beta-hydroxylase,37430,0.0072897199150245,0.0101780269720748,-0.0126592129502421,0.0272386527802911,0.473867025266188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRAS,GTPase Hras,37161,0.00653119177014898,0.00913048840181887,-0.011364565497416,0.024426949037714,0.474425863854083
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.00289267817372342,0.00405077758128694,-0.00504684588559898,0.0108322022330458,0.475174912892709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00577058609083231,0.00808293224797386,-0.0216131332968611,0.0100719611151965,0.475287707694568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGN,Cingulin,37039,-0.00259123223173218,0.00363347112276244,-0.00971283563234656,0.0045303711688822,0.475761772108716
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00159018837295908,0.00223298081127819,-0.00596683076306434,0.00278645401714619,0.476392172078087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00389257564111704,0.00548650768026682,-0.00686097941220593,0.01464613069444,0.478038331676815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13,Interleukin-13,39587,0.00322024240491186,0.00454803865082799,-0.00569391335071101,0.0121343981605347,0.478924204441705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXOSC10,Exosome component 10,37021,-0.00403577193535627,0.00570489772397117,-0.0152173714743398,0.00714582760362723,0.479316601663655
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA11,Integrin alpha-11,39866,0.00224004264860728,0.00317013535734256,-0.00397342265178414,0.0084535079489987,0.479820471612666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00514847481245733,0.00730421635502213,-0.00916778924338606,0.0194647388683007,0.480907701810735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCC,Netrin receptor DCC,37039,0.00148355657406121,0.00211417635386538,-0.00266022907951493,0.00562734222763735,0.482867150045517
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI3,Elafin,39594,0.00345769666840376,0.00494186999539848,-0.00622836852257726,0.0131437618593848,0.484141422704054
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMCH,Pro-MCH,37021,0.00542398245342113,0.00775582205058061,-0.00977742876571686,0.0206253936725591,0.484349850774167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAGE2A,G antigen 2A,36962,-0.00399628744071023,0.00571713474864688,-0.0152018715480581,0.00720929666663766,0.484563318043677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRP15,RRP15-like protein,36991,0.00589775119426617,0.00844632244421771,-0.0106570407964005,0.0224525431849329,0.485025339854876
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.00564872287951328,0.00810346246983588,-0.010234063561365,0.0215315093203916,0.485768089223785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC25A,M-phase inducer phosphatase 1,36962,0.00272009025168193,0.00390586726969885,-0.00493540959692782,0.0103755901002917,0.486183618636941
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0075110911768558,0.0108131459618833,-0.028704857262147,0.0136826749084354,0.487301689611845
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN4,Alpha-actinin-4,39587,0.0020306710387663,0.00292950549911837,-0.0037111597395057,0.0077725018170383,0.488207601519956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR1,Toll-like receptor 1,37056,-0.00169023335854652,0.00243888165499472,-0.00647044140233617,0.00308997468524313,0.488299009143862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00435949229829161,0.00635060134186434,-0.0168066709283457,0.0080876863317625,0.492429231992531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLVRB,Flavin reductase,39858,-0.00409595265446192,0.00601411003676764,-0.0158836083265265,0.00769170301760265,0.495845185266914
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00487809856149483,0.00716569033148026,-0.0189228516111961,0.00916665448820648,0.49603651529223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL14,C-X-C motif chemokine 14,39587,0.00392041614016207,0.00576496530268078,-0.00737891585309226,0.0152197481334164,0.496488140260363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00348196952915582,0.00512933674366964,-0.0135354695467483,0.00657153048843667,0.497254871690528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00375290894191547,0.005539371861564,-0.0146100777905809,0.00710425990674998,0.498102480452305
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0029432370971641,0.00436980179904277,-0.0115080486232879,0.00562157442895974,0.50061365452693
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP13,Collagenase 3,39489,-0.00200386489492756,0.00299170843707291,-0.00786761343159047,0.00385988364173534,0.502991228608716
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171A2,Protein FAM171A2,37411,0.00981984925873542,0.0146896163650603,-0.0189717988167828,0.0386114973342536,0.503832787597605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPT1,Translationally-controlled tumor protein,39587,0.00402234876793861,0.00608747973837481,-0.00790911151927602,0.0159538090551532,0.508777428395693
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00284971166853823,0.00432885590020722,-0.0113342692329444,0.00563484589586791,0.510353111551687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD3,Extracellular superoxide dismutase,37445,0.00371484108017049,0.00568951942510732,-0.00743661699303985,0.0148662991533808,0.513814364375455
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.0020356839268522,0.00314851254093753,-0.00413540065338536,0.00820676850708975,0.517931849897197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA2,Protein disulfide-isomerase A2,36962,0.00238719149865074,0.00372177954263616,-0.00490749640491614,0.00968187940221761,0.521266705443322
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00293551044372046,0.00461495465433172,-0.0119808215662106,0.00610980067876971,0.524729193404234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL25,Interleukin-25,36903,-0.00204397204183556,0.00321695880521597,-0.00834921130005886,0.00426126721638774,0.525195655873949
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00241376116201126,0.00380348375579413,-0.00986858932336775,0.00504106699934523,0.525688314789516
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCG22,Protein PBMUCL2,37021,-0.00321781316529589,0.00507074698788429,-0.0131564772615491,0.00672085093095731,0.525711020550651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37021,0.00275426050554004,0.00434381740361886,-0.00575962160555293,0.011268142616633,0.526049734917925
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00179668775978887,0.00284185227709019,-0.00736671822288564,0.00377334270330789,0.527249646678474
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST7,Cystatin-F,39882,0.00543714320602723,0.00861085811029579,-0.0114401386901525,0.022314425102207,0.527769243378256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.00305398078348274,0.0048504972871249,-0.00645299389928207,0.0125609554662475,0.528952723410453
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00238299847844086,0.00380558902047554,-0.00984195295857292,0.00507595600169121,0.531205184221301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00195707200863755,0.00312717947352299,-0.00417219975946751,0.00808634377674261,0.53143778408506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.00170814352921076,0.00273527648154074,-0.00706928543303061,0.00365299837460909,0.532316862031839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.00690499001458767,0.0110643202509793,-0.0285910577065071,0.0147810776773317,0.532585784512971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE1,Ribonuclease pancreatic,37445,0.00130371724798632,0.00209199152582712,-0.00279658614263483,0.00540402063860748,0.533167292073094
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00147736124575149,0.0023826306796535,-0.00614731737787235,0.00319259488636938,0.535232210307977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00237110895846281,0.00383158971404591,-0.00513880688106717,0.00988102479799278,0.53603597970637
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN6,Prefoldin subunit 6,37039,0.00380892475547322,0.00616954813899103,-0.0082833895969492,0.0159012391078956,0.536998077073301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37021,0.0022456568751776,0.00364969948343554,-0.00490775411235605,0.00939906786271125,0.538367838485677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37056,-0.00534294889878261,0.00870221696053602,-0.0223992941414332,0.011713396343868,0.539242033618481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00158765831503728,0.00264411051927844,-0.00359479830274846,0.00677011493282301,0.548214422197172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF20,Fibroblast growth factor 20,37056,0.00240809723628251,0.00401633531951212,-0.00546391998996124,0.0102801144625263,0.548799310873071
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18BP,Interleukin-18-binding protein,39931,0.00164101274809056,0.00275620346577711,-0.00376114604483257,0.00704317154101369,0.551591976014317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00313204301408027,0.00526745062784481,-0.0134562462446561,0.00719216021649556,0.552118960168047
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK3,Prostate-specific antigen,37437,0.00434040966662275,0.0073473459906821,-0.0100603884751142,0.0187412078083597,0.554700964411809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCL2,Phosducin-like protein 2,36962,-0.00293453208437539,0.00497802841149626,-0.0126914677709081,0.00682240360215728,0.555538186948207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.0011753257168201,0.00199895040022972,-0.00274261706763014,0.00509326850127035,0.556561291595385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN4,Nectin-4,39913,-0.00161051303380746,0.00274517270215077,-0.00699105153002297,0.00377002546240805,0.557432981890948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD10,Frizzled-10,37039,-0.00327741781794368,0.00559893798820323,-0.014251336274822,0.00769650063893466,0.558312882356791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR1,Folate receptor alpha,39809,0.00148118725715673,0.00255615320072145,-0.00352887301625731,0.00649124753057078,0.562287350407314
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBZ,Hemoglobin subunit zeta,37437,-0.00566434686970504,0.00984303818137283,-0.0249567017051958,0.0136280079657857,0.564984818723467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP1,Retinol-binding protein 1,37039,-0.00377853528933626,0.00656620024546275,-0.0166482877704432,0.00909121719177072,0.564995240169724
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37169,0.00449574503985944,0.00782552605666575,-0.0108422860312054,0.0198337761109243,0.565640911750782
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD58,Lymphocyte function-associated antigen 3,39835,0.000929975372462743,0.00162421367290921,-0.0022534834264393,0.00411343417136479,0.566944206121356
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00208695714470913,0.00367466328687214,-0.00928929718697853,0.00511538289756027,0.570091041715531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37021,0.0037920929582438,0.00670233012581786,-0.00934447408835921,0.0169286600048468,0.571548057826829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGR,Progesterone receptor,37056,0.00545340783493063,0.00981679801069895,-0.0137875162660393,0.0246943319359006,0.578549830283807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS8,Regulator of G-protein signaling 8,39587,-0.00338000945822578,0.00613742663716521,-0.0154093656670696,0.00864934675061803,0.581832800018537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5,Interleukin-5,39587,-0.00740525665142371,0.0134619338429294,-0.0337906469835654,0.018980133680718,0.582266401627207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PITHD1,PITH domain-containing protein 1,36931,0.0040566501790915,0.00741124359533835,-0.0104693872677717,0.0185826876259547,0.584137820504478
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM25,RNA-binding protein 25,36962,-0.00234301487709501,0.00428064364898642,-0.0107330764291084,0.00604704667491838,0.584146887827702
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.00139189183641677,0.00256191953691589,-0.00641325412877192,0.00362947045593838,0.586930578227461
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNPO1,Transportin-1,37169,-0.00179256017092353,0.00330807516667905,-0.00827638749761447,0.00469126715576742,0.587914328802884
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.00107399885624276,0.00200451774767102,-0.00285485592919244,0.00500285364167797,0.592111860877361
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3,Interleukin-3,36962,0.00294487761521921,0.00558843664827685,-0.00800845821540342,0.0138982134458418,0.598230904202274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.0016172294111309,0.00308124508811375,-0.00442201096157205,0.00765646978383385,0.59968624887698
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL21,C-C motif chemokine 21,39931,-0.00191561605541506,0.00365183263019748,-0.00907320801060212,0.005241975899772,0.599894291432198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00358381780251773,0.00684810749356329,-0.0170061084899018,0.00983847288486633,0.600753691408723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO1,R-spondin-1,39749,-0.00172256651404157,0.00329231619567874,-0.00817550625757189,0.00473037322948875,0.600836738745962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00356382821817348,0.00682307463286654,-0.00980939806224493,0.0169370544985919,0.601456252350002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUCL3,Mucin-like protein 3,36962,-0.00214223866383979,0.00421542590904193,-0.010404473445562,0.0061199961178824,0.611328430726003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00169910324667392,0.00334724674634937,-0.00486150037617084,0.00825970686951868,0.611733835618094
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM2,Isthmin-2,37437,-0.00209152855076003,0.00415375478069338,-0.0102328879209191,0.00604983081939901,0.61460182467893
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SBSN,Suprabasin,37420,-0.00159203942452266,0.00317147099811977,-0.00780812258083741,0.0046240437317921,0.615684325408985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.00154257361314213,0.00308001479700342,-0.00449425538898457,0.00757940261526883,0.61649538926995
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXK,Tyrosine-protein kinase TXK,37169,-0.0034678812100701,0.00693146760199281,-0.017053557709976,0.0101177952898358,0.616865222980978
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00590849092035607,0.0118405907542183,-0.0172990669579118,0.029116048798624,0.617784262872951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00187919093843917,0.00377108040598879,-0.00551212665729886,0.00927050853417721,0.618269428615886
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA1,Laminin subunit alpha-1,37021,-0.00252256005234128,0.00507418644999125,-0.0124679654943241,0.00742284538964156,0.619101551581574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39489,0.00243004605390275,0.00489161400054396,-0.00715751738716342,0.0120176094949689,0.619352622170187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00258889990514185,0.0052443395787304,-0.0128678054794534,0.00769000566916973,0.621557373233592
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00188709170656551,0.00383181277377652,-0.00562326133003647,0.00939744474316748,0.62238797139002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHC1,SHC-transforming protein 1,36962,-0.00530567829970912,0.0108332256043869,-0.0265388004843074,0.0159274438848892,0.624312087106436
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBN2,Fibrillin-2,37039,0.00274622763882022,0.0056187703340122,-0.0082665622158437,0.0137590174934841,0.625020074112753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUOX2,Dual oxidase 2,39585,-0.00324924831231432,0.0066552994086336,-0.0162936351532362,0.00979513852860754,0.625401036279891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37021,0.00180493636793134,0.00370296768469356,-0.00545288029406804,0.00906275302993072,0.625961980584138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN7,Tetraspanin-7,36991,0.00425189351764357,0.00880257743741489,-0.0130011582596896,0.0215049452949768,0.629083735446086
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53BP1,TP53-binding protein 1,37056,-0.00395715064359442,0.00822125719095552,-0.0200708147378672,0.0121565134506784,0.630288843021046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00219933905795011,0.00457876498112606,-0.0111737184209572,0.00677504030505697,0.630996200646596
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG3,Secretogranin-3,39885,0.0014353811239839,0.00302359828346616,-0.00449087151160978,0.00736163375957757,0.634988657162929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00215126251292152,0.00453459717183816,-0.00673654794388127,0.0110390729697243,0.635214781193513
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.0037217415870524,0.00784728967677677,-0.0191024293535349,0.0116589461794301,0.635314556739056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00218795962272366,0.00461828772960571,-0.0112398035727509,0.00686388432730353,0.63567774189859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD33,Myeloid cell surface antigen CD33,39913,0.0034706628336628,0.00732646023111982,-0.010889199219332,0.0178305248866577,0.635708748152631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD160,CD160 antigen,40058,-0.00197095518522057,0.00418267153521785,-0.0101689913942476,0.00622708102380642,0.63749054656848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00114176279894203,0.00242502328137954,-0.00361128283256187,0.00589480843044593,0.637771798144217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP73,Tumor protein p73,37039,-0.00151533671170454,0.00323618682362402,-0.00785826288600761,0.00482758946259854,0.639615280099974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.00346562193400985,0.00741224012775719,-0.0179936125844139,0.0110623687163942,0.640110142455256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B4,Protein ATP1B4,36962,-0.00182629921569236,0.0039253304470227,-0.00951994689185685,0.00586734846047213,0.641753013739992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00371392689758988,0.00800005662134457,-0.0193940378754252,0.0119661840802455,0.64248513540199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDI2,Protein DDI1 homolog 2,37124,-0.00325656957644248,0.00702599901553747,-0.0170275276468959,0.0105143884940109,0.643011678945081
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TUBB3,Tubulin beta-3 chain,36991,-0.00121611214122564,0.00262962867560386,-0.0063701843454092,0.00393796006295791,0.643755309025872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3B,Sodium channel subunit beta-3,36991,0.0019145042678353,0.00415540805080971,-0.00623009551175172,0.0100591040474223,0.645002874065417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTH3,Cytohesin-3,36962,0.00305531996816879,0.00677811405694841,-0.0102297835834501,0.0163404235197877,0.652168155453619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRV1,Acrosomal protein SP-10,37056,0.00305074442709351,0.00681956373337298,-0.0103156004903175,0.0164170893445046,0.654628380768877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00267908599315298,0.00604630349511855,-0.0145298408435853,0.00917166885727938,0.657704406617533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.0022349624505347,0.00504639778968259,-0.0121259021183126,0.00765597721724318,0.657857754595618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1,DNA topoisomerase 1,37382,0.00471166346852948,0.010643709419023,-0.0161500069927555,0.0255733339298145,0.65801066783435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH3,Cadherin-3,40009,0.0014175121047047,0.00323057563174421,-0.00491441613351395,0.00774944034292335,0.660826794492198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.00105936608328403,0.00241448232600157,-0.00367301927567905,0.00579175144224711,0.660846084435693
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNB2,Ephrin-B2,37039,-0.00245450617710004,0.00563133140870197,-0.0134919157381559,0.00858290338395582,0.662941057404003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00110156048887384,0.00254299788975782,-0.00388271537505148,0.00608583635279916,0.664894202032813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00174441202555391,0.00405319951114157,-0.00968868306739138,0.00619985901628356,0.666926984147078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD5,Sushi domain-containing protein 5,37064,-0.00135946349863286,0.00316690102237316,-0.00756658950248424,0.00484766250521853,0.667731935834279
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.0013776879313438,0.00322892741074706,-0.00770638565640804,0.00495100979372044,0.669626375377517
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00191017666766208,0.00447716404563921,-0.0106854181971149,0.00686506486179077,0.669642107818316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.00350816376292921,0.0082312768729966,-0.0196414664340026,0.0126251389081441,0.669969705724423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37043,-0.00163362766309651,0.00385249933064664,-0.00918452635116392,0.00591727102497091,0.671540939502714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMMR,Hyaluronan mediated motility receptor,36942,-0.00188443999470911,0.00445118095327093,-0.0106087546631201,0.00683987467370191,0.672041546260694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.00230839640602541,0.00547322583894992,-0.0130359190503672,0.00841912623831642,0.673204763606778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTOA,Otoancorin,36991,-0.00207215978534425,0.00494957574991547,-0.0117733282551786,0.00762900868449008,0.675475851003651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.0020802542083233,0.00503668453080351,-0.0119521558886982,0.00779164747205158,0.679598302543468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00167624653621187,0.00406375272146444,-0.00964120187028217,0.00628870879785842,0.679988979445387
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.00166599263284577,0.0040437596138333,-0.00959176147595903,0.0062597762102675,0.680352538555111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00160370948363017,0.00391219729295246,-0.00606419721055665,0.00927161617781698,0.681867251996291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD1,Glutamate decarboxylase 1,36962,0.00098951814584581,0.00243073256729573,-0.00377471768605383,0.00575375397774544,0.683951189243934
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FH,"Fumarate hydratase, mitochondrial",36991,0.00314080984421278,0.00772717433740627,-0.0120044518571035,0.0182860715455291,0.684409120752738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP6,Guanylate-binding protein 6,37021,-0.00174387475163035,0.00432173633999213,-0.0102144779780149,0.00672672847475422,0.68657777649444
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00211129849974523,0.0052649278706657,-0.01243055712625,0.00820796012675954,0.688417934021242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00239128513588101,0.00602849949225309,-0.0142071441406971,0.00942457386893505,0.691622120869942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAG,Myelin-associated glycoprotein,37039,-0.00170989442551998,0.00431362129046229,-0.0101645921548261,0.00674480330378611,0.691820667874093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39477,0.00125577913488547,0.00320968327171577,-0.00503520007767743,0.00754675834744837,0.695619965782553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBQLN3,Ubiquilin-3,37021,-0.00171720481530766,0.00439764610702589,-0.0103365911850784,0.00690218155446309,0.696185950240856
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBX2,Chromobox protein homolog 2,37021,-0.00147725017650915,0.00378561582683099,-0.00889705719709789,0.0059425568440796,0.696374882581797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENG,Endoglin,40052,-0.00061146302109867,0.00158049709639866,-0.00370923733004005,0.00248631128784271,0.698849989769628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00127649521499882,0.00332437009947345,-0.00523927017996915,0.00779226060996678,0.700998484993197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,36991,0.00376592203409974,0.00982410160537896,-0.015489317112443,0.0230211611806425,0.70147759363941
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB2,Integrin beta-2,39731,0.0010198786461035,0.00268145212966023,-0.00423576752803056,0.00627552482023755,0.703693945259152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0024130813360433,0.00647694205630945,-0.0151078877664098,0.0102817250943232,0.709478305972491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.0012365069795373,0.00337038355921188,-0.00536944479651799,0.00784245875559258,0.713718539500052
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00342486119316673,0.00937219319219691,-0.0217943598498727,0.0149446374635392,0.714797865308165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5L,CD5 antigen-like,37380,-0.00159309254034106,0.0043696325613651,-0.0101575723606167,0.00697138727993454,0.715428615079721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.00240450014984949,0.00663940479674004,-0.01541773355146,0.010608733251761,0.717241279596203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.00168898826883363,0.00467814345256452,-0.0108581494358601,0.00748017289819284,0.718075791266445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,39822,0.00157471095998312,0.00441340450068605,-0.00707556186136155,0.0102249837813278,0.721244855882403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG3,Proteoglycan 3,37437,-0.00164769817977804,0.00466416390936194,-0.0107894594421274,0.00749406308257136,0.72389328725567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR3,Folate receptor gamma,39858,-0.00622487994342567,0.0176572512955896,-0.0408330924827813,0.0283833325959299,0.724438285395353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMPD3,AMP deaminase 3,37388,0.00229493964499406,0.00662482831667417,-0.0106897238556873,0.0152796031456754,0.729036270536336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.000954937296328646,0.00276425797443755,-0.00446300833356895,0.00637288292622624,0.729754816148973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANK2,Ankyrin-2,37021,0.00224873658156657,0.00664739070816703,-0.0107801492064408,0.015277622369574,0.735151100173233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.00100607601024895,0.00297988873435627,-0.00684665792958724,0.00483450590908934,0.735653286628315
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.000997890821519944,0.00298108196355498,-0.00484502982704782,0.00684081147008771,0.737825699577494
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00177089085028629,0.0053751815533862,-0.0123062466949232,0.00876446499435067,0.74181543864639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.000854536661788584,0.00261743409133866,-0.00598470748081235,0.00427563415723519,0.744067200012375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00126357148963928,0.00387270873692927,-0.00885408061402065,0.0063269376347421,0.744220802131183
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.00129275134971166,0.00399779428456565,-0.00654292544803702,0.00912842814746033,0.746422187941471
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00105902819937829,0.00328989473391917,-0.00538916547910328,0.00750722187785986,0.747531006130502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN4,Prefoldin subunit 4,36962,-0.00163739573427947,0.00509976899203408,-0.0116329429586663,0.00835815149010732,0.748160547890125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA1,Apolipoprotein A-I,37453,-0.000812417098617223,0.00255378073783861,-0.00581782734478089,0.00419299314754645,0.750396314201542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD82,CD82 antigen,37169,0.00125147377005157,0.00393675683064921,-0.00646456961802088,0.00896751715812403,0.750569870150151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN7,Septin-7,37169,0.00151706308392743,0.00479392315318189,-0.00787902629630909,0.0109131524641639,0.751661801612352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HK2,Hexokinase-2,39585,-0.000789038634579028,0.00255215849174993,-0.00579126927840889,0.00421319200925083,0.757199947284025
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN4,Contactin-4,39858,0.000686815082605409,0.0022257673285537,-0.00367568888135984,0.00504931904657066,0.757649224358484
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.00105201579597756,0.00343230207977261,-0.00567529628037677,0.00777932787233188,0.759225455262904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.000937211293293833,0.00306235294198696,-0.00506500047300061,0.00693942305958827,0.759576835398899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REST,RE1-silencing transcription factor,36962,-0.00101864808367247,0.00334520029228788,-0.00757524065655671,0.00553794448921177,0.760743951503877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.0016219818238236,0.0053981443711941,-0.00895838114371685,0.012202344791364,0.763823248055703
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.00105088426210143,0.00351830809639662,-0.0079467681310388,0.00584499960683595,0.765180289140924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37021,0.00128896174634794,0.00436642157326152,-0.00726922453724463,0.00984714802994052,0.767846791065649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN1,Cerebellin-1,36991,-0.00265004730597218,0.0089826940955105,-0.0202561277331728,0.0149560331212284,0.767985570799947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4,Interleukin-4,39587,-0.00246140086559448,0.0084225559124888,-0.0189696104540725,0.0140468087228836,0.770107609143327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLI2,Zinc finger protein GLI2,37056,-0.000919902631632863,0.00321521835169808,-0.0072217306009611,0.00538192533769538,0.774799195420722
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB5,Serpin B5,39585,-0.00129478320356787,0.00454135532454453,-0.0101958396396752,0.00760627323253942,0.775564064589336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.00138901526379299,0.00487583286579594,-0.010945647680753,0.00816761715316705,0.775741742612504
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F3,Tissue factor,39931,0.000706476756401401,0.00253328355000095,-0.00425875900160046,0.00567171251440326,0.780342129643241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP350,Centrosome-associated protein 350,36962,0.00094045671313525,0.00339278520398891,-0.00570940228668301,0.00759031571295351,0.781636195924519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37039,0.00104089350455564,0.00378986667743558,-0.00638724518321811,0.00846903219232938,0.783588111089375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.000676366592272887,0.00253521914840369,-0.00564539612314412,0.00429266293859834,0.789636296483677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTLA,B- and T-lymphocyte attenuator,36962,0.00216486753410494,0.00813011457175775,-0.0137701570265403,0.0180998920947501,0.790029600175197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASET2,Ribonuclease T2,39974,-0.000631519915710965,0.00237558478529794,-0.00528766609489492,0.00402462626347299,0.790367633948474
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.000916304377032992,0.00351967516355093,-0.00598225894352684,0.00781486769759282,0.794606650092884
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK1,Kallikrein-1,39720,0.00305260850859253,0.0117365062036138,-0.0199509436504906,0.0260561606676756,0.794793744303852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000812277332727505,0.00313040585308353,-0.00532331813931622,0.00694787280477123,0.795268946287486
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSLP,Thymic stromal lymphopoietin,39585,0.00145017715413574,0.00560593565127676,-0.00953745672236671,0.0124378110306382,0.795880896541735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPN3,Calpain-3,37368,-0.000903893230349341,0.00351768991033485,-0.00779856545460564,0.00599077899390696,0.797216279860964
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3D,Protein FAM3D,37382,-0.00199995278205551,0.00780512581594075,-0.0172979993812994,0.0132980938171884,0.797772652350597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA4,Ephrin type-A receptor 4,37124,0.000669912267242992,0.00263210547650856,-0.00448901446671378,0.00582883900119977,0.799101092895154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTKN2,Rhotekin-2,37021,-0.00121755579202619,0.00486333863316676,-0.010749699513033,0.00831458792898065,0.802317585141392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00106478483140917,0.00428933482751133,-0.00947188109333137,0.00734231143051304,0.803952518092344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MKI67,Proliferation marker protein Ki-67,37056,0.000908919834463866,0.00367258168080296,-0.00628934025990993,0.00810717992883766,0.804534440471616
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD2,Bromodomain-containing protein 2,36991,-0.000782550436359836,0.0031626642342511,-0.006981372335492,0.00541627146277233,0.804576287661577
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.00146571755492517,0.00594891527604913,-0.0131255914959815,0.0101941563861311,0.805388848727158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.00108658768797081,0.00450326191867806,-0.00773980567263819,0.00991298104857981,0.809334260641401
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.000558729300677096,0.00231649714382854,-0.00509906370258104,0.00398160510122685,0.809407033162105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHDC3L,KH domain-containing protein 3,36962,0.00149854602163728,0.0062312688845883,-0.0107147409921558,0.0137118330354304,0.809955649196509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00151742940683065,0.00634706964303764,-0.0139576859071844,0.0109228270935231,0.811050652159901
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00134297646363999,0.0057202380235525,-0.00986869006252292,0.0125546429898029,0.814385902331501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37368,0.0012537412465982,0.005355563930948,-0.00924316405805987,0.0117506465512563,0.814910352991208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37382,0.00100141289159949,0.00435092368382686,-0.00752639752870114,0.00952922331190013,0.817970157161023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH4,Cadherin-4,36991,0.00100600167988115,0.00437252143281575,-0.00756414032843772,0.00957614368820001,0.818038174605142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNL1,Thioredoxin-like protein 1,36971,0.00210093174261771,0.00913891184421657,-0.0158113354720468,0.0200131989572822,0.818181913373271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG2,"Arginase-2, mitochondrial",37368,0.000939618811852238,0.00409829026138582,-0.00709303010046398,0.00897226772416845,0.818661818826324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKKL1,Dickkopf-like protein 1,39788,-0.00179547691327462,0.00786433229881676,-0.0172095682189555,0.0136186143924062,0.81941102789773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH15,Cadherin-15,39973,-0.00107881780287942,0.00499940836339441,-0.0108776581951325,0.00872002258937363,0.829154880923501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00109674332131853,0.00509489345687688,-0.00888924785416015,0.0110827344967972,0.829565431173534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37039,0.000731670187740386,0.00344247878515701,-0.00601558823116735,0.00747892860664812,0.831687759964984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.000819709295179989,0.00387697967203323,-0.00841858945236513,0.00677917086200515,0.832555090528406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.00102624123920327,0.0048976576791576,-0.0106256502903522,0.00857316781194562,0.834031669473397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORN4,MORN repeat-containing protein 4,36962,0.0015472271013375,0.00747518243508409,-0.0131041304714273,0.0161985846741023,0.836027248449462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUK1,Guanylate kinase,37021,0.000777673813806913,0.00387736795930576,-0.00682196738643237,0.00837731501404619,0.841039909193225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASQ2,Calsequestrin-2,37021,0.000904816824881806,0.00456345822476214,-0.00803956129565198,0.0098491949454156,0.842833462296367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00118859053785169,0.0060241777406936,-0.0106187978339078,0.0129959789096112,0.843592712181569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.000529813253158808,0.00269026872299542,-0.00474311344391221,0.00580273995022983,0.843879944467778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHISA5,Protein shisa-5,37437,-0.000412613085066473,0.00213992441274494,-0.00460686493404656,0.00378163876391362,0.84710543692387
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH22,Cadherin-22,37169,0.000508380672585,0.00270765048518587,-0.0047986142783793,0.0058153756235493,0.851069908976772
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37169,0.00134023512502951,0.00716693000381771,-0.0127069476824532,0.0153874179325122,0.851661381361662
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLHL41,Kelch-like protein 41,37411,-0.000888966779120533,0.00477851406530609,-0.0102548543471205,0.00847692078887941,0.852420769325702
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00124359985826194,0.00674384186496814,-0.0144615299135995,0.0119743301970756,0.853698397680102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRX,Cone-rod homeobox protein,39585,-0.00185246826863106,0.0100993712772794,-0.0216472359720986,0.0179422994348365,0.854467618345309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZPR1,Zinc finger protein ZPR1,36991,0.00164542185846346,0.00897181229037186,-0.0159393302306654,0.0192301739475923,0.854487752191959
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG1,Arginase-1,39754,-0.000885102063614712,0.0048274962778657,-0.0103469947682315,0.00857679064100205,0.854528893198944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAX,Integrin alpha-X,37169,-0.000902520640112136,0.00493900575876258,-0.0105829719272868,0.00877793064706253,0.855010098094542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB44,Ras-related protein Rab-44,37368,0.000714484629610658,0.00394690497405525,-0.00702144911953762,0.00845041837875894,0.856351433212855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.000738101262365323,0.00407848136668415,-0.00873192474106626,0.00725572221633561,0.856390364564133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00153053726908678,0.00850291991353345,-0.0151351857614388,0.0181962602996124,0.857154253267797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.000794368911175049,0.00448608958579389,-0.00799836667698098,0.00958710449933108,0.859453079431561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00102252815693451,0.00578952629085222,-0.0123699996870049,0.0103249433731358,0.859812040034466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.000829070485933494,0.00475450725264574,-0.0101479047011191,0.00848976372925215,0.861572869967855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFRC,Transferrin receptor protein 1,39918,-0.000630845274747721,0.00364480896130107,-0.00777467083889782,0.00651298028940238,0.862590351655619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00156526854601654,0.00911902049072465,-0.0163080116158038,0.0194385487078369,0.86371624376462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNG,Interferon gamma,39587,-0.00181354637904503,0.0106707060024764,-0.0227281301438988,0.0191010373858088,0.865047230514618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLLT1,Protein ENL,36962,-0.00112835441037033,0.00668981894907665,-0.0142403995505606,0.0119836907298199,0.866060861066473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMP,Olfactory marker protein,36991,0.000749987249027795,0.00454163379437134,-0.00815161498794004,0.00965158948599563,0.868839478250341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNNI3,"Troponin I, cardiac muscle",39585,-0.0012969489442184,0.00785492113490726,-0.0166925943686366,0.0140986964801998,0.868857228380315
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.000743301352459684,0.00455038199207377,-0.00966205005692428,0.00817544735200491,0.870246001156587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERVV_1,,37021,0.000731223297382539,0.00450213098423941,-0.0080929534317267,0.00955540002649177,0.870979857388391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS2,Podocin,37056,-0.00149500663131478,0.00953724787840282,-0.0201880124729843,0.0171979992103547,0.875440722246566
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNLZ,DNL-type zinc finger protein,36991,0.00129435301240373,0.0083906982764621,-0.015151415609462,0.0177401216342694,0.877406739712119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.000890665620673314,0.0058029543355643,-0.0122644561183793,0.0104831248770327,0.878017850609282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.000932390681012856,0.00612950345314769,-0.0129462174491823,0.0110814360871566,0.879098376804431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLNL,Mesothelin-like protein,37039,-0.000493185439942864,0.00339199405593536,-0.00714149378957617,0.00615512290969044,0.884399731117278
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD6,Programmed cell death protein 6,39868,0.000936221587889654,0.00649720619748661,-0.0117983025591841,0.0136707457349634,0.885426457284312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMD,Osteomodulin,39931,0.000584089358553618,0.00405741744876445,-0.0073684488410247,0.00853662755813194,0.885537063850195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.000426950687229651,0.00300957765825335,-0.00632572289740621,0.00547182152294691,0.887189616763318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLINT1,Clathrin interactor 1,36962,0.000643881765752172,0.00458519661990359,-0.00834310360925886,0.00963086714076321,0.88832541215185
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPP,"Alkaline phosphatase, placental type",39788,-0.00134895608153022,0.00986648776449362,-0.0206872720999377,0.0179893599368773,0.891253057138827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMBS,Porphobilinogen deaminase,40030,0.000512094614536413,0.00400961448554173,-0.00734674977712538,0.0083709390061982,0.898374784677742
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RUVBL1,RuvB-like 1,39477,-0.00120289731709741,0.00947319571132185,-0.0197703609112882,0.0173645662770934,0.898958621009319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALMS1,Alstrom syndrome protein 1,37169,0.000530911066864573,0.00418411231642193,-0.00766994907332241,0.00873177120705155,0.899031448765227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37368,-0.000540241907223891,0.00431197836691658,-0.00899171950638038,0.0079112356919326,0.900296909388891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GJA8,Gap junction alpha-8 protein,36962,-0.000658566287072924,0.00559888781319736,-0.0116323864009398,0.0103152538267939,0.906367007616955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.000269260449602294,0.00240210909099569,-0.00497739426795384,0.00443887336874925,0.910751109100849
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTNL10,Butyrophilin-like protein 10,36962,0.000388250883470992,0.00370016706108364,-0.00686407655625293,0.00764057832319492,0.916434599731723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00046800477060082,0.00473288592620926,-0.00880845164476933,0.00974446118597097,0.921232188141165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.00035463755150272,0.00381997592175165,-0.00713251525513051,0.00784179035813595,0.926033958447459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZU1,Azurocidin,39344,0.00066155836475075,0.00715045524678726,-0.0133533339189523,0.0146764506484538,0.926286293564614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.000415803108162181,0.0045017549847674,-0.00840763666198193,0.00923924287830629,0.926409718646451
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.000303215014056465,0.00334803512200358,-0.00625893382507056,0.00686536385318349,0.927839555831185
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.000281146970158103,0.00323419566763468,-0.00605787653840588,0.00662017047872209,0.9307288834782
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB118,Beta-defensin 118,36991,0.000458112712462623,0.00542741092034641,-0.0101796126914163,0.0110958381163416,0.932733947219161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39477,-0.000244405529253316,0.00292611348281835,-0.00597958795557728,0.00549077689707065,0.933434653812212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.000396812759650007,0.00476323368282728,-0.00893912525869147,0.00973275077799148,0.933608159764352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000250082743080778,0.00301718134327503,-0.00616375817589983,0.00566359268973827,0.933943280944638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.000425340743197573,0.00528523850018148,-0.00993372671715812,0.0107844082035533,0.935859026441709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.000358108040724709,0.00459537278255169,-0.00864882261307659,0.00936503869452601,0.93788654034172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.00108422899382558,0.0139161482815887,-0.0261914216380883,0.0283598796257395,0.937899367863315
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRING1,SREBP regulating gene protein,36962,-0.000434543693192617,0.00561239649797655,-0.0114348408292267,0.0105657534428414,0.938286083640907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37021,0.000324510944660917,0.0044705150812159,-0.00843769861452225,0.00908672050384408,0.94213415427847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37147,-0.000319820093034628,0.0048950106335856,-0.00991404093486241,0.00927440074879315,0.947907514973036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.000380199869700286,0.00584667596934791,-0.0118396847696222,0.0110792850302216,0.948152393595076
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCLN,Nicalin,39587,-0.000310447154772334,0.004918133609345,-0.00994998902908853,0.00932909471954387,0.949669392918417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,39585,-0.000185219906002333,0.00299081740802285,-0.00604722202572712,0.00567678221372245,0.950619740923277
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00025738838095191,0.00427013059351141,-0.00811206758233045,0.00862684434423427,0.951936358160785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.000196464021129734,0.00330869743250514,-0.00628858294658034,0.00668151098883981,0.952651733782479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.000275635950773035,0.00468127813993065,-0.00945094110503712,0.00889966920349105,0.953048167874903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.000276879340304543,0.00525503739395275,-0.0100229939518429,0.0105767526324519,0.957981007370208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00019742578227455,0.00389333511249167,-0.00743351103820913,0.00782836260275823,0.95955844829216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP1,Dipeptidase 1,39713,0.000223735633059712,0.00441978788587215,-0.00843904862324969,0.00888651988936912,0.959627886907126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKZF2,Zinc finger protein Helios,39477,0.000410560539302991,0.00877126434725,-0.016781117581307,0.017602238659913,0.962667287815549
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM3,Paralemmin-3,37021,-0.000320069229876757,0.00708056643595539,-0.0141979794443493,0.0135578409845958,0.963945470055848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37021,0.000266815746610841,0.00594211224780059,-0.0113797242590783,0.0119133557523,0.964185698480382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.000313180432201553,0.00728513963384612,-0.0139656932501368,0.0145920541145399,0.965711001386321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000141486822701937,0.00399978899076363,-0.00798107324459865,0.00769809959919477,0.971782393964111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,36991,0.00013226356437447,0.00405666743098139,-0.00781880460034905,0.00808333172909798,0.973990879568841
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,39587,9.96757717148959e-05,0.00338703755775042,-0.00653891784147593,0.00673826938490572,0.976523137002697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6B,Ras-related protein Rab-6B,39489,0.000125269676047347,0.00438486197900765,-0.00846905980280764,0.00871959915490234,0.97720896414955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC123,Cell division cycle protein 123 homolog,36962,0.000166351142719002,0.00596346460426984,-0.0115220394816499,0.0118547417670879,0.977746281364204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,39949,4.79612708712524e-05,0.00188531768024663,-0.00364726138241214,0.00374318392415465,0.979704833837351
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NENF,Neudesin,37368,-0.000255761291662225,0.0102593724040166,-0.0203641312035348,0.0198526086202104,0.980111544404331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.000115102733334132,0.00470664738135096,-0.00910992613411375,0.00934013160078201,0.980489755333056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37056,9.30543023684002e-05,0.00403791482000022,-0.00782125874483203,0.00800736734956883,0.981614616393822
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-7.04910774186274e-05,0.00309206979826699,-0.00613094788202193,0.00598996572718467,0.981812186801734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI2,Protein-arginine deiminase type-2,39587,-0.000116254611417963,0.00531773577487938,-0.0105390167301815,0.0103065075073456,0.982558573700101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STEAP4,Metalloreductase STEAP4,36991,0.00015021056262956,0.00702065960332916,-0.0136102822598956,0.0139107033851547,0.982930483757752
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,7.40275994656617e-05,0.00470608124020151,-0.0091498916313293,0.00929794683026063,0.987449871606733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37021,6.01941023102539e-05,0.00475427190292373,-0.00925817882742026,0.00937856703204077,0.98989840077496
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37039,-0.000109920943763077,0.00966849781247082,-0.0190601766562059,0.0188403347686797,0.99092923507634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,2.53765964712721e-05,0.00236721267656232,-0.00461436024959088,0.00466511344253343,0.991446949187325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37021,2.70627487284456e-05,0.00260672274984181,-0.0050821138409615,0.00513623933841839,0.991716744211535
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-3.24261551725251e-05,0.00698164595260027,-0.0137164522222691,0.013651599911924,0.99629432040006
